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SUMMARY
Growth and monoclonal antibody production kinetics of the hybridoma cell line NBl were studied in batch, chemostat and two-stage chemostat culture.
Growth associated production kinetics were observed in batch culture when glutamine was the first nutrient to be depleted. The growth phase was extended and production increased by supplementing the culture with extra glutamine, essential and non-essential amino acids. Monoclonal antibody was produced by the viable cell population with no evidence for its release from lysing cells.
Increasing the concentration of individual amino acids in batch culture appeared to have a negative effect on cell growth and in some cases a positive effect on antibody production. The effect on production may have been indirect, due to the effect on growth rate. Under conditions of leucine and isoleucine limitation the kinetics of antibody production in batch culture were changed to growth dissociated with the majority of the antibody being produced during the decline phase of the culture. The kinetics of production were therefore dependent on the nutrient limiting growth.
In single-stage chemostat culture monoclonal antibody production was negatively growth rate associated, in contrast to the positively growth associated production generally observed in batch culture. Therefore the feasibility of optimising negatively growth associated antibody production in the second stage of a two-stage chemostat was studied.
Steady states in terms of cell concentration, nutrient utilisation and antibody production were observed in both stages of a two-stage chemostat. Monoclonal antibody production in both stages of a two-stage chemostat was negatively growth rate associated. Specific production rate increased with decreasing dilution rate. The specific production rate in the second stage was less than the first stage at an equivalent dilution rate even though the growth 
rate was less, except at dilution rates below 0.02 h"  ^ when the growth rate in stage two was negative.
Feeding the second stage of a two-stage chemostat with amino acids increased the growth rate but decreased the specific production rate. Attempts to decrease the growth rate of a fed second stage by increasing the volume and therefore decreasing the dilution rate relative to the first stage were unsuccessful. Growth rate remained high, however volumetric production was significantly increased.
The concentration of an amino acid in the medium appeared to influence its rate of utilisation in batch and chemostat culture. Increasing the concentration of an individual amino acid tended to have a negative effect on cell growth. Decreasing the concentration of an individual amino acid reduced the extent to which it was utilised. Increasing the concentration of all amino acids increased their rate of utilisation without increasing the cell concentration.
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1.0 INTRODUCTION
1.1 Development of Animal Cell Culture
The in vitro cultivation of animal cells was a natural progression from 
the early successes of tissue explantation. Wilhelm Roux (1885) 
reported the first successful explantation when he was able to maintain 
the medullary plate of a chick embryo in warm saline for a few days. 
However, Harrison (1907) is generally regarded as the father of tissue 
culture because of his experiments with nerve fibres. Harrison 
demonstrated that it was possible to keep tissues alive in vitro and also 
that the technique was capable of making a fundamental contribution to 
biological knowledge. The first paper to describe true cell culture was 
published by Rous and Jones (1916) who cultured individual chick cells 
rather than explanted tissue. Cells were dispersed from cultured pieces 
of tissue by digesting with the proteolytic enzyme trypsin. Suspensions 
of individual cells were obtained. However for continued growth and 
division the cells required the solid support of a plasma clot. The 
characteristics of growth observed were typical of an anchorage 
dependent cell, that is, losing their spherical shape, putting out processes 
and proliferating until the scattered cells connected with each other to 
form a monolayer. Owens, Gey and Gey (1954) were the first to grow 
cells in suspension. This was achieved by culturing the cells in a rotating 
drum. As a result of this it was noticed that some of the cells underwent 
a 'transformation' after which they grew spontaneously in suspension in 
stationary flasks. Animal cells can therefore be classified into one of two 
groups depending on their requirement or not for a surface on which to 
grow in culture. Anchorage dependent cells require a surface to grow 
on and are typified by primary and diploid cells. Suspension cells do not 
require a surface to grow on and are typified by transformed cell lines. 
However, primary cells which grow in suspension in vivo, such as
lymphoid cells, continue to grow in suspension in vitro. This 
classification is not absolute as cells such as Chinese hamster ovary 
(CHO) and baby hamster kidney (BHK) are able to grow in suspension 
and attached to surfaces.
1.2 Types of Animal Cell in Culture
Animal cells are divided in their classification not only by their 
requirement or not for a surface on which to grow but also by their life 
span in culture. When a cell is first isolated from animal tissue or an 
organ, a primary culture is established. Such a culture retains the 
morphology, karyotype and function observed in vivo and grows for 
only a few generations. If this primary culture successfully adapts to the 
in vitro conditions it may continue to grow for generally up to fifty 
generations after which it loses its capacity for continued replication. 
Such a culture is known as a cell line (for definition of terms see 
Schaeffer, 1984).
Cell lines sometimes spontaneously 'transform' to become a continuous 
cell line, or are transformed by infecting with viruses. Continuous cell 
lines tend not to have the same morphology as the original cell in vivo, 
they are aneuploid, have a relatively short doubling time, grow to 
higher cell concentrations than cell lines, and do not appear to have a 
limited life span. Continuous cell lines can also originate directly from 
tissue where they tend to be associated with tumours. The characteristics 
of continuous cell lines, in particular their ability to grow to high cell 
concentrations, their indefinite life span, and their generally less 
demanding requirements in terms of nutrition, have made them the 
favoured vehicle for the production of various reagents for research, 
medical, veterinary and industrial use.
The characteristics of continuous cell lines have now been widely 
exploited in mammalian cell culture. The exploitation ranges from using 
continuous cell lines as research tools in virology, toxicology and 
genetics laboratories (Klausner, 1987; Ramabhadran, 1987; Sedivy, 
1988; Tartaglia and Paoletti, 1988) to their industrial exploitation, as in 
the large scale production of foot-and-mouth disease vaccine (Radlet et 
al., 1985). However, one of the most widespread examples of the 
industrial use of continuous cell lines is their use in the production of 
monoclonal antibodies by hybridoma cell lines, developed over the last 
fifteen years.
1.3 Monoclonal Antibodies
Kohler and Milstein (1975) pioneered the science of hybridoma 
technology from which monoclonal antibodies were developed. 
Antibodies are produced in vivo by B lymphocytes in a specific response 
to a foreign antigen. However in culture, B lymphocytes exhibit the 
properties of all primary cell lines, that is limited life span and slow 
growth rate. These drawbacks were overcome by fusing a B lymphocyte 
with a continuous cell of the immune system, a myeloma, resulting in 
the production of a hybrid or hybridoma cell. Hybridomas express the 
lymphocyte's property of specific antibody production, and the 
myeloma's properties of indefinite life and rapid growth rate. It is now 
theoretically possible to produce virtually unlimited amounts of highly 
pure antibody of defined and consistent antigen specificity originating 
from a single clone of cells.
The specificity of monoclonal antibodies combined with the ability to 
produce them in unlimited quantities has resulted in their industrial
exploitation in a number of areas. Monoclonal antibodies have had 
possibly their biggest impact in the field of in vitro diagnostics with a 
U.S. market expected to be in excess of $500 million in the 1990's. 
Other areas under extensive investigation are the use of monoclonal 
antibodies for affinity purification, in vivo imaging, and 
immunotherapy with an estimated demand for kilogram amounts. For 
this reason efforts are being made at universities and by industry to 
develop efficient methods for their large scale production (Reuveny and 
Lazar, 1989).
1.4 Mammalian Cell Culture Systems
A wide range of cultivation systems for propagating monoclonal 
antibody secreting hybridomas have been developed in recent years 
(Randerson, 1985; Lydersen, 1987), however, in each system the 
restraints associated with large scale cell culture remain similar. Shevitz 
et al., (1989) identified the following areas:
1. Defining the nutrient needs of the culture.
2. Accumulation of metabolic by-products and problems associated with 
their removal in continuous culture.
3. Oxygen mass transfer.
4. Sensitivity of cells to physical and physiological constraints to 
growth.
5. Process analysis and control.
6. Maintaining cultures at an optimum cell concentration and 
productivity by limiting excessive cell growth.
The present culture systems for suspension cell cultures such as 
hybridoma cells fall into one of two categories: 1. homogeneous systems 
in well agitated reactors; and 2. heterogeneous systems which include 
hollow fibre reactors, ceramic matrix reactors, entrapment and
microencapsulation (Lambe and Walker 1987). Methods of operating 
each of the culture systems varies between batch, perfusion and 
continuous mode.
1.4.1 Heterogeneous Cell Culture
In heterogeneous systems the cells are retained in an enclosed chamber 
at a high concentration into which growth medium is perfused. The 
advantages of such a system are that a high cell concentration is 
maintained in a small volume, thereby mimicking the in vivo 
environment to a certain extent. The cells are entrapped or innnobilised 
and therefore not damaged by mechanical agitation. Feeding and waste 
product removal can be achieved without disrupting the cells. The high 
cell concentration and low volume results in a concentrated product. 
The heterogeneity of the system is its major disadvantage. Concentration 
gradients are generated inside the growth chamber resulting in non­
homogeneity in terms of cell concentration, viability and productivity 
making it nearly impossible to take a representative sample from the 
reactor. Therefore the monitoring and control of key parameters such 
as pH, dissolved oxygen tension, glutamine and other metabolites in the 
microenvironment of the cell culture are difficult.
Hybridoma cell cultures have been grown in a number of different 
heterogeneous culture systems. Microencapsulation has been developed 
as a compromise between the desire for highly concentrated perfused 
cultures and homogeneity, resulting in a semihomogeneous system in 
which the cells are entrapped inside relatively large capsules. This 
allows easy separation of cells from culture supernatant for continuous 
harvesting of product as well as the advantages of a concentrated cell 
culture. Cellular microencapsulation was first developed by Lim and
Sun, (1980) and has been applied to monoclonal antibody production 
(Jarvis and Gardina, 1983). The technique consists of placing living cells 
inside an alginate sphere, followed by bonding of a polymer to the 
sphere surface to create a semi-permeable membrane. The membrane 
allows diffusion of nutrients and waste metabolites to support high cell 
densities and retains monoclonal antibodies (Rupp et al., 1987). 
Alternatively, cells have been entrapped in agarose beads which, due to 
their porous nature, allow the diffusion of antibody into the medium 
(Nilsson, 1987). The difference between the two systems is the method 
of harvesting the product. Another method of entrapping hybridoma 
cells has been pioneered by the Verax Corporation using macroporous 
collagen microcarriers. Collagen microspheres containing cells are 
cultured in fluidised-bed reactors up to concentrations greater than 10^ 
viable cells/ml of matrix. Cell specific productivity in such a system has 
been reported to be 5 times higher than batch culture and 1.8 times 
higher than chemostat culture (Runstadler et al., 1992).
As previously stated, one of the aims of a nonhomogeneous perfusion 
system is to achieve high cell densities by mimicking the in vivo 
environment. This is typified by hollow-fibre reactors, first described 
by Knazek et al. (1972). Cells are grown in the space outside bundles of 
semipermeable fibres through which medium flows. Nutrients and 
metabolic waste products pass through the membrane while cells and 
product are retained in the extracapillary space. The cells can grow to 
very high concentrations and be maintained for extended periods of 
time, resulting in very high monoclonal antibody titre (Hirschel and 
Gruenberg, 1987). Other heterogeneous perfusion systems which have 
been applied to monoclonal antibody production include flat membrane 
reactors (Klement et ah, 1987), in which cells are located between two
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membranes. An ultrafiltration membrane on one face of the chamber 
separates cells from medium so that nutrients diffuse into the cell 
growing space while a microfiltration membrane on the opposite face 
separates cells from product, allowing cell free product to be harvested. 
Ceramic matrix reactors (Marcipar et al., 1983) and fixed bed reactors 
(Lazar et al., 1987) have also been developed in which the cells are 
immobilised within a solid support through which medium is perfused.
1.4.2 Homogeneous Cell Culture
In homogeneous systems the cells are grown in agitated suspension with 
the major advantage being culture homogeneity. Samples representative 
of the whole reactor can be readily obtained, the macroenvironment of 
the culture can be m onitored and controlled while the 
microenvironment is reduced to a minimum. Homogeneous culture 
systems, due to their ease of monitoring and control, have been more 
widely used in research laboratories to study the parameters affecting 
cells in culture than heterogeneous systems. In the industrial production 
of mammalian cell products, homogeneous systems have so far proved 
more popular than heterogeneous systems, largely due to the transfer of 
reliable tried and tested methods from microbial fermentation processes.
The simplest and therefore most common method of homogeneous 
animal cell culture is stirred batch culture. Batch culture of hybridoma 
cells has been described by numerous workers and a typical pattern of 
cell growth has emerged. When the cells are inoculated into a medium 
containing all the nutrients essential for growth, in an environment 
controlled within limits permissive for growth in terms of temperature, 
oxygen concentration and pH, the cell population will grow and divide 
at a maximum rate until a nutrient essential for growth becomes
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depleted and/or a growth inhibitory waste metabolite accumulates to a 
significant level. The cell population then enters a brief stationary phase 
followed by a decline phase. In terms of cell and antibody yields, batch 
culture tends to be the least efficient production process available 
(Reuveny and Lazar, 1989; Shevitz et a l, 1989; Runstadler et a l, 1992) 
therefore several modifications have been devised.
Fed-batch culture, in which the culture is fed intermittently or 
continuously with whole medium or specific limiting nutrients, results 
in higher cell concentrations, prolonged viability and a resultant 
increase in antibody titre. Growth and production of hybridoma cells 
have been compared in batch and fed-batch systems (Reuveny et aL, 
1986; Reuveny and Lazar, 1989), in each instance higher antibody titres 
were obtained in fed-batch compared to batch culture.
Perfusion culture may be seen as a natural progression of fed-batch 
culture. However, in this case batch culture is fed with fresh medium 
while maintaining a constant volume. The cells are physically retained in 
the reactor therefore the cell concentration constantly increases until it 
becomes limited at a high cell concentration. The advantage of such a 
system is the increased volumetric productivity achieved as a result of 
the increased cell concentration. Methods of retaining cells within the 
reactor are numerous, including rotating filters, hollow fibre bundles, 
nylon cloth and various membrane configurations (Reuveny and Lazar, 
1989). Total cell retention in perfusion systems results in a steadily 
decreasing viability of the culture, therefore methods for sustaining 
viability have been developed which include the selective recycle of 
viable cells (Hulscher et a l, 1992) and the inclusion of a cell bleed rate 
(HiUer et a l, 1993).
1.4.3 Continuous Cliemostat Culture
During batch and perfusion culture the cell population experiences 
continually changing environmental conditions in terms of nutrient 
depletion and waste metabolite and product accumulation. This results in 
changes in the cell physiology, growth rate, which is constant for only a 
short period of time during the exponential growth phase, and 
production kinetics. Such a constantly changing system is difficult to 
analyse and control. Chemostat culture differs in that it allows the cells 
to grow at a constant growth rate under environmental conditions which 
do not change with time. The culture is generally started as a batch 
system and then a continuous medium feed is initiated during the 
exponential phase of growth. Culture medium, containing cells and cell 
products, is removed at the same rate as the feed. The result is that the 
cells achieve steady state conditions in which a state of exponential 
growth is maintained. The cell population density is maintained in steady 
state by the depletion of an essential nutrient or by accumulation of a 
waste product at a toxic level. The specific growth rate is controlled by 
varying the rate of medium feed. Provided the dilution rate does not 
exceed the maximum growth rate of the cells then a physiological steady 
state is established in which any measured parameter should be constant 
with respect to time. Operating single or multiple stage chemostats 
under steady state conditions provides the opportunity to examine the 
cellular physiology of cultures growing at various rates and under 
various environmental conditions. The ability to control the growth rate 
allows the reproduction of physiological and environmental conditions 
observed only transiently during batch culture.
Theoretically, to maximise the productivity for strictly growth-
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associated production the chemostat should be operated at high dilution 
rates. For a product which follows partially growth-associated or 
growth-dissociated production the dilution rate should be low to 
optimise production. Because growth is a prerequisite for steady state 
chemostat operation, such a culture system is inappropriate for the 
production of metabolites which can only be synthesised by non­
growing cells. The use of multiple-stage chemostats adds a versatility to 
this mode of operation which allows more in depth study of growth- 
dissociated phenomena. Because the first stage of a multiple chemostat 
culture provides a continuous inoculum for subsequent stages, growth is 
only required in the first stage. Subsequent stages can therefore be used 
for the study of non growth-associated product formation. Also, because 
conditions optimal for growth and monoclonal antibody production are 
often different, variations in operating conditions between stages which 
could enhance productivity are possible.
1.5 Requirements for the Growth of Hybridoma Cells in Culture 
In order for animal cells to grow in culture, a number of minimum 
conditions must be met in terms of the physical and chemical 
environment. However, factors which influence the growth and viability 
of cells in culture also affect the production of monoclonal antibody by 
hybridoma cells. The growth requirements of animal cells in culture 
will, therefore, be discussed with particular reference to hybridoma cell 
lines and the influence of culture conditions on antibody production.
In order for cells to be grown in vitro the environment must mimic 
conditions in vivo . This entails provision of a controlled environment 
in terms of temperature, dissolved oxygen tension and pH. In addition, 
suspension cultures must be stirred to maintain homogeneity. The
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nutritional requirements of the cells are met by the components of the 
cell culture medium. The basic constituents of media include amino 
acids, glucose, vitamins, inorganic ions and a buffering system to 
maintain a stable pH. Although such media may successfully maintain 
cells in a viable condition, they are not suitable for prolonged or 
optimal cell growth. Growth factors are also generally required to 
stimulate cell proliferation. The requirement for these factors has 
traditionally been met by supplementing the basal medium with animal 
serum although a number of serum substitutes have now been identified 
allowing cells to be grown in a more defined, serum-free medium.
1.6 Effect of Culture Conditions on Hybridoma Growth and Antibody 
Production
a. Serum
The necessity of providing serum in cell culture media to promote cell 
proliferation was established (Willmer, 1958). and the role of serum 
constituents in cell proliferation is now well documented (Griffiths, 
1986; Maurer, 1986). Serum provides the cells with a variety of 
essential nutrients. These include lipids, carried by albumin, various 
growth factors, such as platelet derived growth factor and epidermal 
growth factor, the requirements for which are cell line dependent. 
Serum also contains various hormones that stimulate cell proliferation, 
cell attachment factors, transport proteins, various trace elements and 
cell growth inhibitors. The major disadvantages of supplementing media 
with animal serum are its complex and undefined nature and potential 
batch to batch variability, high cost and interference in down-stream 
processing as well as risks of contamination with virus, mycoplasma and 
bacteriophage. For these reasons a number of serum-free and protein- 
free defined media have been developed. (Barnes and Sato, 1980;
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Franek et aL, 1992; Inouye et al., 1992). The success of these media is 
very much dependent on the individual requirements of cell lines.
Hybridoma cells have been grown in serum-containing and serum-free 
media and the effect of serum on antibody production appears to be cell 
line dependent. Reducing the concentration of serum in the medium has 
been reported to have a positive effect on antibody production 
(Tharakan et a l, 1986; Schliermann et al., 1987), a negative effect (Low 
and Harbour, 1985) or no effect at all (Renard et a l, 1988; Lee et al., 
1989). The fact that antibody production has been observed when 
hybridoma cells were grown in serum-free media (Tharakan et aL, 
1986; Cole et aL, 1985; Glassy et aL, 1987) demonstrates that serum is 
not essential for antibody production.
b. Amino Acids
The amino acids required for the growth of animal cells in culture were 
originally determined by Eagle, (1955 and 1959) who identified the 
essential and non-essential requirements of mouse L cells. Thirteen 
essential amino acids were required, while sufficient non-essential amino 
acids could be made by the cell for them not to be necessary in the 
culture medium. The thirteen essential amino acids identified by Eagle 
are arginine, cystine, glutamine, histidine, isoleucine, leucine, lysine, 
methionine, phenylalanine, threonine, tryptophan, tyrosine, and valine. 
Non-essential amino acids which are also commonly added to media are 
alanine, asparagine, aspartic acid, proline, glycine and serine. The 
classification of amino acids into essential and non-essential differs 
between cell lines. For example serine, normally considered non- 
essential, is required by lymphoblastoid cell lines (Birch and Hopkins, 
1977^
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The role of amino acids in the culture media is the same as that in the 
blood stream of the whole animal, i.e. to act as precursors for protein, 
purine and pyrimidine synthesis as well as being involved in many other 
biochemical pathways (see Stryer, 1981). There is nothing to suggest 
that their role in animal cell culture differs from their role in vivo 
except for the extent to which glutamine is involved in supplying the 
energy necessary for growth as opposed to glucose (Reitzer et aL, 
1979).
The rates of utilisation and production of amino acids varies between 
different cell lines (reviewed by Thomas, 1986). However, the rate of 
glutamine utilisation is consistently 5 - 1 0  times higher than all other 
amino acids (Griffiths and Pirt, 1967; Blaker et aL, 1971; Lambert and 
Pirt, 1975). The reason for this high rate of utilisation is likely to be the 
use of glutamine as an energy source. Approximately 40% of the energy 
requirement of Chinese hamster fibroblasts (Donnelly and Scheffler, 
1976) and 30% of the energy requirement of human diploid fibroblasts 
(Zielke et aL, 1978) were found to be met by glutamine in the presence 
of excess glucose.
The supplementation of hybridoma cultures with extra essential amino 
acids has been reported to increase antibody titre in batch culture (Rupp, 
1985; Luan et aL, 1987; Duval et aL, 1989 and 1991). However, the 
specific role of individual amino acids in antibody production is not yet 
known, neither is it known whether the positive effect of supplementing 
batch cultures with extra amino acids has a positive effect on antibody 
production directly or indirectly through its effect on cell viability and 
growth rate. For example, Rupp and Geyer, (1985) suggested that the
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beneficial effect of increased amino acid concentration in the medium on 
antibody production was due to the increased osmolarity.
c. Glucose
Glucose is present in the medium as an energy source and is also 
implicated in the formation of intermediates for nucleotide, amino acid 
and lipid biosynthesis (Zielke et aL, 1978; Pouysseguv et aL, 1980; 
Romano and Connell, 1982). As with amino acids, the effect of glucose 
concentration on antibody production would appear to be indirect 
through its effect on growth. Therefore Birch et aL, (1985) and Miller 
et aL, (1988a) observed increased antibody production at low glucose 
concentrations in glucose limited chemostats, however, this also 
coincided with reduced growth rates. Glucose concentration has also 
been shown to have no effect on antibody production (Tharakan and 
Chau, 1986). Duval et aL, (1992) observed that feeding fructose instead 
of glucose during the stationary phase of a culture prolonged the life 
span of the culture which had a positive effect on antibody production, 
and demonstrated that glucose was not essential to antibody production.
d. Vitamins
The requirement for vitamins by animal cells has been reviewed by 
Higuichi, (1973). Members of the B group of vitamins are the most 
commonly included in cell culture media. Mostly they are cofactors for 
enzymes. Folic acid, nicotinamide, pantothenic acid, pyridoxine, 
riboflavin and thiamine are required by most cultured cells and included 
in most media. Although vitamins are present in the media little is 
known concerning their turnover or possible exhaustion during a 
culture. However, Duval et aL, (1992) observed vitamin limitation 
during fed batch cultures of hybridoma cells. Supplementation of the
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culture with daily feeds of vitamin solution resulted in increased cell 
survival without any significant increase in antibody production.
e. Inorganic Ions
Inorganic ions are included in animal cell culture media where they 
have essential physiological functions, such as maintaining osmotic 
pressure and membrane potentials and buffering, as well as promoting 
cell attachment or acting as cofactors for enzyme reactions. 
Concentrations of inorganic ions have traditionally been based upon 
those in general purpose balanced salt solutions. Inorganic ions essential 
for the growth of HeLa cells were shown to be sodium, potassium, 
calcium, magnesium, phosphate, bicarbonate and chloride (Eagle, 1955). 
Increased concentrations of inorganic ions have been added to 
hybridoma cultures to increase the osmolarity of the medium. Under 
conditions of osmotic stress the cells have been observed to increase 
their specific antibody production rate and decrease their specific 
growth rate (Oyass et aL, 1989; Reddy et aL, 1992; Ho et aL, 1993).
1.7 Kinetics of Monoclonal Antibody Production
The kinetics of product formation in microbial cultures has been 
discussed by Pirt (1975). The relationships between growth and product 
formation observed in microbial cultures may also be observed in 
animal cell cultures, therefore the discussion of Pirt is equally applicable 
here. In general, the relationship between growth and production falls 
into one of two classes, growth-linked and non-growth-linked. When a 
product is growth-linked, or growth-associated, the amount of product 
formed is directly proportional to the biomass formed, i.e. the specific 
production rate is proportional to the growth rate. This is demonstrated 
in batch culture by an increase in product titre during the exponential
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phase of growth, with no further increase once the population enters the 
decline phase. In chemostat culture growth-associated production is 
demonstrated by increasing specific production with increasing growth 
rate. Growth-linked processes are generally those which are essential to 
the function of the organism. Non-growth-linked, or growth- 
dissociated, product formation can be of two types, either specific 
production rate is independent of growth rate or it varies with specific 
growth rate in a complex way. In batch culture, such non-growth-linked 
product formation is demonstrated by changing specific production rate 
or no production during the exponential phase during which growth rate 
is constant, and increased production during the stationary and decline 
phases of the growth cycle. Non-growth -associated product formation 
in chemostat culture is demonstrated by product output that remains 
constant over a range of dilution rates, or that varies in a more complex 
way. In chemostat culture specific production rate which is inversely 
proportional to growth rate has also been observed where production is 
negatively growth-associated rather than growth-dissociated. This is 
demonstrated by an increase in specific production rate with decreasing 
growth rate.
Several types of production kinetics of antibody in batch culture have 
been described by various investigators and these have been classified 
into three groups by Merten et al, (1987) as follows:
Type 1: the highest specific production rate of antibody occurs before 
the beginning of the exponential growth phase, i.e. during the 
lag phase.
Type 2: the highest specific production rate of antibody occurs at the 
beginning of the exponential growth phase and during the 
stationary and decline phases.
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Type 3: a constant specific production rate of antibody is seen only in 
the exponential growth phase, with no production during 
stationary and decline phases.
Type 1 has been described by Merten et al. (1985) for one cell line and 
is explained by feedback inhibition. However, this type of production 
kinetic is not very common.
Type 2 is the most commonly observed form of antibody production 
kinetic. During the exponential phase a relatively low concentration of 
antibody is produced, this level is greatly increased during the stationary 
and decline phases. Such observations have led to the proposal that 
antibody production is growth-dissociated, i.e. growth of the cell is not 
necessary for antibody production.
Type 3 is often referred to as growth-associated production as antibody 
is produced only during the growth phase of the cell population. This 
implies that antibody can only be produced while the cell is actively 
dividing, and when growth ceases so does production.
A large number of studies have been carried out in order to try to 
optimise antibody production by a growth-associated or dissociated 
producer cell line without really understanding what causes a cell to 
demonstrate growth-associated or dissociated production characteristics. 
Therefore production decisions are made based on batch culture results 
in which the cells are growing in a constantly changing environment of 
depleting nutrients and increasing inhibitory metabolites. For example, 
perfusion systems (which hold the cell at the stationary state) are used 
for hybridoma cell lines showing Type 2 production kinetics, and batch
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or fed-batch systems (in which the cells are in the exponential growth 
phase for much of the time) for hybridoma cell lines showing Types 1 
and 3 production kinetics (Merten et aL, 1987; Reuveny and Lazar, 
1989). A long term optimisation strategy which seeks to understand 
what causes a cell to follow a particular production profile in batch 
culture, and demonstrates whether it is more than just an artifact of the 
culture system but an inherent characteristic of the cell line would be of 
obvious benefit.
Various studies on the kinetics of monoclonal antibody synthesis in batch 
culture have reached different conclusions to explain growth-associated 
and dissociated production.
1.7.1 Growth-Associated Monoclonal Antibody Production 
It has been proposed that production of monoclonal antibody is not 
growth-dissociated but is produced during the growth of the cell, stored 
in cytoplasmic vesicles and released during the death phase when the 
dead cells break up. Al-Rubeai, Rookes and Emery (1989) used 
immunogold anti-mouse IgG labelling to show that cells store the 
synthesised IgG in vesicles, and suggest that only a small amount is 
secreted during the life of the cell and that most is released after cell 
death. However, the antibody levels measured by ELISA in freeze 
thawed samples of cells taken throughout the growth cycle of a 
hybridoma cell line showing increased specific rate of monoclonal 
antibody secretion during the decline phase of growth proved to be 
small and insufficient to account for the observed kinetics (Birch et aL,
1987).
Walker et aL, (1987) investigated the timescale of antibody secretion
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and their results indicate continuous secretion of antibody with 
negligible storage. Five mouse hybridoma cell lines of diverse 
background were used in pulse-chase experiments where radiolabelled 
methionine was traced to extracellular antibody. The rate of radioactive 
antibody secretion reached a peak within two hours of the pulse; this 
was followed by a rapid decline and a negligible rate of labelled 
antibody appearance over the following days during which the cells 
died.
Velez et al. (1986) observed that a significant amount of monoclonal 
antibody was produced during the decline phase when the cells had 
already stopped growing, however they found a direct correlation 
between the concentration of living cells in the culture during the latter 
stages of propagation and the amount of monoclonal antibody produced. 
It was concluded that maintenance of cell viability was more important 
than growth rate in production of antibody.
1.7.2 Growth-Dissociated Monoclonal Antibody Production 
The growth-dissociated mode of antibody production is supported by the 
fact that conditions optimal for hybridoma growth are not necessarily 
optimal for monoclonal antibody production. Reuveny et aL, (1986) 
found that the highest cell concentration of a certain hybridoma was 
obtained at a dissolved oxygen tension of 60% air saturation, while the 
highest titre of monoclonal antibody was obtained at 25%. Miller et aL, 
(1988) found that specific monoclonal antibody production rate was 
higher at extreme pH values (pH 6.8 and 7.7) than in the pH range for 
optimal cell growth (pH 7.1 - 7.4). Merten et aL, (1985) found that 
cultivating cells below 3 7 resulted in higher titres of monoclonal 
antibody because the cells remained viable for longer while Reuveny et
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al., (1986) observed an increase in cell viability but a decrease in 
monoclonal antibody production rate. It has been generally observed 
that the growth rate of hybridomas in serum-free media is lower than in 
serum-supplemented media while the specific rate of monoclonal 
antibody secretion is higher (Glassy et al., 1988). Therefore, 
hybridomas are more efficient in terms of monoclonal antibody 
production but less efficient in terms of growth under serum-free 
conditions.
The precise relationship between cell growth and antibody production 
has so far not been elucidated, however several possible theories have 
been proposed.
1.7.3 Stress and Monoclonal Antibody Production
Animal cells are frequently exposed to environmental stress under their 
research and production conditions (reviewed by Goochee and Passini,
1988). A simple definition of stress is a change in the cells environment 
which results in a reduction in its growth rate. Stress may be induced by 
the change in environment that accompanies inoculation into fresh 
medium. Cells may experience a variety of stressful environmental 
conditions as they circulate in a large scale culture vessel, including 
exposure to local variations in dissolved oxygen concentration and 
hydrodynamic shear stress. In batch culture, nutrient depletion or the 
accumulation of toxic metabolic byproducts are sources of stress. The 
overproduction of a protein, for example monoclonal antibody, could 
also be stressful. The exposure of cells to many types of environmental 
stress results in the increased synthesis of intracellular proteins that 
apparently counteract the detrimental effects of the stress. In response to 
a sudden increase in temperature, a set of 'heat shock' proteins is
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induced in bacteria, yeast, insect, plant, and mammalian cells. In 
bacteria, many additional stress agents have been identified that cause 
the increased synthesis of specific subsets of intracellular proteins, 
including amino acid/energy limitation (the stringent response), and 
DNA damage (the SOS response). In addition to the heat shock proteins, 
a set of 'glucose regulated' proteins have been identified in eucaryotic 
cells subjected to glucose starvation. The induction of stress in 
hybridoma cultures has been shown to have a positive effect on the 
specific rate of monoclonal antibody production. This has been 
demonstrated for hyperosmotic stress (Oyass et aL, 1989; Ozturk et aL, 
1992), nutritional stress (Miller et aL, 1988; Linardos et aL, 1991) and 
environmental stress (Miller et aL, 1988). Linardos et aL, (1991) claim 
that the pattern of monoclonal antibody production in their experiments 
bears some important similarities with the production of stress proteins 
in mammalian cells, and that one of the glucose regulated stress proteins 
is identical to an immunoglobulin heavy chain binding phosphoprotein 
(BiP) which is found associated with Ig heavy and light chains in the 
endoplasmic reticulum of antibody secreting hybridoma cells (Knittler 
and Haas, 1992). However, an increase in the stress on a cell population 
results in a decrease in the growth rate. The effect of stress on 
monoclonal antibody production may therefore be indirect and the 
increase in production be due to the decreasing growth rate.
1,7.4 The Cell Cycle and Monoclonal Antibody Production 
There are four successive phases of the cell cycle, M, G l, S and G2. The 
M phase consists of nuclear division (mitosis) and cytoplasmic division 
(cytokinesis) resulting in two daughter cells which begin the interphase 
of the next cell cycle. Interphase begins with the Gl phase, in which the 
cells, whose biosynthetic activities have been greatly slowed during
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mitosis, resume a high rate of biosynthesis. The S phase begins when 
DNA synthesis starts, and ends when the DNA content of the nucleus has 
doubled and the chromosomes have replicated. The cell then enters the 
G2 phase, which ends when mitosis starts. The M phase begins with 
mitosis and ends with cytokinesis.
DNA synthesis in animal cells is confined to the S phase of the cell cycle 
while RNA synthesis is continuous throughout, except during mitosis 
when synthesis appears to stop. Protein synthesis also occurs 
continuously with only a reduction in the rate during mitosis and not a 
complete cut off.
The few reports that are available on the relationship between the cell 
cycle and monoclonal antibody synthesis suggest that the relationship is 
cell line dependent. Alshuler et al. (1986) reported the detection of 
intracellular antibody throughout the cell cycle in mouse hybridomas 
while Al-Rubeai et al. (1989) claimed production was G l phase-specific. 
Suzuki and Ollis (1989) proposed a cell cycle model based on 
experimental evidence which showed that antibody production was 
restricted to the late G l and S phases. The rate of monoclonal antibody 
production would therefore be related to the proportion of cells in those 
particular phases of the cell cycle which would in turn be affected by the 
growth rate. The model showed good correlation with the experimental 
data. However, Hayter et al. (1992) have shown for another hybridoma 
cell line that monoclonal antibody production is not restricted to the Gl 
and S phases. Linardos et al. (1991) suggest that high levels of 
environmental stress can lead to a higher percentage of cells in the Gl 
phase and therefore higher monoclonal antibody production rates based 
on reports by Suzuki et al. (1988, cited Linardos, 1991) that cells
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arrested in G l phase produce more antibody than cells in other phases 
of the cycle.
1.7.5 Control or Competition in Monoclonal Antibody Production 
The observed profiles of growth and monoclonal antibody production in 
the batch culture of a large number of hybridomas demonstrating 
growth-dissociated production suggest that while growth of the cell is 
uninhibited by nutrient limitation or toxin accumulation, monoclonal 
antibody production occurs at a low level. Once growth becomes 
inhibited the rate of monoclonal antibody production increases until it 
too becomes inhibited by nutrient depletion, toxin accumulation or cell 
lysis. Such an observation may be the result of competition or control. 
These two concepts are discussed below.
a) Control _^_
The production of monoclonal antibody may be under the i ^ r e f u ^  
control of the cell. During the exponential phase of the culture's growth 
the cell may be actively repressing the whole or a part of the 
monoclonal antibody production pathway and this repression ceases once 
the cell stops growing, or in a particular phase of the cell cycle, or when 
the cell experiences stressful conditions. However, hybridomas result 
from the fusion of two cells one of which supplies the capacity for 
infinite growth while the other supplies the genes necessary for 
monoclonal antibody production. As the resulting cell line has not 
undergone evolutionary pressure any form of global control exerted 
over monoclonal antibody production would occur by chance. It may be 
more feasible to look at growth and production in terms of competition 
rather than control.
o
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b) Competition
The pathways of growth and antibody production may be competing for 
a common pool of energy, nutrients, precursors or enzymes, resulting 
in the most efficient pathway being favoured. If the two pathways of 
growth and production have a greater or lesser requirement for a 
limiting nutrient or a greater or lesser tolerance to a toxic catabolite 
then one pathway may continue after the other has been inhibited. 
Therefore, under optimum conditions for growth, monoclonal antibody 
production is out competed because growth is essential to the survival of 
the cell while antibody production is not. However as conditions change 
during batch culture they become suboptimal for growth and the 
monoclonal antibody production pathway becomes the more 
competitive. Thus monoclonal antibody production increases as growth 
decreases. This would account for the positive effect of stress on 
monoclonal antibody production, and could explain observed growth 
phase specific monoclonal antibody production where certain phases 
require less resources for growth processes making more available for 
monoclonal antibody production.
The true relationship between growth and monoclonal antibody 
production can best be studied in chemostat culture in which the growth 
rate of the cell can be controlled while its environment is kept constant. 
Two-stage chemostat culture is theoretically the ideal medium for 
studying the growth-dissociated kinetics of antibody production. The 
aim of this project was therefore to identify the kinetics of growth and 
production of the NB1 hybridoma cell line in batch culture and to assess 
the feasibility of using two-stage chemostat culture to study in greater 
depth the factors affecting the kinetics of antibody production. If stable 
steady states could be demonstrated in two-stage chemostat culture and
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antibody production was shown to be growth-dissociated, the possibility 
of \^timigmg production independently of growth in the second stage 
would be explored.
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2.0 MATERIALS and METHODS
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2.1 Cell Line
The cell line used in this study was the mouse hybridoma, NBl, derived 
from a fusion between mouse spleen cells primed by human red blood 
cell group B antigen and a mouse myeloma NSl cell line (Sacks and 
Lennox, 1981). The antibody produced was an IgM which has 
agglutinating activity against the group B antigen of human red blood 
cells.
2.2 Cell Propagation
2.2.1 Storage and Recovery of Frozen Cell Stocks
Cells cultured in serum-supplemented or serum-free media were 
centrifuged (400g for 5 minutes) and resuspended in cell storage 
medium at a concentration of between 1 and 2 x 10^ viable cells/ml. 
Cell storage medium consisted of DMBM supplemented with 20% (v/v) 
foetal calf serum and 10% (v/v) dimethyl sulphoxide (Sigma, D-5879). 
The cells were then dispensed into 2ml labelled freezing ampoules and 
placed at -70^C overnight before being transferred to liquid nitrogen, 
-196% .
Recovery of cells from liquid nitrogen storage was achieved by rapidly 
thawing an ampoule and slowly diluting the cells to 10ml with growth 
medium. After centrifugation (400g for 5 minutes) the cells were 
resuspended in 10ml of fresh growth medium, transferred to a tissue 
culture flask, gassed with 5% carbon dioxide in air and incubated at 
36.5% .
2.2.2 Growth Medium
Cell stocks were grown in Dulbecco's modified Eagle's medium 
(DMEM) supplemented either with 5% foetal calf serum (Imperial
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Laboratories) or a serum-free supplement mix. The DMEM was 
supplied in powdered form by Gibco (Cat. No. 074-02100) and was 
made up following their recommendations after which it was sterilised 
by filtration through a 0.2 jxm filter. DMEM was used in all batch and 
chemostat experiments performed unless otherwise stated. The 
formulation of DMEM is given in Appendix 1. Where specified, culture 
medium was supplemented with MEM amino acid solution (Appendix 
2.), MEM Non-essential amino acid solution (Appendix 3.) and MEM 
Vitamin solution (Appendix 4.), all supplied by Gibco.
2.2.3 Cultivation of a Cell Stock
A 100ml stock of growing cells was maintained in a spinner culture 
consisting of a 250ml Duran containing a magnetic flea placed on a 
stirrer base and incubated in a 5% carbon dioxide air atmosphere at 
36.5^C with a loosened cap to maintain the pH between 7.0 and 7.2. 
Diffusion of carbon dioxide into the bottles did not always adequately 
maintain the pH, in which case cultures were directly gassed with a 5% 
carbon dioxide in air mixture and the bottles sealed. The cells were 
diluted at intervals to maintain a concentration between 1.0 and 6.0 xlO^ 
viable cells/ml. Cells were removed from the stock culture to initiate 
expansion cultures.
2.2.4 Determination of Cell Concentration
Cell concentration was determined using a Fuchs-Rosenthal 
heamocytometer. The culture samples were first diluted in 0.04% w/v 
solution of erythrosin B stain (Sigma, E-7379) in saline, the dilution 
varying between 1:4 and 1:10 depending on the concentration of cells 
present. Dead cells stained red while live cells remained colourless. All 
counts were performed in duplicate. The standard deviation of all cell
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counts was within
2.2.5 LH Fermentation 2000 Series Fermenter
Batch and chemostat experiments were performed using an LH 2000 
series fermenter fitted with a two litre working volume glass vessel. 
Temperature was controlled at a set-point of 36.5®C by passing water 
through a finger from a thermostatically controlled supply. The culture 
was stirred at a rate of 60 rpm by a top driven agitator fitted with a 
single Rushton turbine impeller. Dissolved oxygen tension (DOT) was 
measured using an autoclavable polarographic oxygen electrode 
(Ingold). The DOT was controlled at 40% of air saturation by the 
sparging of air into the culture when required. pH was monitored by a 
pH electrode (Ingold) and controlled between setpoints of 7.0 - 7.2 by 
the addition of carbon dioxide or alkali (IM NaOH). Carbon dioxide 
was used to reduce the pH of the culture after it was discovered that IM 
HCl resulted in death of the cells possibly due to leaching out of 
chromium ions from the stainless steel ports.
A single-stage chemostat was set up by using a peristaltic pump to feed 
medium from a refrigerated reservoir into the culture vessel. The 
culture volume was kept constant by pumping excess culture out through 
a weir in the culture vessel.
A two-stage chemostat consisted of two LH 2000 fermenters in series 
where the overflow from the first stage was fed into the second stage 
(Figure 2.1).
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Figure 2.1 : The configuration of a Two-Stage Chemostat
Medium feed rates were measured by a pipette fitted to the feed line via 
a T ' piece connector.
2.3 Biochemical Analyses
During the course of a fermentation samples were removed from the 
culture and, after centrifugation to remove cells and cellular debris, 
were dispensed into 1.5ml vials and stored at -20^C. These samples 
were used for biochemical analyses and determination of antibody 
concentration.
2.3.1 Glucose Assay
Glucose analysis was carried out using a GM7 analyser (Analox 
Instruments Ltd.). The GM7 analyser functions by measuring the 
oxygen change when oxidoreductase enzymes (oxidases) react with their 
substrate under controlled semi-anaerobic conditions. Thus, for the 
glucose/glucose oxidase (GO) system: 
beta-D Glucose + O2  —GO— > Gluconic acid + H2 O2
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Under appropriate conditions the resultant oxygen change is monitored 
by an oxygen sensor. The total change and the maximum rate of change 
are both proportional to the substrate concentration initially present. 
The analyser was calibrated with a 8 mM (144.1 mg/dl) standard and 
checked with a 300 and 500 mg/dl standard. A lOp.1 sample was used 
and each sample was assayed in duplicate with a standard deviation of no 
more than +/-10%. The method followed was as supplied by Analox 
Instruments Ltd (Analox Instruments Ltd Technical Note Glu/6.90).
2.3.2 L-Lactate Assay
Lactate analysis was carried out using a GM7 analyser, employing the 
same principles as for the glucose analysis. In this case L- 
lactate: Oxidoreductase (LCD) catalyses the oxidation of L-lactate to 
pyruvate:
L-lactate + O2  —LCD—> Pyruvate + H2 O2
LCD is highly specific for L-lactate and under appropriate conditions 
the maximum rate of oxygen consumption is directly related to lactate 
concentration. A 7|Li1 sample was used and calibration was carried out 
with a 8.0 mM (72.1 mg/dl) lactate standard. Calibration is checked by a 
second standard of 40 mg/dl. Each sample was assayed in duplicate with 
a standard deviation of no more than ‘^ /-10%.The method followed was 
as supplied by Analox Instruments Ltd (Analox Instruments Ltd 
Technical Note LII/2.91).
2.3.3 Glutamine Assay
Glutamine analysis was carried out using the Boehringer Mannheim 
glutamic acid assay kit (Cat. No. 130 092). In the presence of the 
enzyme glutamate dehydrogenase (GIDH), L-glutamic acid (L- 
Glutamate) is deaminated oxidatively by nicotinamide-adenosine
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dinucleotide (NAD) to a-ketoglutarate. In the reaction catalysed by 
diaphorase and the NADH formed converts iodonitro tétrazolium 
chloride (INT) to formazan which is measured in the visible range at 
492 nm. This assays for L-glutamate. To assay for L-glutamine, 
asparaginase (Grade V Asparaginase. Sigma Cat. No. A4887) was added 
to the above reaction mixture, converting L-Glutamine into L- 
Glutamate resulting in the formation of more formazan and a 
subsequent increase in absorbance at 492 nm. The method followed was 
as supplied by the manufacturers (Boehringer Mannheim method sheet 
691.150.248 932). Each sample was assayed in duplicate with a standard 
deviation of no more than +/-10%.
2.3.4 Ammonia Assay
Ammonia concentration was determined using a Sigma Diagnostics 
ammonia determination assay (Cat. No. 170-10). The method is based 
on the reductive amination of 2-oxoglutarate, using glutamate 
dehydrogenase (GLDH) and reduced nicotinamide adenine dinucleotide 
(NADH) as follows:
2-Oxoglutarate + NHg + NADH —LDH—> Glutamate + NAD 
The decrease in absorbance at 340 nm, due to the oxidation of NADH, is 
proportional to the ammonia concentration. The method followed was as 
supplied by the manufacturers (Sigma Diagnostics Procedure No. 171- 
UV). Each sample was assayed in duplicate with a standard deviation of 
no more than "•“7-10%.
2.3.5 Amino Acid Analysis
The amino acid concentrations in culture supernatant were analysed 
using a Waters PICO.TAG Amino Acid Analyser system (Buzsàky, 
Zachrisson and Boork, 1993). This is an automated gradient liquid
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chromatography system designed for analysis of amino acids.
The method involves two steps:
1. pre-column derivitisation of the sample
2. analysis hy reverse phase high pressure liquid chromatography 
(HPLC).
In the first stage the samples were derivitised with phenylisothiocyanate 
(PITC) to produce phenylcabamyl (PTC) amino acids. In the second 
stage the amino acids were separated using a CIS column and their 
elution detected at 440nm. The procedure followed is given in Appendix 
5.
2.4 Double-Antibody Sandwich ELISA for Estimation of Mouse IgM 
The concentration of IgM monoclonal antibody in cell culture 
supernatant was determined by douhle-antihody sandwich ELISA. A 
standard protocol was followed (supplied hy Celltech) which was 
optimised for the particular reagents used in our laboratory. The ELISA 
was optimised for antibody coating concentration, conjugate 
concentration, standard concentration and substrate incubation time 
(Catty and Raykundalia, 1988).
1. Coating Antibody: less than adequate coating of the solid phase will 
reduce the sensitivity of the ELISA and allow non-specific binding of 
the conjugate to the plastic. Over-coating may lead to non-specific 
trapping of the conjugate. The optimum concentration of coating 
antibody was therefore determined.
2. Antibody-Enzyme Conjugate: a conjugate should show a) high 
antibody titre and avidity so that the conjugate can be used at a high 
dilution to give minimal non-specific binding effects; b) specificity at a 
working dilution; c) low background readings; d) adequate enzyme 
activity. The conjugate antibody concentration was therefore optimised
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in terms of working dilution, low background reading and specificity.
3. Standard Antigen Dilutions: the concentrations of standard antigen 
which gave a linear standard curve was determined.
4. Substrate Incubation Time: the optimal incubation time results in the 
greatest difference between positive and negative readings, and between 
positive readings of different concentrations. Keeping to the same 
incubation time also allows standardisation between tests. The ELISA 
protocol is given in Appendix 6.
2.5 Cell Cycle Analysis
Analysis of the percentage of a cell population in various stages of the 
cell cycle was performed on a Becton Dickson FACS can System. This is 
an automated cell analyser consisting of a bench-top flow cytometer and 
computer system. The system identifies and characterises cells as they 
pass through a focused laser beam one at a time. DNA cell cycle analysis 
was carried out using single colour fluorescence, performed on a single 
cell suspension stained with propidium iodide.
A cell suspension of approximately 1 x 10^ cells/ml was fixed in 70/30 
ethanol and PBS followed by centrifugation and resuspension in PBS 
containing DNase free RNase (Boehringer Mannheim, Cat. No. 1119) 
and propidium iodide (Sigma). All RNA present is digested while the 
DNA is stained by the propidium iodide. The amount of dye that binds 
is proportional to the amount of DNA present in the cell which is 
related to the stage of the cell cycle the cell has reached. The cell 
suspension was then analysed by the FACS can and the fluorescence 
measurements were accumulated to form a distribution of DNA content. 
The final results were analysed by the SPIT software program which 
calculates the percentage of the cell population present in the Gl/GO, S,
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and G2/M phases of the cell cycle.
3.0 KINETICS OF GROWTH, ANTIBODY 
PRODUCTION AND NUTRIENT UTILISATION 
IN BATCH CULTURE
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3.1 SUMMARY
The kinetics of growth, antibody production, and nutrient utilisation 
demonstrated by the NBl hybridoma cell line in batch culture were 
studied. A typical batch culture was compared with cultures fed with 
extra glutamine and supplemented with extra essential and non-essential 
amino acids. The effects of the various nutrient additions on growth and 
antibody production kinetics were studied. Different methods of 
analysing the data for specific growth rate and specific production rate 
were compared. Amino acid analysis was performed on samples from a 
typical batch culture and glutamine-fed batch culture. Specific rates of 
utilisation or production of the various amino acids were calculated. The 
distribution of cells in the cell cycle during the course of a typical batch 
culture was also studied. Glutamine was an essential nutrient for cell 
growth and monoclonal antibody production. Feeding a culture with 
extra glutamine and other essential and non-essential amino acids 
resulted in an increase in both cell growth and antibody produced. The 
majority of the antibody was produced during the growth phase of the 
culture and was related to the time integral of viable cell concentration 
(viable cell hours) in a growth-associated manner. Accumulation of the 
cell population in the Gl/GO phase of the cell cycle towards the end of 
the batch culture did not result in an increased rate of monoclonal 
antibody production.
3.2 INTRODUCTION
In batch culture of hybridoma cells, when the cells are inoculated into a 
medium containing all the nutrients essential for growth, in an 
environment optimised in terms of temperature, oxygen and pH, the cell 
population will grow and divide at a maximum rate until a nutrient 
essential for growth becomes depleted and/or a growth inhibitory waste
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metabolite accumulates to a significant level. The cell population then 
enters a brief or prolonged stationary phase followed hy a decline phase.
The various types of production kinetics of antibody in batch culture 
have been classified into three groups by Merten et al. (1987) as 
follows:
1) the highest specific production rate of antibody occurs at the 
beginning of the exponential growth phase.
2) the highest specific production rate of antibody occurs at the 
beginning of the exponential growth phase and during the 
stationary and decline phases.
3) a constant specific production rate of antibody is seen only in the 
exponential growth phase, with no production during stationary and 
decline phases.
Batch cultures of the NBl hybridoma were carried out in serum- 
supplemented and serum-free media and the growth and monoclonal 
antibody production profiles determined. The effects of increased 
concentrations of various essential and non-essential amino acids on cell 
growth and production were also investigated. Specific rates of growth, 
monoclonal antibody production, nutrient utilisation and waste 
metabolite production were calculated.
3.3 AIM
The aim of this set of experiments was to ascertain the growth and 
production kinetics of the NB1 hybridoma cell line under batch culture 
conditions, and to compare different methods of analysing the data.
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3.4 RESULTS AND DISCUSSION
A series of experiments was set up in order to study the effects of 
increases in glutamine concentration, and other essential and non- 
essential amino acids on growth and production in batch culture as 
follows:
1. Control; cells inoculated into DMEM plus serum.
2. Glutamine-Fed; 4mM of glutamine added towards the end of the 
exponential phase of growth.
3. Supplemented with 2X MFM amino acids and glutamine-fed.
4. Supplemented with 2X MFM amino acids and IX MFM non-
essential amino acids and glutamine-fed.
5. Supplemented with 2X MFM amino acids and IX MFM non-
essential amino acids without heing glutamine-fed.
3.4.1 Typical Batch Culture
A typical unfed batch culture is shown in Figure 3.1. Increasing viable 
cell concentration was accompanied by decreasing glucose and glutamine 
concentrations and increasing lactate, ammonia and monoclonal antibody 
concentration. The point at which the culture entered the decline phase 
coincided with the point at which glutamine became depleted. After this 
point there was no further increase in viable or total cell concentration, 
glucose utilisation, lactate or ammonia production. Monoclonal antibody 
production occurred predominantly during the growth phase with 30% 
being produced during the decline phase.
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Figure 3.1a Batch Culture of NBl Cells. Profiles of cell concentration
and antibody accumulation.
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Figure 3.1b Batch Culture of NBl Cells. Profiles of glutamine and 
glucose utilisation and ammonia and lactate production.
41
This result indicates that glutamine was essential for cell growth and the 
requirement for glutamine was not being met by another source.
The majority of the monoclonal antibody production occurred during 
the growth phase of the culture, typical of growth-associated 
production. However, production did not cease immediately the culture 
entered the decline phase but continued for a short while afterwards. 
This may have been due to production continuing through a brief 
stationary phase, or a delay between synthesis and secretion of the 
antibody, or simply that although the majority of antibody is produced 
during the growth phase of the culture, growth and production are not 
limited to the same extent by depletion of some nutrient (such as 
glutamine) or accumulation of a toxin. Dalili, Say les, and Ollis (1990) 
observed that the time of exhaustion of glutamine coincided with the 
cessation of both cell growth and monoclonal antibody production up to 
a certain initial concentration of glutamine. When glutamine was present 
in the medium at a low concentration antibody production was growth- 
associated. When the initial concentration of glutamine was increased, 
glutamine was still present in the medium when the culture entered the 
decline phase and production continued in a growth-dissociated manner. 
They suggested that the presence of glutamine, rather than continued 
cell growth, was necessary for monoclonal antibody production.
3.4.2 Batch Culture With Glutamine Feed
To assess whether cessation of growth and production was due to 
glutamine depletion a batch culture of NBl hybridomas was fed with 
extra glutamine. The results are shown in Figure 3.2. The extra 
glutamine was added as a single 'shot' during the batch culture (at the
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end of ’exponential phase') to reduce the amount lost through 
spontaneous decomposition in the medium into pyrrolidone-carboxylic 
acid and ammonia (Tritsch and Moore, 1962). Rather than entering a 
rapid decline phase immediately after the growth phase as in the unfed 
culture, the viable cell population stabilised in a prolonged stationary 
phase. During the stationary phase the extra glutamine was utilised, as 
was glucose to a lesser extent. Monoclonal antibody production 
continued through the stationary phase in what appeared to be a growth- 
dissociated manner as the viable cell population was stationary. 
However, the increase in total cell concentration indicates that although 
the viable cell population was stationary, individual cells were still 
dividing.
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Figure 3.2a Glutamine-Fed Batch Culture of NBl Cells. Profiles of cell 
concentration and antibody accumulation.
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Figure 3.2b Glutamine-Fed Batch Culture of NBl Cells. Profiles of 
glutamine and glucose utilisation and ammonia and lactate production.
Monoclonal antibody production was therefore still associated with a 
growing viable cell population. This suggests that glutamine was 
essential for maintaining a viable cell population and that the continued 
production of monoclonal antibody depended on the presence of a viable 
cell population and/or on the presence of glutamine, and continued 
growth.
3.4.3 Amino Acid Supplemented Batch Culture
A batch culture of N Bl hybridoma cells was also carried out in 
DMEM.FCS supplemented with extra minimum essential medium 
(MEM) essential amino acids (Appendix 2) and non-essential amino 
acids (Appendix 3) and the effect on the kinetics of growth and 
production were observed.
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When a batch culture was supplemented with extra MEM essential 
amino acids and fed with extra glutamine the cells entered a prolonged 
stationary phase, similar but on a larger scale to the glutamine-fed 
culture, during which a large amount of monoclonal antibody was 
produced (Figure 3.3).
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Figure 3.3 Glutamine-Fed Batch Culture of NBl Cells Supplemented 
with 2X MEM Amino Acids. Profiles of cell concentration and antibody
accumulation.
Once again the total cell concentration was increasing even though the 
viable cell population was stationary or decreasing. Monoclonal 
antibody production therefore appeared to be associated with the viable 
cell population once again.
When extra MEM essential and non-essential amino acids were present 
in a culture which was fed with glutamine, an increased maximum 
viable cell concentration was observed compared with the control and
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non-supplemented glutamine-fed cultures, as was an increased maximum 
monoclonal antibody concentration (Figure 3.4).
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Figure 3.4 Glutamine-Fed Batch Culture of NBl Cells Supplemented 
with 2X MEM and IX Non-Essential Amino Acids. Profiles of cell 
concentration and antibody accumulation.
A brief stationary phase was observed followed by a decline phase. 
However, although glutamine was depleted by the end of the culture, the 
start of the decline phase did not coincide with glutamine depletion and 
may have been associated with depletion of another nutrient or 
accumulation of an inhibitory waste metabolite. Although there was 
some monoclonal antibody production during the decline phase, the 
majority was produced during the stationary phase.
When extra essential and non-essential amino acids were present in a 
culture which was not fed with extra glutamine (Figure 3.5), the
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maximum viable cell concentration was slightly less than the control 
while total monoclonal antibody production was slightly greater. Once 
again growth and production ceased when glutamine became exhausted.
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Figure 3.5 Batch Culture of NBl Cells Supplemented with 2X MEM 
and IX Non-Essential Amino Acids. Profiles of cell concentration and
antibody accumulation.
Similar results to these have been obtained by Luan et al. (1987) who 
extended the stationary phase of cell growth for several days, and 
thereby increased the final monoclonal antibody concentration, by 
adding essential amino acids, glutamine and vitamins. However, in the 
control culture growth was limited by an essential amino acid other than 
glutamine. Similar results have also been reported by Duval et al. (1989 
and 1991)
3.4.4 Growth Kinetics
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Before discussing nutrient utilisation and monoclonal antibody 
production kinetics in batch culture it is important to have a clear 
understanding of what is meant by growth and how rates of growth are 
calculated. Growth, according to the Concise Oxford Dictionary, is 
"increase in size or value", this is described in biological terms by 
Brock et al. (1984) as "an orderly increase in all the cellular constituents 
and structures of an organism". In most microorganisms and animal cell 
cultures this increase continues until the cell divides into two new cells.
An important distinction must be made between the growth of individual 
cells and the growth of populations of cells. The growth of a cell is an 
increase in its size and weight and is usually a prelude to cell division. 
Population growth, on the other hand, is an increase in the number of 
cells as a consequence of cell growth and division. Because of the 
difficulty in studying the growth of individual cells quantitatively almost 
all growth and production studies of hybridomas are population studies. 
For this reason Type 2 production kinetics described by Merten et al. 
(1987) may appear to be growth-dissociated because monoclonal 
antibody production occurs principally during the lag and stationary 
phases of batch culture when the viable cell population is not growing 
but individual cells may be. This would be demonstrated by an 
increasing total cell population provided that the rate of increase in total 
cell concentration was greater than the rate of lysis of dead cells. Type 3 
production kinetics are generally referred to as growth-associated 
because most of the monoclonal antibody is produced during the 
exponential phase of the culture and production ceases when population 
growth ceases due to nutrient depletion or metabolite inhibition.
To determine the effect of growth rate on nutrient utilisation and
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monoclonal antibody production it is first necessary to assess how 
growth rate is defined. Most of the following equations are taken from 
Pirt (1975).
In batch culture of hybridoma cells, when the cells are inoculated into a 
medium containing all the nutrients essential for growth, in an 
environment that is permissive for growth, the cell population will grow 
and divide at a maximum rate until a nutrient essential for growth 
becomes depleted and/or a growth inhibitory waste metabolite 
accumulates to a significant level. The cell population then enters a brief 
or prolonged stationary phase followed by a decline phase.
The basic measure of growth rate is the specific growth rate (p.) which 
states that the increase in biomass (dx) is proportional to the amount 
present (x) and to the time interval (dt), provided that the time interval 
is infinitely small:
|i = dx /d t. 1/x (equation 3.1)
In reality it is very difficult to perform an experiment in which samples 
are taken during an infinitely small time period, making this equation 
difficult to apply. Alternatively, an approximation to p can be obtained 
by replacing d with delta, however this assumes linear growth between 
two time points and introduces inaccuracies into the calculation. When p, 
is constant, integration and rearrangement of equation 3.1 gives:
p = (Inx  ^- lnxQ)/t (equation 3.2)
where x  ^ is biomass concentration at time (t), and xq is biomass
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concentration at time (0).
This allows the calculation of specific growth rate between two time 
points, assuming exponential growth. A plot of In x against time should 
therefore give a straight line with slope jLi. The validity of these 
assumptions was tested against the unfed (Figure 3.6) and glutamine-fed 
(Figure 3.7) batch cultures as shown below.
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Figure 3.6a Batch Culture of NBl Cells. Inx (viable cells) against Time
with a slope of p,.
Figure 3.6a demonstrates that during the growth phase of the batch 
culture a constant exponential growth rate of 0.039h“l was observed, as 
indicated by the high correlation between Inx and time.
In order to test whether the value for p accurately described the growth 
rate of the population, the derived viable cell concentration (calculated /
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from the known concentration of viable cells at the begining of the 
culture and the calculated growth rate from Equation 3.2) and the actual 
concentration of viable cells were compared (Figure 3.6b).
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Figure 3.6b Batch Culture of NBl Cells. Observed and calculated 
values for viable cell concentration.
Up to 35 hours the derived growth is an accurate reflection of the 
actual growth, while between 35 and 48 hours the growth is under 
estimated and over estimated between 48 and 60 hours. Use of the 
growth equation is obviously not applicable to the decline phase of the 
culture because cell death is not necessarily exponential.
In the glutamine-fed culture (Figure 3.7), equation 3.2 was once again 
shown to accurately derive the growth of the viable cell population 
during the exponential phase, but was not applicable to the stationary 
and decline phases as neither demonstrate exponential growth or death.
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Figure 3.7a Glutamine-Fed Batch Culture of NBl Cells. InX (viable 
cells) against Time with a slope of jui.
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Figure 3.7b Glutamine-Fed Batch Culture of NBl Cells. Observed and 
calculated values for viable cell concentration.
52
The validity of this method of calculating specific growth rate may be 
questioned when a culture is not growing at a constant exponential rate, 
but is also not a true reflection of the specific growth rate of a culture 
which is less than 100% viable. This is demonstrated most noticeably by 
the glutamine-fed batch culture (Figure 3.7) when during the 
'stationary' phase the viable cell population is not increasing and 
therefore is calculated as a negative growth rate, but the total cell 
population is still increasing significantly. For a more accurate 
estimation of specific growth rate equations 3.1 and 3.2 are modified to 
allow for the generation of viable and non-viable cells from the viable 
biomass (Pirt, 1975) as follows:
\i = dx^/dt. 1/Xy (Equation 3.3)
p. = (In (x^  ^- x^ Q + XyQ) - In XyQ)/t (Equation 3.4)
Therefore the change in total biomass (X|.|. - x^ -q) between time 0 and 
time t results from the viable cell biomass present at time 0 (x^q). A 
plot of In (X|-^  - x^ Q + XyQ) against time should therefore have a slope of 
p.
Equation 3.4 was tested against the data from the unfed (Figure 3.8) and 
glutamine-fed (Figure 3.9) batch cultures.
Equation 3.4 was derived from Equation 3.3 assuming that there was no 
change in the number of non-viable cells, between tO and tt, or in the 
death rate constant.
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Figure 3.8a Batch Culture of NBl Cells. ln(Xtt-XtO+XvO) against Time
with a slope of [i, accounting for the generation of viable and non-viable
cells.
2.5
0.5
12020 40 60 100 140 160
Time (hours)
Calculated Xt Observed Xt
Figure 3.8b Batch Culture of NBl Cells. Observed and calculated total
cell concentration.
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The validity of equation 3.4 is demonstrated by the high correlation 
exhibited in Figure 3.8a, and the closeness of fit between observed and 
calculated total cell concentrations shown in Figure 3.8b. However, even 
this calculated growth rate slightly underestimates the cell concentration 
at 48 hours. The deviation between the calculated and observed cell 
concentrations may be accounted for by error in cell counts which are 
typically
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Figure 3.9a Glutamine-Fed Batch Culture of NBl Cells. ln(Xtt- 
XtO+XvO) against Time with a slope of jl, accounting for the generation
of viable and non-viable cells.
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Figure 3.9b Glutamine-Fed Batch Culture of NBl Cells. Observed and 
calculated total cell concentration.
Figure 3.9 demonstrates the validity of the application of equation 3.4 to 
a culture with an extended stationary phase, as in the glutamine-fed 
batch culture.
A disadvantage of the above method of calculating growth rate is that by 
taking logarithms small deviations are eliminated and a straight line is 
forced where a straight line does not necessarily exist. This method is 
therefore insensitive to small fluctuations in growth rate during the 
exponential phase as well as the point at which the cell population enters 
the stationary phase. Equation 3.3 is by its nature responsive to 
fluctuations in growth rate but is not particularly practical. Its 
application may be made practical however by fitting a curve to the data 
points and applying the equation to the curve. This has been achieved by 
employing a partial cubic spline computer program (Oner et a l, 1986,
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Bushell et a l, 1993, McDermot et al,, 1993). The program fits an 
equation through three points, i.e. 1, 2, and 3. It then fits an equation 
through points 2, 3, and 4 and so on through all the points. As the curve 
fitting proceeds the slopes are calculated in order to yield the rates of 
change by applying equation 3.1. This method allows the estimation of 
both volumetric and specific rates of growth. Figure 3.10 shows the 
curve of specific growth rate obtained by this method for unfed and 
glutamine-fed batch cultures applying equation 3.3 to the partial cubic 
spline curve (95% fit).
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Figure 3.10a. Batch Culture of NBl Hybridoma Cells. 
Specific growth rate calculated by partial cubic spline method
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Figure 3.10b. Glutamine-Fed Batch Culture of NBl Hybridoma Cells. 
Specific growth rate calculated by partial cubic spline method
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As would be expected, maximum growth rate calculated in this way is 
higher than maximum growth rate calculated using Equation 3.4, as it is 
much more sensitive to fluctuations in the growth rate as shown in the 
Table 3.1.
Table 3.1
Comparison of | i  max Calculated Using Partial 
Cubic Spline and Equation 3 .4
Batch Culture Partial Cubic Spline Equation 3.4
Unfed 0 .0 5 0 0 .0 4 0
Gin Fed 0 .0 5 0 0 .0 4 0
Essential Amino 
Acids and Gin Fed 0 .0 5 5 0 .0 3 5
Essential and Non 
Essential Amino 
Acids
0 .0 6 0 0 .0 3 6
Essential and Non- 
Essential Amino 
Acids and Gin Fed
0 .0 6 0 0 .0 3 9
3.4.5 Kinetics of Monoclonal Antibody Production 
From the graphs shown above (Figures 3.1a and 3.1b) it is apparent that 
the majority of the monoclonal antibody is produced during the 
exponential phase of cell growth, and once glutamine becomes depleted 
growth ceases, shortly followed by production. In a culture fed with 
extra glutamine at the end of the exponential phase, growth and 
production continued during the stationary phase. The association 
between growth and antibody production would therefore not appear to
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be strictly growth-associated, nor necessarily growth-dissociated. The 
characteristics of production may in fact be dependent on the supply of 
glutamine in the medium. Whether production can occur in the absence 
of growth can only be tested in a non-growing culture in the presence of 
all the nutrients necessary for production.
A theory has been proposed that monoclonal antibody is not actively 
secreted by viable cells but stored in vesicles and released by dead cells 
in some cell lines (Al-Rubeai, Rookes and Emery, 1989), If this were 
the case for this cell line, monoclonal antibody production would not be 
expected to cease shortly after the cells entered the decline phase in the 
unfed culture. It is therefore likely that in the glutamine-fed culture 
monoclonal antibody is being actively secreted from the viable cell 
population rather than being released from dead cells breaking up.
Renard et al. (1988) related monoclonal antibody production kinetics to 
the time integral of viable cell concentration in batch culture to provide 
evidence that monoclonal antibody is secreted by viable cells rather than 
released by dead cells. If their hypothesis is correct then the titre of 
antibody in the supernatant at any time should be proportional to the 
time integral of viable cell concentration. Thus, the production curve 
and the integral curve should show analogous profiles and regression of 
one over the other should be linear. This hypothesis has been tested 
against these data and the results are shown in Figure 3.11. The results 
show that this holds true for the glutamine-fed and unfed cultures.
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Figure 3.11 The relationship between the time integral of viable cell 
concentration and antibody concentration in batch culture of NBl cells.
Evidence for the growth-associated nature of monoclonal antibody 
production is obtained from a partial cubic spline plot of volumetric 
antibody production and volumetric viable cell production showing that 
peaks in the two curves coincide (Figure 3.12). The peaks are displaced 
in the glutamine-fed batch culture because growth of viable cells in the 
stationary phase is not accounted for.
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Figure 3.12a. Batch Culture of NBl Hybridoma Cells 
Volumetric Viable Cell and Antibody Production Rates
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Figure 3.12b. Glutamine-Fed Batch Culture 
Volumetric Viable Cell and Antibody Production Rates
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3.4.6 Specific Production Rate of Monoclonal Antibody
The specific rate of product formation during an infinitely small time
interval (dt) in batch culture is given by:
qp = dp/dt. 1 / ^ ^  (Equation 3.5)
If qp is constant it may be calculated from the following equation (Pirt 
1975):
qp = p - Pq / XQ(eP^ i^-l) / jLL (Equation 3.6)
This may be simply calculated from the slope of the curve when the 
time integral of viable cells is plotted against antibody production, as in 
Figure 3.11.
qp was therefore calculated by applying equation 3.5 to a partial cubic 
spline plot of the viable cell and product data, and by calculating the 
slope of the curve from Figure 3.11. The results for the glutamine-fed 
and unfed batch cultures are shown in Figure 3.13 and Table 3.2 and 
3.3.
Figure 3.13 is a plot of the specific growth rate and specific antibody 
production rate for the glutamine-fed and unfed batch culture. Table 3.2 
gives the data for specific antibody production rate calculated from the 
slope of the curve of viable cell hours against antibody concentration 
shown in Figure 3.11 for the glutamine-fed and unfed batch culture. 
Table 3.3 lists the maximum specific rates of monoclonal antibody 
production in all of the variously supplemented and fed batch cultures 
calculated using the partial cubic spline and the time integral of viable
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cells against antibody concentration methods.
Table 3 .2
Specific Antibody Production Rate in Glutamine-Fed 
and Unfed Batch Culture, Calculated From The Slope Of 
The Viable Cell Hours Against Antibody Curve
Culture Time Specific Antibody Production Rate
(hours) ( u g /1 0 °  '
Unfed
/iable cells/h)
Glutamine-Fed
0 - 22.5 0 .5 6 0 .55
2 2 .5  - 34 .5 0 .7 4 0 .96
3 4 .5  - 47 .5 0 .76 0 .63
4 7 .5  - 58.5 0 .28 0.31
58 .5  - 71 .5 0 .59 0.71
7 1 . 5 - 8 3 . 0 -0 .08 0 .49
8 3 .0  - 98 .5 0 .53 0 .88
98 .5  - 1 2 3 .0 1.50 0 .57
1 2 3 .0  - 1 4 6 .0 -6.61 0 .45
The results for specific antibody production rate calculated by the two 
different methods using Equation 3.5 and Equation 3.6, are shown in 
Table 3.2 and Figure 3.13. Both methods show similar general trends in 
the rate of antibody production during the course of the batch culture. 
One of the benefits in using the partial cubic spline method is that it 
plots the trend in the data, rather than forcing a curve through each 
point. It is also possible to state the percentage fit of the line to the data 
points, thereby compensating for the normal error experienced in assays
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such as an ELISA. Undue significance is therefore not placed on a 
particular data point in isolation, but the trend between several points is 
coM dered simultaneously. Equation 3.6 is only valid when production 
rate is constant between two time points. It does not allow for any 
standard deviation around a data point and does not cdtlcjdor any 
underlying trend. Therefore, calculated rates of production can fluctuate 
wildly, as for the unfed batch culture after 58.5 hours.
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Figure 3.13a. Batch Culture of NBl Hybridoma Cells
Specific Rates of Growth and Antibody Production
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Figure 3.13b. Glutamine-Fed Batch Culture of NBl Hybridoma Cells 
Specific Rates of Growth and Antibody Production
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In unfed batch culture the peaks in specific growth rate and specific 
antibody production rate coincide, providing further evidence for the 
growth-associated nature of antibody production. The glutamine-fed 
batch culture shows two peaks in specific production, the first coincided 
with the peak in specific growth rate while the second occurred during 
the decreased growth rate of the prolonged stationary phase. This 
double peak in specific production rate was observed in all glutamine- 
fed batch cultures and suggests that monoclonal antibody production is 
not always strictly growth-associated.
Table 3.3
Maximum Specific Rate of Monocional i 
Batch Cuiture. Comparison Between Part 
Siope Of The Time Intégrai Of Viabie CCurve
Antibody Production in 
iai Cubic Spiine And The 
eiis Against Antibody
Batch Culture 
Conditions
Exponenti
Partial
Cubic
Spline
al Phase
Cell Hours
Against
Antibody
Stationary
Partial
Cubic
Spline
f Phase
Cell Hours
Against
Antibody
Unfed 0.81 0 .76 No Stati 3nary Phase
Gin Fed 0 .8 4 0 .96 0 .72 0 .88
Gin Fed and 
Essential Amino 
Acid
1.00 0 .99 0 .9 0 1.20
Essential and Non 
Essential Amino 
Acids
1.41 1.22 1.41 1.22
Gin Fed, Essential 
and Non-Essential 
Amino Acid
1.14 0 .9 4 1.15 1.14
Table 3.3 compares the maximum specific rates of antibody production 
in batch culture calculated using Equation 3.5 and Equation 3.6. Similar
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conclusions may be drawn as for the comparison between results 
presented in Table 3.2 and Figure 3.13. The partial cubic spline method 
of calculating specific production rate, by plotting the trend with a 
percentage fit to the data points, gives values for specific rates of 
production which may differ from specific production rates calculated 
by applying Equation 3.6. However, the extent of the difference between 
calculated values, in the majority of cases is less than ten percent of the 
mean..
From the results presented for specific growth rate (Table 3.1) and 
specific production rate, calculated using partial cubic spline, (Table 
3.3) it would appear that in batch culture, an increasing specific growth 
rate resulted in an increasing specific production rate during the 
exponential phase of growth. This is typical of growth-associated 
product formation. However when the growth rate fell during the 
stationary phase a corresponding fall in specific production rate was not 
observed suggesting that the increased specific production rate was 
possibly due to the increased concentration of amino acids rather than 
the increased growth rate.
3.3.7 Amino Acid Utilisation
Amino acid analysis of the unfed batch culture and the glutamine-fed 
batch culture revealed that amino acids can be classified into three 
groups; a) those which are produced; b) those which are alternately 
consumed and produced; c) those which are consistently consumed by 
the cells. The classification of individual amino acids is shown in the 
Table 3.4.
6 8
Table 3 .4
Classification of Amino Acids in Terms of Consumption
and Production in Batch Culture
Consumed Only Produced Only Consumed and 
Produced
ARG ALA* ASN*
CYS PRO* ASP*
GLN GLU*GLY
SERHISILE TYR
LEU
LYS
MET
PHE
THR
TRP
VAL
*Amino Acids not present in DMEM
Similar classifications have been arrived at by other workers (Griffiths 
and Pirt, 1967; Duval et al., 1989; Duval et a l, 1991), however the 
distribution of amino acids between the three groups appears to differ 
for each cell line.
In the unfed batch culture glutamine was the only amino acid which was 
totally exhausted from the medium, while in the glutamine-fed culture 
methionine and cystine were also exhausted and histidine, arginine and 
tryptophan were depleted to low levels (data shown in Appendix 7).
3.3.8 Specific Rates of Amino Acid Utilisation
Volumetric and specific rates of utilisation of amino acids were plotted 
using the partial cubic spline program (Figure 3.14). The peak in
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volumetric utilisation rate coincided with the peak in growth rate. The 
specific utilisation rate was high at the beginning of the culture and 
gradually decreased as the batch culture proceeded. In the glutamine-fed 
batch culture, the volumetric utilisation rate peaked twice. The first 
peak coincided with the peak in growth rate, while the second coincided 
with the stationary phase of the culture. The specific utilisation rate 
began high and gradually decreased as the batch culture proceeded, 
levelling off to an almost constant rate during the stationary phase. This 
general trend was observed for all amino acids which were consumed by 
the cell and is shown for valine in Figure 3.14. A high specific uptake 
rate of amino acids during the initial phase of growth has been observed 
before (Griffiths and Pirt, 1967). This correlates well with the peak in 
specific rates of glucose uptake observed in this study, and protein, RNA 
and DNA synthesis observed by other workers (King et a l 1959; 
Ruekert and Mueller 1959; Salzman 1959; and Swaffield and Foley 
1960).
The maximum specific utilisation rates of amino acids in unfed and 
glutamine-fed batch culture are shown in Table 3.5.
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Figure 3.14a. Unfed Batch Culture of NBl Hybridoma Cells 
Volumetric and Specific Rates of Valine Utilisation
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Figure 3.14b. Glutamine-Fed Batch Culture of NBl Hybridoma Cells
Volumetric and Specific Rates of Valine Utilisation
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Table 3.5
Maximum Specific Utiiisation Rates Of Amino Acids In Non 
Glutamine-Fed And Giutamine-Fed Batch Cuiture
Non GLN Fed GLN FedAmino Acid (pm oles/l 0^ viable 
cells/h)
(p m oles/10^ viable cells/h)
Growth Phase Growth Phase Stationarv Phase
SER 0 .0 0 2 5 0 .0 0 1 6 0 .0 0 0 0
GLN 0 .1 0 0 0 0 .1 1 0 0 0 .0 3 1 0
GLY 0 .0 0 4 5 0 .0 0 7 0 0 .0 0 0 0
HIS 0 .0 0 2 0 0 .0 0 1 0 0 .0 0 0 9
ARG 0 .0 0 4 5 0 .0 0 2 6 0 .0 0 2 2
THR 0 .0 0 7 6 0 .0 0 7 6 0 .0 0 3 4
ALA -0 .0 2 5 0 -0 .0 2 8 0 -0 .0 1 0 0
PRO -0 .0 0 5 0 -0 .0 0 6 0 -0 .0 0 4 0
TYR 0.0021 0 .0 0 6 6 0 .0 0 1 3
VAL 0 .0 1 0 0 0 .0 0 7 8 0 .0 0 2 6
MET 0 .0 0 3 0 0 .0 0 2 4 0 .0 0 1 5
CYS 0 .0 0 2 4 0 .0 0 1 0 0 .0 0 0 4
ILE 0 .0 1 1 0 0 .0 0 6 0 0 .0 0 3 0
LEU 0 .0 1 3 0 0 .0 0 8 7 0 .0 0 2 9
PHE 0 .0 0 3 7 0 .0 0 2 4 0 .0 0 2 2
TRP 0 .0 0 3 0 0 .0 0 0 9 0 .0 0 0 6
LYS 0 .0 0 9 0 0 .0 0 7 2 0 .0 0 2 4
The rate of utilisation of glutamine was approximately 10-50 times the 
rate for other amino acids. This is typical for cultures of mammalian 
cells (for example: Mohberg and Johnson, 1963; Griffiths and Pirt, 
1967; Blaker et al., 1971; Lambert and Pirt, 1975). The reason for this 
high rate of utilisation is related to the use of glutamine as an energy 
source, as demonstrated by Donnelly and S chef Her (1976) and Zielke et 
al. (1978). The branched chain amino acids, leucine, isoleucine and 
valine, also disappeared from the medium at relatively high rates, but at 
much slower rates than glutamine. These amino acids, along with others, 
as well as being incorporated into protein, can also function as energy 
sources besides glutamine.
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3.3.9 Glucose Utilisation.
Glucose utilisation followed the same general trend as amino acid 
utilisation (data not shown). Volumetric utilisation rate peaked during 
the growth phase of the culture while specific utilisation was initially 
high but decreased as the culture progressed. The trend in glucose 
utilisation was mirrored in the trend for lactate production (data not 
shown).
There was no obvious change in the rate of glucose utilisation when 
glutamine became exhausted to suggest that it could be used as an 
alternative energy source as has been demonstrated for some cell lines 
(Zielke et al., 1978). However, glucose may have been able to replace 
glutamine as an energy source but not as a precursor in protein 
synthesis, therefore growth ceased not due to the lack of an energy 
source but due to a lack of an essential protein precursor. Further 
experiments are necessary in order to determine this.
3.3.10 Metabolite Production: Alanine, Proline, Ammonia and Lactate 
Alanine, proline and ammonia were consistently produced during the 
course of a batch culture. These waste metabolites are all end products 
of amino acid transamination (Stryer, 1981). Alanine has also been 
shown to derive from glucose metabolism in L929 cells (Lanks, 1987).
A proportion of amino acids utilised by the cell which are not used for 
the synthesis of proteins and other biomolecules are used as metabolic 
fuel. The a-am ino group is removed and the carbon skeleton is 
converted into acetyl CoA, acetoacetyl CoA, pyruvate, or one of the 
intermediates of the citric acid cycle. The oc-amino group of many 
amino acids is transferred to a-ketoglutarate to form glutamate, which
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is then oxidatively deaminated to yield ammonia. The transient 
appearance of glutamate during the exponential phase of batch culture 
when amino acid utilisation is at its highest rate was therefore not 
surprising.
Glutamate is involved in the synthesis pathways of all the other amino 
acids which were not originally present in DMEM but were produced 
during a batch culture. Alanine is synthesised from pyruvate and 
glutamate, while aspartate is synthesised from oxaloacetate and 
glutamate which can then lead on to the synthesis of asparagine. 
Glutamate is also the precursor of proline. It is therefore likely that the 
appearance of these amino acids simply reflects the transamination of 
other amino acids. Utilisation rates and requirements for such amino 
acids are difficult to determine since it is not known to what extent they 
are produced and utilised by the cell without ever appearing in the 
medium.
Tyrosine can be produced simply by the hydroxylation of phenylalanine 
or by a more complex pathway involving chorismate, an intermediate in 
the biosynthesis of phenylalanine, tyrosine and tryptophan. Serine is 
synthesised from 3-phosphoglycerate, an intermediate in glycolysis, and 
acts as a precursor in the synthesis of glycine. These three amino acids 
were both consumed and produced in batch culture.
Ammonia concentrations in the range of 2.0 - 5.0 mM were observed at 
the end of batch cultures supplemented with extra glutamine and other 
amino acids. This is typical for batch culture of hybridoma cells (Ozturk 
et al., 1992). However, the effect of such concentrations of ammonia 
does vary between cell lines in general and between hybridoma cell lines
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in particular. Several studies have shown that ammonia inhibits cell 
growth, however the sensitivity of the growth rate to ammonia 
concentration varied among the cell lines used. The ammonia 
concentration required to inhibit cell growth rate by 50% of the 
maximum is in the range of 2 to 10 mM (Reuveny et al, 1987; Thorpe, 
1989; Miller et al, 1988; Truskey et al, 1990; McQueen and Bailey, 
1990; Ozturk et al, 1992). Reports on the effect on specific antibody 
production rates suggest that there is no change with increasing 
ammonia concentration (McQueen and Bailey, 1990; Ozturk et al, 
1992).
Studies with this cell line have shown that ammonia concentrations up to
5,8 mM reduced the maximum viable cell concentration by 17% while 
the growth rate was reduced by 25% (Boraston, 1990). The effect on 
the specific production rate of antibody was not reported.
Lactate is mainly produced from glucose metabolism but can also be 
produced in small amounts from glutamine (Zielke et al, 1990). In this 
set of batch experiments final lactate concentrations between 19 and 26 
mM were observed, which, from the data of Boraston (1990), translates 
into a possible 20% decrease in maximum viable cell concentration and 
a 25% decrease in growth rate. However, as these concentrations were 
only observed towards the end of the decline phase, any negative effect 
during the growth phase was likely to be small. Studies on other 
hybridoma cell lines have revealed no inhibition at concentrations up to 
40 mM lactate (Thorpe, 1988; Miller et al, 1988), stimulation of 
growth at concentrations up to 22 mM, followed by inhibition above 28 
mM (Reuveny et al, 1986). Ozturk et al, (1992) observed an increasing 
specific rate of antibody production with increasing lactate
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concentration, however this was ascribed to an increasing osmolarity of 
the medium.
3.3.11 Cell Cycle Analysis
The cell cycle through a typical unfed batch culture was analysed, the 
results are shown in Table 3.6.
Table 3 .6
Cell Cycle Distribution During The Course Of A 
Typical Batch Culture
Culture Age Culture Viability % Of Cells In Stages Of The Cell Cvcle(hours) (%) Gl/GO S G2/M
0 95 33 .95 4 1 .6 8 2 4 .6 6
45 92 3 6 .0 8 4 7 .9 3 12 .98
66 93 4 8 .1 7 4 1 .8 7 1 0 .40
78 85 4 8 .8 8 3 7 .5 2 14.11
89 51 68 .33 24 .85 7 .4 0
101 21 a.1.74 _ J 4 .0 7 2 .73
During the exponential growth phase the percentage of cells in Gl/GO 
phase of the cell cycle increased. The increase in Gl/GO was offset by a 
decreasing percentage of cells in the S phase and G2/M phases. Cell 
cycle analysis of hybridoma cell lines by other workers is in agreement 
with this general observation of cells accumulating in the Gl/GO phases 
of the cell cycle as the culture ages (Schliermann et al.\ Linardos et al. 
1991). In many cell lines of lymphoid origin the production of antibody 
appears to be restricted to the G1 and S phases of the cell growth cycle 
(Byars and Kidson, 1970; Buell and Fahey, 1969; Takahashi et al., 1969; 
Garatun-Tjeldsto et al., 1976; Turner et al., 1985). However, with this 
cell line, cells accumulated in the Gl/GO phases of the cell cycle during
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the decline phase of the culture but with no increase in the specific rate 
of antibody production. Studies by Hayter et al. (1992) demonstrated 
that antibody production was not restricted to a particular cell cycle 
phase for their cell line. There is obviously therefore no simple 
relationship between specific antibody production rate and cell cycle 
with all hybridoma cell lines. It is possible in this case that increased 
specific antibody production does occur during the G1 phase of the cell 
cycle, but that under the nutrient depleted conditions experienced during 
the decline phase, the nutrients required for antibody production are 
limiting. As glutamine appears to be essential for both growth and 
antibody production, and the batch culture was glutamine depleted, then 
this is a distinct possibility.
3.5 CONCLUSIONS
• Glutamine is an essential nutrient for both growth and monoclonal 
antibody production. When glutamine runs out growth ceases, 
shortly followed by production.
• Death of a cell population in DMEM.FCS is due to nutrient 
depletion, not inhibitor accumulation, demonstrated by continued 
growth when extra nutrients were added. However the drop in 
viability during extended stationary phases may be due to stress or 
inhibitor accumulation.
• Growth and production can be extended and increased by 
supplementing and feeding the culture with glutamine, essential and 
non-essential amino acids.
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Monoclonal antibody appears to be produced by the viable cell 
population with no evidence of large scale release by lysing cells. 
Peaks in specific growth rate and specific production rate coincide 
suggesting growth-associated production, however, production does 
continue into the decline phase of batch culture but at a reduced rate.
Accumulation of the cell population in the Gl/GO phase of the cell 
cycle does not result in increased monoclonal antibody production 
under glutamine depleted conditions.
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4.0 SINGLE-STAGE CHEMOSTAT CULTURE
The results reported in this chapter are the results of the first stage of a 
two-stage chemostat experiment reported in Chapter 5.
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4.1 SUMMARY
Single-stage chemostat culture of the NBl hybridoma cell line was 
performed. The effects of various dilution rates on specific growth rate, 
cell concentration, specific production rate of monoclonal antibody, and 
specific rate of nutrient utilisation and waste metabolite production were 
studied. Steady states were maintained at various dilution rates over a 
number of volume changes. Monoclonal antibody production was 
negatively growth rate associated and specific rates of amino acid 
utilisation decreased with decreasing dilution rate along with a 
decreasing viable cell concentration and viability.
4.2 INTRODUCTION
Chemostat culture has been extensively used in the study and 
exploitation of microbial processes, however its use in animal cell 
culture has, until recently, been limited.
The theory of chemostat culture was first established in 1950 by Monod 
and at the same time, independently, by Novick and Szilard. A 
chemostat culture is established by feeding a culture, initiated as a batch 
culture, with medium in which a single substrate, or inhibitory 
catabolite is at a concentration which will limit growth. The flow of 
medium into the vessel is equal to the flow of medium and culture out, 
thereby maintaining a constant volume with a dilution rate, D, of 
medium feed rate, F, divided by culture volume, V:
D = F/Y Equation 4.1
A self regulating steady state is established during which the specific 
growth rate of the culture is equal to the dilution rate provided that the
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culture is 100% viable:
jT = D Equation 4.2
This occurs because growth of the culture is reliant on the supply of the 
growth-limiting substrate, which is determined by the dilution rate. 
When a culture is 100% viable the growth rate is equal to the dilution 
rate, however, if a culture is not 100% viable then the specific growth 
rate (|Ll) exceeds the dilution rate (because the viable cell population 
generates the non-viable as well as the viable cells) according to the 
equation:
|LL = D/p Equation 4.3
where D is the dilution rate and P is the fraction of the culture which is 
viable (Pirt 1975).
In chemostat culture under steady state conditions specific rates of 
substrate utilisation (q^) are estimated according to the equation:
qg = D.(Sr - S)/x Equation 4.4
where D is the dilution rate, S is the concentration of substrate in the 
culture, Sr is the concentration in the medium feed (for example, amino 
acid concentration) and x is the viable cell concentration.
Specific rates of product synthesis (qp) are calculated according to the 
equation:
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qp = D.(p - pr)/x Equation 4.5
where p is the product concentration in the culture and pr is the 
concentration in the medium feed (zero in the case of antibody). The 
productivity of a chemostat can be determined by calculating volumetric 
production rate according to the following equation:
volumetric production = D.(p - pr) Equation 4.6
The first published account of an attempt to cultivate animal cells in 
chemostat culture did not appear until 1958 (Cooper et al, 1958). An 
embryo rabbit kidney (ERK) cell line was used but steady states were 
not observed and the system was not self balancing so that if the cells 
overgrew they then entered a stationary phase and were washed out. 
However the chemostat achieved its desired purpose of providing a 
continuous supply of cells for agar-suspension plaque assays and 
suspension growth of poliovirus in a more efficient and less troublesome 
way than batch culture. The same authors reported their attempts at 
continuous flow culture of animal cells in more detail in another paper 
(Cooper et a l,  1959) in which they combined the principles of 
chemostat culture with turbidostat culture as a safety device to overcome 
the problems of irreversible fluctuations in the steady states. A 
successful attempt at maintaining steady states in chemostat culture of 
animal cells was reported by Cohen and Eagle (1961) with HeLa cells. 
However, steady states were only observed at high dilution rates. Low 
dilution rates resulted in a cyclic variation in cell concentration and the 
growth-limiting factor was not identified. Pirt and Callow (1964) made 
the first successful attempt to identify the growth-limiting nutrient in 
their chemostat cultures of L cells and ERK cells. They were also able
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to study the effect of pH on steady state cell concentration and on the 
specific utilisation rate of glucose. Moser and Vecchio (1967) were able 
to obtain stable steady states at low dilution rates using mouse ascites 
mast cells in chemostat cultures. However, long adjustment periods were 
necessary before oscillations were totally eliminated. The growth- 
limiting nutrient was not identified. Griffiths and Pirt (1967) used 
chemostat culture in their study of the uptake of amino acids by mouse 
LS cells. They were able to demonstrate steady and reproducible 
metabolic states, and show for the first time a relationship between cell 
growth rate and nutrient requirements. Other workers also reported the 
successful cultivation of animal cells in chemostat culture around this 
time (Holmstrom, 1968; Kilburn and Van Wezel, 1970; Tovey et al, 
1973; Tovey et al, 1975). The first detailed analysis of the chemostat 
culture of animal cells was reported by Tovey and Brouty-Boye (1976). 
Reproducible and stable steady-state cultures of mouse L 1210 cells over 
a wide range of growth rates were obtained with glucose as the growth- 
limiting substrate. The problems encountered previously, such as failure 
to obtain steady states, cyclic variations in cell number at low dilution 
rates, and wide variations between different cultures at the same dilution 
rate, were overcome.
De St. Groth (1983) was the first to report the growth of hybridoma 
cells in continuous culture in what he termed a 'Cytostat'. The cytostat 
differed from a chemostat in that the growth rate was not specifically 
controlled by a growth-limiting nutrient, but medium was supplied at a 
rate which matched the maximum growth rate of the cells, thus 
maintaining the cells at a constant concentration (i.e. a turbidostat). He 
successfully grew ten hybridomas in this form of culture. Boraston et a l  
(1984) successfully grew a hybridoma cell line in a true chemostat
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under oxygen-limited steady state conditions. From the data obtained, 
values for the specific respiration rate and growth yield from oxygen 
over a range of growth rates could be determined. In a later paper, 
Birch et a l  (1985) presented chemostat data for a hybridoma cell line 
which demonstrated that antibody synthesis was not growth-associated 
because as the growth rate was slowed the specific rate of antibody 
secretion increased. Several studies of hybridoma growth and 
monoclonal antibody production in chemostat culture have since been 
carried out (Miller et a l,  1988 and 1989; MacMichael, 1989; Harbour et 
al., 1989; Ray et a l,  1989; Frame and Hu, 1990, and 1991a and b; 
Hayter et a l,  1992). In each case stable steady states were obtained, and 
monoclonal antibody production kinetics appeared to be cell line 
dependent.
In this study, single-stage chemostat studies of the NBl cell line were 
carried out in DMEM supplemented with 5% FCS over the dilution 
range of 0.05 to 0.01 h"^.
4.3 Aim
The aim of this set of experiments was to determine the monoclonal 
antibody production kinetics exhibited by the hybridoma cell line NBl 
in chemostat culture.
4.4 RESULTS AND DISCUSSION
Single-stage chemostat culture of NB1 hybridoma cells was carried out 
at dilution rates of 0.05, 0.04, 0.03, 0.02 and 0.01 h"l. Steady state 
conditions in terms of cell, antibody, glucose, glutamine, lactate and 
ammonia concentrations, was generally observed after four volume 
changes. Figure 4.1 shows the steady state obtained after four volume
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changes and maintained for four volumes changes at a dilution rate of 
0.03 h"^ for viable, non-viable and total cell and monoclonal antibody 
concentration.
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Figure 4.1 Single-Stage Chemostat Culture. The steady states observed
at a dilution rate of 0.03h"l for total, viable and non-viable cell 
concentrations and monoclonal antibody titre.
4.4.1 Cell Concentration
In single-stage studies steady state total cell concentration remained 
fairly constant across the dilution rate range, while viable cell 
concentration decreased (Figure 4.2).
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Figure 4.2 Single-stage chemostat culture. Viable and total cell 
concentrations observed between dilution rates of 0.05 - 0.0 Ih"^,
The viability of the culture therefore fell with decreasing dilution rate.
The effect of dilution rate on hybridoma cell concentration would 
appear to be cell line dependent. Viable cell concentration has been 
reported to remain constant across a dilution rate range (Ray et al., 
1989; Hayter et al, 1992; Martens et al, 1993), increase with increasing 
dilution rate (Frame and Hu, 1991; Linardos et al,  1991) or show a 
maximum concentration at an intermediate dilution rate, possibly 
because the higher dilution rates were approaching washout (Miller et 
a l,  1988). Total cell concentration has been reported to increase with 
increasing dilution rate (Frame and Hu, 1991), decrease with increasing 
dilution rate (Miller et a l,  1988; Martens et al,  1993) or reach a 
maximum concentration at an intermediate dilution rate (Ray et a l.
8 6
1989). Viability of hybridoma cells in chemostat culture appears to 
always decrease with decreasing dilution rate, except in the case of 
Hayter et al, (1992) where it remained constant.
Figure 4.3 shows the theoretical growth rate based on the dilution rate 
(Equation 4.2) and the specific growth rate after taking into account 
culture viability (Equation 4.3). Based on similar results obtained by 
other workers (Tovey and Brouty-Boye, 1976; Boraston et a l,  1984; 
Miller et a l ,  1988) it has been suggested that there is a minimum 
required growth rate to maintain cell viability. Pirt (1975) discussed the 
possibility of a minimum growth rate for bacteria in chemostat culture. 
The possibility of part of the population differentiating into dormant 
cells allowing a minimum growth rate to be maintained by the growing 
fraction of the population was proposed. The results of Boraston et a l  
(1984), using the same cell line as in this study, suggested the possibility 
of a minimum growth rate of around 0.02h"l for NBl hybridoma cells. 
However, although a growth rate below 0.02h"l was not observed here, 
it was not possible to conclude on the likelihood of a minimum growth 
rate without reducing the dilution rate further. There is no suggestion 
that animal cells are able to enter a dormant stage in chemostat culture 
unless the GO phase of the cell cycle were classed as the equivalent, and 
its existence in a large proportion of the cell population at low dilution 
rates demonstrated. FACScan cell cycle analysis carried out in this study 
(Section 5.4.6) demonstrated the accumulation of cells in the G 1/GO 
phase of the cell cycle at low dilution rates but was unable to distinguish 
between the G1 and GO fraction of the cell population.
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Figure 4.3 Single-Stage Chemostat Culture. The effect of dilution rate 
on specific growth rate. Theoretical growth rate, based on jii = D, and 
specific growth rate based on culture viability (Equation 4.3)
The maximum growth rate observed in chemostat culture was 0.053h~^ 
at a dilution rate of 0.05b" 1. The fact that a steady state was observed at 
this dilution rate indicates that the maximum growth rate of the cell line 
was not reached. At a dilution rate greater than p.max washout of the 
cell population from the chemostat occurs because removal of cells by 
the dilution rate exceeds the replacement of cells by the growth rate. In 
batch culture the maximum growth rate observed when the cells were 
grown in serum-supplemented DMEM was only 0.05b"
4.4.2 Glutamine Utilisation and Ammonia Production 
The total amount of glutamine utilised and ammonia produced was 
relatively constant over the dilution rate range (Figure 4.4). The change 
in the concentration of residual glutamine between different dilution
8 8
ratés was in fact only 0.00 - 0.18 mM out of an original concentration 
of 4.00 mM. Glutamine was the most likely candidate for growth- 
limiting substrate and the linearity results because almost all of the 
glutamine was utilised at all dilution rates.
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Figure 4.4 The copjcemration of glutamine utilised and ammonia 
produced in singlefs^age chemostat culture between dilution rates of 
/  0.01 and O.OSh’!.
The specific rate of glutamine utilisation and ammonia production 
(Equation 4.4 and 4.5) decreased with decreasing dilution rate (Figure 
4.5). This is in keeping with the results of other workers (Griffiths and 
Pirt, 1967; Miller et al, 1988; Hayter et al, 1992).
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Figure 4.5 Single-Stage Chemostat Culture. The effect of dilution rate 
on specific rates of glutamine utilisation and ammonia production
between dilution rates of 0.01 and 0.05h"^.
The ratio of glutamine consumed to ammonia produced, shown in Table
4.1 below, remained fairly constant across the dilution rate range and 
showed that for every mole of glutamine utilised half a mole of 
ammonia was produced out of a theoretical maximum of two. The 
remaining ammonia was either incorporated into the cellular biomass or 
into waste metabolites such as alanine and proline.
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Table 4,1
Ratio of Ammonia Produced to Glutamine Utilised in 
Single-Stage Chemostat Culture
Dilution Rate (1/h) Molar Ratio
0.05 0.55
0.04 0.56
0.03 0.59
0.02 0.55
0.01 0.54
During the growth phase of batch culture a value of 1.5 mM ammonia 
per mole m  glutamine was generally observed. Glutamine utilisation in 
the chemostat therefore resulted in less ammonia being released than in 
batch culture. The fact that the ammonia concentration was almost the 
same for all dilution rates means that any inhibitory effect caused by 
ammonia on growth or production was the same at all dilution rates.
4.4.3 Glucose Utilisation and Lactate Production
Glucose showed a general trend of decreasing specific utilisation rate 
with decreasing growth rate and lactate production mirrored this trend 
(Figure 4.6). This is in agreement with the observations of other 
workers (Robinson and Memmert, 1991; Hayter et al, 1992; Miller et 
al, 1988; Ray et al, 1989).
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Figure 4.6 Single-Stage Chemostat Culture. Specific rates of glucose 
utilisation and lactate production between dilution rates of 0.01 and
O.OSh-l.
The specific rates of glucose utilisation and lactate production in Figure
4.6 shows the relationship between lactate production and glucose 
consumption as well as showing that specific glucose utilisation is non­
linear. A non-linear rate of glucose consumption has been observed by 
other workers (Miller et al., 1988). The specific rate of glucose 
utilisation appears to have become saturated above a dilution rate of 
0.03h"l. This is possibly because the demand for glucose was limited by 
some other factor, or because the efficiency of glucose utilisation 
increased with decreasing growth rate, demonstrated by a general trend 
of decreasing glucose:lactate ratio, particularly at the lower dilution 
rates, which has a theoretical maximum of 2.0 (Table 4.2). The ratio of 
glucose consumed to lactate produced at the higher dilution rates is 
comparable to the ratio of 1.53 seen during the growth phase of batch 
culture. The ratio seen at lower dilution rates although lower than the
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growth phase ratio is not as low as the batch culture stationary phase 
ratio of 0.69.
Table 4.2
Ratio of Lactate Produced to Glucose Utilised In
Single-Stage Chemostat Culture
Dilution Rate 
(1/h)
Glucose
Utilised
(mM)
Lactate
Produced
(mM)
Molar Ratio
0.05 18.34 30.00 1.64
0.04 18.86 29.69 1.57
0.03 22.67 38.30 1.69
0.02 16.17 16.27 1.01
0.01 14.24 14.99 1.05
The concentration of lactate in the medium decreased dramatically at the 
two lowest dilution rates. Judging from the data showing the effect of 
lactate concentration on growth (Boraston, 1990) this should have a 
positive effect on growth rate.
For some cell lines it has been demonstrated that glucose and glutamine 
can be used interchangeably as an energy source (Zielke et ah, 1978). If 
this were the case for this cell line it would be expected that as 
glutamine became more limiting at the lower dilution rates then the 
specific rate of glucose utilisation would increase. In fact the specific 
utilisation rate of glucose decreased with glutamine concentration, 
(data shown in Appendix 8). However, the ratio of lactate produced to 
glucose utilised decreased therefore less glucose was more fully 
metabolised making it difficult to determine what the actual glucose 
demand of the cells was.
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4.4.4 Monoclonal Antibody Production
Monoclonal antibody concentration increased with decreasing dilution 
rate (Figure 4.7), as did the specific rate of monoclonal antibody 
production. This has been described as typical of growth-dissociated 
production kinetics by several workers (Miller et al, 1988; Hayter et 
al, 1992), however as this implies that specific growth rate and specific 
production rate should vary independently of each other it is more 
accurately described as inversely (or negatively) growth-associated and 
is in contrast to the growth-associated production kinetics observed in 
batch culture.
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Figure 4.7 Single-Stage Chemostat Culture. Volumetric antibody titre 
and specific rates of antibody production between the dilution rates of
0.01 and O.OSh’!.
In general the characteristics of specific monoclonal antibody 
production observed in batch culture have been reflected in chemostat
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culture resulting in reports of positively growth-associated antibody 
production (Low et a l,  1987; MacMichael, 1989), inversely growth- 
associated production (Boraston et a l,  1984; Reuveny et al., 1986; 
Miller et a l ,  1988; and Frame and Hu, 1991), as well as growth- 
dissociated production (Ray et a l, 1989; Hiller et al, 1991). Besides this 
case, only Goergen et a l  (1992) have reported seeing a positive 
association between growth and monoclonal antibody production in 
batch culture, and a negative association in glucose limited chemostat 
culture. However their chemostat data were based not on steady states 
but on the transient phase leading up to steady state. The effect of 
varying the dilution rate on steady state monoclonal antibody production 
was not reported.
4.4.5 Amino Acid Utilisation
As with batch culture, in single-stage chemostat culture amino acids 
could be classified in terms of those which were utilised only, those 
which were utilised and produced and those which were produced only. 
Alanine and proline were produced only, glycine, tryptophan, 
asparagine, aspartic acid and glutamic acid were produced and 
consumed while all other amino acids were consumed only. An example 
from each of these three categories is shown in Figure 4.8 in which 
negative values indicate amino acid production.
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Figure 4.8 Single-Stage Chemostat Culture. Specific rates of histidine,
tryptophan and proline production between dilution rates of 0.01 and
0.05h-l.
The amino acids which were utilised only all followed the general trend 
of decreasing specific utilisation rate with decreasing dilution rate and 
growth rate, as has been reported by other workers (Miller et al., 1989; 
Hiller et a l,  1991). Glycine and tryptophan, the two amino acids present 
in DMEM which were produced and consumed, both followed a trend 
of increasing specific utilisation with decreasing dilution rate. While 
tryptophan was produced at the highest dilution rates, glycine was 
produced at the lowest dilution rate. Alanine and proline were produced 
only and both followed a trend of decreasing production rate with 
decreasing dilution rate.
Cystine was not detected in the spent medium. This may have been 
because cystine was the growth-limiting substrate and therefore 
exhausted from the medium. Addition of extra cystine to the culture
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would therefore expect to result in an increase in cell concentration 
provided it was the sole growth-limiting substrate. Subsequent studies 
(reported in Chapter 6) demonstrated that addition of extra glutamine to 
a two-stage chemostat resulted in an increase in cell concentration. No 
further increase was observed however when both glutamine and cystine 
were added in excess, suggesting that cystine was not a growth-limiting 
substrate. The apparent depletion of cystine from the medium could 
have been due to its instability in the amino acid analysis method used 
(Sarah Boork, Personal Communication). Methionine was depleted 
below a dilution rate of 0.02 h '^, tryptophan was depleted at a dilution 
rate of 0.01 h“ .^
Table 4.3 compares the specific utilisation rates of amino acids in 
chemostat culture with batch culture.
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TABLE 4-3
Specific R ates Of Amino Acid Utilisation During The 
Growth Phase Of Batch Culture Com pared To Single- 
S tag e  C hem osta t Culture A t D =  0 .0 3  h ^
Batch Culture Chemostat Culture
Amino Acid 0 - 5 8  hours D = 0.03h"'*
p m oles /10^ cells/h pm oles/10^  cells/h
GLN 0 .0 7 6 7 0 .0 7 5 8
THR 0 .0 0 8 9 0 .0 0 9 5
LEU 0 .0 0 8 4 0 .0 0 9 2
LYS 0 .0 0 7 7 0 .0 0 8 0
VAL 0 .0 0 7 2 0 .0 0 7 4
ILE 0 .0 0 6 6 0 .0 0 6 6
TYR 0 .0 0 4 7 0 .0 0 4 5
ARG 0 .0 0 4 3 0.0041
PHE 0 .0 0 3 4 0 .0 0 3 3
SER 0 .0 0 3 3 0 .0 0 4 5
CYS 0 .0 0 2 9 0 .0 0 3 9
GLY 0 .0 0 2 8 0 .0 0 1 6
MET 0 .0 0 2 3 0 .0 0 2 5
HIS 0 .0 0 2 2 0.0021
TRP 0 .0 0 0 3 0 .0 0 0 2
PRO -0 .0 0 4 2 -0 .0 0 5 5
ALA -0 .0 1 9 5 -0 .0 1 6 8
At a dilution rate of 0.03h“  ^ the specific rates of utilisation of amino 
acids were very similar to batch culture. Also, the order of amino acids 
in terms of rate of utilisation was very similar in batch and chemostat 
culture. This indicates that at an intermediate dilution rate, the metabolic 
rate of amino acid utilisation is no greater in chemostat culture than 
batch culture. As the specific utilisation rate tended to decrease with 
decreasing dilution rate, the amino acid metabolic rate was greater than 
batch culture at higher dilution rates, but was less than batch culture at 
low dilution rates. For other cell lines Griffiths and Pirt (1967) and 
Ozturk and Palsson (1990) have reported a lower rate of amino acid 
utilisation in chemostat culture compared to batch culture.
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4.5 CONCLUSIONS
• Steady states in terms of cell concentration, antibody production, and 
nutrient utilisation were observed at all dilution rates.
• With decreasing dilution rate total cell concentration remained 
constant while the viable cell concentration and viability decreased.
• Specific rates of amino acid utilisation decreased with decreasing 
dilution rate.
• The specific growth rate did not fall below 0.02 h"l, and therefore 
did not rule out the possibility of a minimum growth rate.
• Glutamine was the most likely candidate for growth-limiting 
substrate. The apparent depletion of cystine was possibly due to its 
instability in the HPLC assay used for amino acid analysis.
• Monoclonal antibody production was negatively growth rate 
associated.
• The results of the batch and chemostat experiments indicate that 
viable cell concentration and growth rate control are two key 
parameters in the optimisation of volumetric antibody productivity. 
As has been demonstrated, single-stage chemostat culture results 
either in high viability and high growth rate or low viability and low 
growth rate while maximum productivity would seem to require 
high viability and low growth rate. The feasibility of achieving this 
with two-stage chemostat culture was therefore explored.
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5.0 TWO-STAGE CHEMOSTAT CULTURE
1 0 0
5.1 SUMMARY
Two-stage chemostat culture of the NBl hybridoma cell line was 
performed. The effect of dilution rates between 0.01 h’ l and 0.05 h"l 
on specific growth rate, cell concentration, specific production rate of 
monoclonal antibody, and specific rate of nutrient utilisation and waste 
metabolite production were studied. The distribution of cells in the 
various stages of the cell cycle at different dilution rates was also 
studied. Steady states were maintained at each dilution rate over a 
number of volume changes. Monoclonal antibody production was 
negatively growth rate associated. The specific monoclonal antibody 
production rate was greater in stage two compared to stage one only at 
the lowest dilution rates even though several amino acids were totally 
exhausted from the medium in stage two. A general trend of an 
increasing percentage of cells in the G 1/GO phase of the cell cycle with 
decreasing dilution rate was observed in stage one and stage two.
5.2 INTRODUCTION
If monoclonal antibody production is truly negatively growth-associated 
and the optima for growth and production are different it is logical to 
assume that this could be best studied and exploited in a two-stage 
chemostat system in which a growth stage feeds cells into a second 
production stage with the conditions in each being tailored to their 
specific function.
Within a few years of the establishment of chemostat culture it was 
realised that the productivity of many metabolites observed in batch 
culture was not always being matched in the chemostat. This lead to the 
development of multi-stage chemostat systems, discussed initially in 
theory by Maxon (1955) and Deindoerfer and Humphrey (1959) and
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developed by Herbert (1961) and others. The reason for such low 
productivity may have been due to one or more of a number of 
possibilities. In a batch culture, each point on the growth curve is 
dependent on those preceding it, the culture therefore has a 
developmental history. However, in a single-stage chemostat the 
population is multiplying under constant environmental conditions in a 
steady state. The physiological state of the culture is therefore no longer 
dependent on its history but on the dilution rate. The biosynthesis of 
certain products is dependent on the passing of the cell population 
through certain physiological phases, for example, the induction of 
spore formation by Bacillus cereus was attempted in two-stage 
chemostat culture (Humphrey et a l, 1966). However the dependence of 
each physiological state on the previous states is so significant that spore 
formation was only observed in continuous culture when the organism 
was grown in a multistage chemostat consisting of six stages (Ricica, 
1969).
Chemostat culture steady states tend to become easily destabilised at 
dilution rates close to the maximum growth rate of a culture, and at 
very low growth rates. If the maximum rate of product synthesis occurs 
during the growth phase of the population maximum productivity will 
be observed at maximum growth rate. To overcome the problem of 
studying product formation at growth rates close to the maximum, two- 
stage chemostat culture has been employed (Main et a l,  1969). Main et 
al. studied the effect of growth rate on enzyme activity in yeast and 
employed a multi-stage continuous system to overcome the problems of 
perturbations in steady state at values close to the maximum growth rate 
where small changes in the substrate concentration could result in 
complete washout. The dilution rate in the first stage was kept near to
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the maximum growth rate. The cells were then passed on to the second 
stage which was also supplied with fresh medium. The conditions in the 
second stage were changed from low values of dilution rate to very high 
and the maximum attainable specific growth rate, nucleic acid and 
carbohydrate catabolising enzyme concentrations were determined. 
Wash out of the culture from the second stage did not occur because of 
the constant flow of inoculum from the first stage.
Two-stage chemostat culture is also applicable at the other end of the 
scale, when the specific rate of product formation is inversely 
proportional to the rate of growth and reaches its maximum, or only 
occurs, when the growth rate is equal to zero. Under most growth 
conditions Bacillus species produce extracellular protease only after the 
exponential growth phase. The production of protease was therefore 
studied in a two-stage chemostat (Fabian, 1969) and an industrially 
important strain of Bacillus was made to produce extracellular protease 
continuously in a two-stage fermenter for extended periods of time 
(Jensen, 1972). Single-stage chemostat culture of plant cells has 
generally resulted in poor secondary product synthesis (Tal and 
Goldberg, 1982). However, the total phenolic concentration obtained in 
a two-stage culture of Nicotiana tabacum was higher than that obtained 
in batch culture under identical nutrient conditions or in a single-stage 
system under identical conditions (Sahai and Shuler, 1984).
The versatility of multistage chemostat culture allows the study of 
cultures at maximum or zero growth rate, the development of culture 
history under steady state conditions, switches in the growth-limiting 
nutrient in different stages and changes in the physical conditions 
between stages such as temperature and pH. Although multistage
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chemostat culture has been used in the study of bacteria, fungi, and plant 
cells there is not at present a report of its use in the study of the growth 
and physiology of animal cells. The advantages of using multistage 
culture in the study of hybridoma cell growth, metabolism and 
monoclonal antibody production are numerous and will be explored 
more fully in this study.
A two-stage chemostat culture, using DMEM supplemented with 5% 
foetal calf serum, with no extra feed to the second stage was set up as 
shown in the Materials and Methods (Figure 2.1). Steady states at 
dilution rates of 0.05, 0.04, 0.03, 0.02 and 0.01 h”  ^ were obtained.
5.3 AIMS
The aim of this set of experiments was to explore the possibility of 
culturing animal cells in a two-stage chemostat, and to observe the 
effects of such a culture system on cell growth and monoclonal antibody 
production.
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5.4 RESULTS AND DISCUSSION
5.4.1 Cell Concentration
Total cell and viable cell concentration in the second stage compared to 
the first stage is shown in Figure 5.1a, and Figure 5.1b.
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Figure 5.1a Two-Stage Chemostat Culture. Steady-state total cell 
concentration observed in stage one and stage two of a two-stage
chemostat culture at dilution rates of 0.01 - 0.05h"^.
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Figure 5.1b Two-Stage Chemostat Culture. Steady-state viable cell 
concentration observed in stage one and stage two of a two-stage 
chemostat culture at dilution rates of 0.01 - 0.05h“l.
At the highest dilution rates essential nutrients remaining from stage one 
were utilised in stage two resulting in higher total cell concentrations, 
while at lower dilution rates less nutrients were available from stage one 
resulting in decreased viable and total cell concentrations in stage two. 
Viable cell concentration was higher in stage two only at the highest 
dilution rate.
Growth rates in the second stage of a microbial two-stage chemostat 
culture with no extra feed to the second stage were calculated according 
to the following equation (Pirt, 1975):
(J-2 = ^2(^2 - xi)/%2 Equation 5.1
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where D 2  is the dilution rate in stage two; X2  is the biomass 
concentration in stage two and xj is the biomass concentration in stage 
one. However, this assumes that the culture is 100% viable. 
Determination of viable cell and total cell concentrations in animal cell 
culture allows growth rate to be calculated accounting for the viable cell 
population only.
Growth rate calculated in this way indicates that a positive growth rate 
is only observed in stage two at a dilution rate of 0.05 h 'l  where viable 
cell concentration is greater in stage two than stage one. At the lower 
dilution rates, where the viable cell concentration in stage two is equal 
to or less than stage one, growth rate is zero (D=0.04h"l) or negative 
(D=0.03 - O.Olh-1).
However, although the viable cell population may show a negative 
growth rate there is no reason to suppose that individual cells are not 
growing and dividing. This would typically be shown by an increase in 
the total cell concentration between stage one and stage two, unless the 
dead cells were being broken up into small fragments. Dilution rates of
0.05, 0.04, and 0.03h"l showed an increase in total cell concentration 
between stages one and two while only a dilution rate of 0.05 h~^ 
showed an increase in viable cell concentration. Dilution rates of 0.02 
and 0.01 h'^ showed a decrease in total cell concentration.
Specific growth rate in stage two (P2 ) accounting for the generation of
non-viable cells was calculated using Equation 5.2 which assumes that 
the change in total cell concentration between stage one and two results 
from the viable cell concentration in stage two as follows:
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M-2 -  D2 (xt2  - X(i)/Xy2  Equation 5.2
The calculation of growth rate in the second stage of the two-stage 
chemostat culture indicates that the cells have a minimum growth rate 
of around 0.02 h^l as was suggested by single-stage culture both here 
and by other workers (Tovey and Brouty-Boye, 1976; Boraston et al., 
1984; Miller et al., 1988). However, an unknown factor in the equation 
is the number of non-viable cells not accounted for due to their 
disintegration in the chemostat. The loss of non-viable cells from the 
count would make the growth rate appear to be lower than it actually is. 
Therefore, the negative growth rate calculated at dilution rates of 0.02 
and O.Olh"^ may be falsely depressed by disintegration of some of the 
non-viable population. The reality may be a growth rate which is 
positive or much closer to zero than has been calculated.
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Figure 5.2 Two-Stage Chemostat Culture. The theoretical growth rate 
assuming 100% viability, and the calculated growth rates accounting for 
the generation of non-viable cells in stage one and stage two of a two-
stage chemostat.
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5.4.2 Monoclonal Antibody Production
The specific rate of antibody production, as well as the volumetric titre 
(steady state concentration), increased with decreasing dilution rate in 
stage one and stage two (Figure 5.3a and b).
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Figure 5.3a The steady state monoclonal antibody titre in both stages of
a two-stage chemostat culture at dilution rates of 0.01 - 0.05h"l.
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Figure 5.3b. Specific rate of monoclonal antibody production in both 
stages of a two-stage chemostat culture at dilution rates of 0.01-0.05h"l,
At high dilution rates the specific production rate was greater in stage 
one, but at the lowest dilution rates was greater in stage two. By 
increasing the mean residence time of a culture due to the addition of a 
second stage, the time available for production by the cells was 
increased, therefore the antibody titre was much greater in a two-stage 
culture compared to a single-stage culture at the same dilution rate, with 
no extra cost in terms of medium, serum and preparation time. For 
example, at a dilution rate of 0.03h“l antibody titre in single-stage 
culture was 32.15 p,g/ml while at the end of two-stage culture at the 
same dilution rate it was 54.07 |ULg/ml. The antibody titre of a single- 
stage chemostat at a dilution rate of 0.02h"l and a mean residence time 
of 50 hours was 33.04 jlg/ml. A dilution rate of 0.04h~^ in a two-stage 
chemostat gives a mean residence time equivalent to a single-stage
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culture at 0.02h"l, i.e. 50 hours, however the antibody titre of the two- 
stage system was 43.15 fxg/ml. A two-stage system can therefore be 
much more productive than a single-stage system. However, at lower 
dilution rates of 0.01 h"l in single-stage and 0.02 h"^ in two-stage, mean 
residence times of 100 hours, the antibody titre was 88.19 jilg/ml in 
single-stage and only 46.55 p,g/ml in two-stage culture. The productivity 
of a fermenter can also be measured in terms of volumetric output. As a 
two-stage system has twice the volume of a single-stage system, to 
maintain or increase volumetric output antibody titre must be at least 
doubled in stage two compared to stage one. Volumetric output from 
stage two was less than stage one at all dilution rates.
The results for specific production rates at high dilution rates are 
consistent with observations in glutamine depleted batch culture, that is, 
antibody production stopped shortly after glutamine ran out, therefore 
we see reduced production in stage two where glutamine is depleted. 
However, the increase in production rate seen in stage two compared to 
stage one at a low dilution rate is not consistent with batch culture. This 
may be partly due to the fact that batch culture results in nutrient 
depletion, while chemostat culture results in nutrient limitation.
There are several other possible reasons why antibody production rate 
was greater in stage two at low dilution rates.
1. Antibody production was better able to compete with growth for 
common precursors or pathways because either a nutrient essential 
for growth but not for production was limiting; or toxins produced 
by the cells may have been inhibiting growth but not antibody 
production. This is supported by the fact that at dilution rates of
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0.02 and O.Olh'^ when the growth rate was negative specific 
monoclonal antibody production was greater, indicating that when 
no cell growth occurs production is greatest.
2. The cells are accumulating in the Gl/GO phase of the cell cycle due 
to their slowed growth rate resulting in opportunity for increased 
production. This is supported by FACScan data which showed that 
the percentage of cells in the various stages of the cell cycle does 
change with growth rate (see section 5.4.6). However, the batch 
culture data demonstrate that this does not necessarily have a 
positive effect on antibody production (see Section 3.4.11).
3. Cells increase production of some proteins when they are subject to 
stress; the cells are likely to be very stressed at low dilution rates 
which may result in greater antibody production rates.
5.4.3 Glutamine Utilisation and Ammonia Production 
Total glutamine decreased with decreasing dilution rate in stage one and 
any remaining from stage one was fully utilised in stage two (Figure 
5.4). The concentration of glutamine in stage two was below the limits 
for accurate measurement by the assay used.
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Figure 5.4. The steady state glutamine concentrations in both stages of a 
two-stage chemostat culture at dilution rates of 0.01 - O.OSh" .^
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Figure 5.5. The steady state ammonia concentrations in both stages of a 
two-stage chemostat culture at dilution rates of 0.01 - 0.05h“l.
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Very little extra ammonia was produced in stage two, reflecting the 
limited amount of glutamine left over from stage one (Figure 5.5). 
Because of the low concentrations involved, a small concentration 
change had a significant impact on the calculated ratio of 
glutamine: ammonia. No significant conclusions concerning the ratio of 
ammonia produced to glutamine utilisation could therefore be drawn 
(data shown in Appendix 8).
5.4.4 Glucose Utilisation and Lactate Production
The specific rate of glucose utilisation showed a general trend of a 
decreasing rate of utilisation with decreasing dilution rate, with a slight 
digression at the dilution rates where a negative growth rate was 
observed (Figure 5.6).
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Figure 5.6. The specific rates of glucose utilisation in both stages of a 
two-stage chemostat culture at dilution rates of 0.01 - 0.05h“l.
Lactate production was once again closely related to glucose utilisation
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(Figure 5.7), and the same trend of decreasing lactate:glucose ratio with 
decreasing growth rate was observed as in stage one.
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Figure 5.7. The specific rates of lactate production in both stages of a 
two-stage chemostat culture at dilution rates of 0.01 - 0.05h"^.
Therefore, in stage two less glucose was utilised more efficiently than 
stage one. There did not appear to be an increased demand for glucose 
as an energy source due to glutamine depletion (data shown in Appendix 
8). At a dilution rate of 0.03h"^ lactate was consumed, this has 
frequently been observed particularly towards the end of a batch culture 
(Velez et a l, 1986).
This result is similar to the trend observed in batch culture 
supplemented with extra glutamine and essential amino acids. During the 
extended stationary phase observed in such a culture glucose is utilised 
at a greatly reduced rate but with very little increase in the lactate
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concentration. Therefore, as in batch culture in chemostat culture at a 
low growth rate, less glucose is being utilised much more efficiently.
5.4.5 Amino Acid Utilisation
The specific rates of amino acid utilisation show a general trend towards 
decreasing rates of utilisation with decreasing growth rate in both stage 
one and stage two. However, at lower dilution rates several amino acids 
were totally exhausted from the medium, while others may have been at 
limiting concentrations. As in batch culture, after glutamine, methionine 
was the first amino acid to become depleted from stage one and two at a 
dilution rate of 0.02 h"^ (data shown in Appendix 9). Tryptophan was 
depleted from stage one and two at a dilution rate of 0.01 h‘ l, while at 
this dilution rate leucine was depleted from stage two only. Histidine and 
isoleucine were also approaching very low concentrations in the second 
stage at a dilution rate of O.Olh"^. Although histidine was present at 
dilution rates of 0.01 and 0.02 h“  ^ none was utilised. Serine was the 
only amino acid which showed an increasing rate of utilisation with 
decreasing growth rate however this did decline at a dilution rate of 
0.01 h"^. The trends of amino acid utilisation for certain amino acids in 
stage two are shown in Figure 5.8.
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Figure 5.8. The specific rates of amino acid utilisation in the second
stage of a two-stage chemostat culture at dilution rates of 0.01 - 0.05h"^, 
negative values indicate net production.
As in batch culture, in chemostat culture proline and alanine were 
produced by the cells, and glycine was produced and consumed. In 
addition arginine and threonine were also both produced and consumed 
in the second stage. The specific rates of utilisation of amino acids were 
less in the second stage than in the first stage of the chemostat culture. 
This is consistent with the reduced growth rate in stage two compared to 
stage one.
5.4.6 Cell Cycle Analysis
The percentages of the cell population in the various stages of the cell 
cycle was determined across the dilution rate range in the two stages of 
the two-stage chemostat. The results are shown in Table 5.1.
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Table 5.1
Cell Cycle Distribution Of NB1 Hybridoma Ceils In 
Two-Stage Chemostat Culture
Dilution 
Rate (h"1) Growth Rate (h-1)
Viability
(%)
Percents 
Stage Of 
Gl/GO
ge Of C( 
The Cell 
S
3lls In 
Cycle G2/M
Stage 1 0 .05 0 .0 5 4 93 4 1 .7 50.7 7.60 .0 4 0.051 79 44.1 4 2 .9 12.9
0 .03 0 .0 3 7 82 4 9 .7 31 .9 18.4
0 .02 0.041 50 4 7 .9 36 .9 9.3
0.01 0 .0 2 4 41 60 .0 3 1 .8 8.2
Stage 2 0 .05 0 .0 2 7 68 55.5 38 .9 5.6
0 .0 4 0 .0 1 7 59 4 9 .0 4 4 .7 6.3
0 .03 0 .0 1 9 46 81 .6 14.2 4.2
0 .02 -0 .0 0 8 20
0.01 -0 .0 0 7 16 6 1 .4 35.3 3.3
In the first stage of a two-stage chemostat there was a general trend 
towards an increasing percentage of cells in the Gl/GO phases of the cell 
cycle with decreasing growth rate while the percentages of cells in the 
other phases of the cell cycle decreased. This is consistent with the 
decreasing viability observed. The same general trend was also observed 
in the second stage of the chemostat culture. This result is consistent 
with other work which has also shown an increase in the percentage of 
cells in the Gl/GO phase with decreasing growth rate in chemostat 
culture (Martens et al., 1993). This suggests the possibility that the 
increase in specific rate of antibody production with decreasing growth 
rate could be the consequence of increased synthesis of antibody in the 
Gl/GO phase compared to the other phases. However, the increase in the 
percentage of cells in the Gl/GO phase of the cell cycle in the second 
stage of a two-stage chemostat is not reflected by an increase in the 
specific production rate compared to stage one. Therefore, with this cell 
line, either the association between cell cycle and specific production is
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incidental or it is also dependent on other factors such as the availability 
of nutrients essential for production. This was also the case for this cell 
line in batch culture (Chapter 3), where cells accumulated in the Gl/GO 
phase of the cell cycle during the decline phase without any increase in 
specific antibody production. In batch and chemostat culture glutamine 
may have been limiting both growth and antibody production.
5.5 CONCLUSIONS
• Two-stage chemostat culture has been shown to be a practical 
possibility in the culture of animal cells, and is a technique which can 
be further used in the study of factors involved in negatively growth- 
associated monoclonal antibody production.
• Steady states in terms of cell concentration, antibody production and 
nutrient utilisation were observed in stage one and stage two of a 
two-stage chemostat at all dilution rates.
• Monoclonal antibody production in both stages of a two-stage 
chemostat culture was negatively growth-associated.
• In the second stage, total cell and viable cell concentration and 
viability decreased with decreasing dilution rate.
• A positive growth rate in the second stage was observed only at 
dilution rates above 0.03 h“ .^ Below this a negative growth rate was 
observed.
• Cell growth appeared to be limited by glutamine in single-stage 
culture and glutamine and several other amino acids in the second
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stage of a two-stage system.
In contrast to batch culture, glutamine depletion in chemostat culture 
did not appear to result in a decline in monoclonal antibody 
production at low growth rates.
The NBl cell line appeared to have a minimum growth rate of 
around 0.02 h“  ^ in single-stage culture and in two-stage culture.
Specific rates of synthesis for the energy catabolites ammonia and 
lactate reflect the rates of glutamine and glucose utilisation 
respectively.
It is possible that other medium components besides glutamine are 
used as energy substrates at low growth rates resulting in increased 
monoclonal antibody production despite the depletion of glutamine.
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6.0 EFFECT OF INCREASING THE 
CONCENTRATION OF POTENTIALLY 
LIMITING AMINO ACIDS ON GROWTH AND 
PRODUCTION IN BATCH CULTURE AND 
TWO-STAGE CHEMOSTAT CULTURE
121
6.1 SUMMARY
The concentrations of specific individual amino acids were increased in 
stirred batch culture of NBl hybridoma cells. This tended to have a 
negative effect on cell growth, and only in some cases had a positive 
effect on antibody production, possibly due to the negative effect on 
growth. The same phenomenon was observed when specific amino acids 
were fed to the second stage of a two-stage chemostat, specific growth 
rate tended to increase while specific production rate tended to decrease. 
An attempt was made to decrease the growth rate of a fed second stage 
by increasing its volume relative to stage one. This also resulted in an 
increased specific growth rate and a consequential decreased specific 
production rate, however, volumetric production was substantially 
increased.
6.2 INTRODUCTION
During the course of a typical batch culture of NBl hybridoma cells 
growth ceased when glutamine was exhausted from the medium shortly 
followed by cessation of monoclonal antibody production. When extra 
glutamine was fed to the culture an extended stationary phase was 
observed during which both growth and production continued. At the 
end of this extended batch culture both methionine and cystine along 
with glutamine were exhausted from the medium and the concentrations 
of several other amino acids were significantly reduced, in particular 
tryptophan, leucine, histidine and arginine. It was thought possible that 
one or other of these amino acids may also be limiting growth and/or 
production in batch culture. Therefore an experiment was set up in 
which batch cultures of NB1 hybridoma cells were supplemented with 
double the concentration of these particular amino acids. Duval et al. 
(1991) showed that for their particular cell line vitamins were a limiting
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nutrient in batch culture. Therefore a batch culture of NB 1 hybridoma 
cells was also set up in which the vitamin concentration was doubled.
In two-stage chemostat culture, besides glutamine depletion, cystine 
appeared to be depleted at all dilution rates, while at the lower dilution 
rates methionine, tryptophan and leucine were depleted.
It was hoped that by supplementing batch culture with the potentially 
limiting amino acids their relative importance in growth and production 
would be revealed by increasing or decreasing the viable cell 
concentration and/or final antibody titre. By feeding the second stage of 
a two-stage chemostat with the potentially limiting amino acids and 
observing the effects on growth and production their relative 
importance may be determined under more controlled steady state 
conditions.
6.3 AIM
At low dilution rates in chemostat culture and towards the end of batch 
culture certain amino acids were depleted from the medium, or present 
at very low concentrations. The reduced concentration of these amino 
acids may be having a negative or positive effect on growth and/or 
monoclonal antibody production. The effect on growth and production 
of supplementing the medium with these amino acids was studied in 
batch and two-stage chemostat culture.
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6.4 RESULTS AND DISCUSSION
6.4.1 Batch Culture
The effect of increasing the concentration of a particular amino acid on 
growth and production in stirred batch culture was determined by 
calculating the maximum specific growth rate and the maximum specific 
production rate by the partial cubic spline method. The total viable cell 
hours (integral of the viable cell curve), and the amount of antibody 
produced per viable cell hour were also calculated. Calculation of p-max 
and maximum q^ntibody iii^icates the effect of an amino acid on the
interaction between growth and production. Calculation of viable cell 
hours demonstrates how effective the particular amino acid is at 
maintaining viability without necessarily effecting specific growth rate. 
Calculation of antibody produced per viable cell hour gives the overall 
specific production rate throughout the entire period of the batch 
culture without placing undue emphasis on the maximum specific rate of 
production.
Non-Fed Batch Culture
A compilation of the results for the non-fed batch culture is shown in 
Table 6.1. None of the amino acids added had a positive effect on either 
the maximum viable cell concentration obtained or on the total number 
of viable cell hours. In non-fed batch culture the maximum viable cell 
concentration observed was 1.53 xlO^ cells/ml. The maximum viable 
cell concentration seen in the amino acid supplemented cultures was in 
the range of 1.11 - 1.34 xlO^ cells/ml. This was also reflected in the 
total viable cell hours of the cultures. The total viable cell hours of the 
control culture was 95.54 hours, while the other cultures were in the 
range of 73.19 - 80.13 hours. The negative effect of adding double the
124
concentration of certain amino acids on cell growth was also reflected 
by the calculated Pmax, which for the control was 0.072 h“l, while the 
other cultures were in the range of 0.046 - 0.065 h"T The maximum 
growth rate of the control culture was greater than that observed in 
earlier batch culture experiments. Many factors may have contributed to 
this variation including variability in media, serum and culture 
conditions. This fact highlights the need to design experiments which 
are complete within themselves and the care which must be taken in 
making comparisons between experiments performed at different times.
Table 6.1
Results of Unfed Batch Culture Supplem ented With 2X 
C oncentration of Specified Amino Acids
Culture
Supplement
Maximum 
Viable Cell 
Concentration
(x10^/ml)
Final
Antibody
Titre
(ug/ml)
Viable Cell 
Hours/ml 
(x10"^)
Antibody 
per 10^  
Viable Cell 
Hours 
(u g /10^  
cell h)
u max 
(h-1)
max q 
antibody 
(ug/IOG 
cells/h)
Control 1.53 2 9 .29 9 5 .5 4 0 .3 0 7 0 .0 7 2 0 .4 6
Leucine 1.31 21.61 7 5 .33 0 .2 8 7 0 .0 5 6 0 .39
Arginine 1.23 19 .37 7 7 .8 0 0 .249 0 .0 6 5 0 .33
Methionine 1.12 3 3 .1 6 7 9 .2 0 0 .4 1 9 0 .0 4 9 0 .8 0
Tryptophan 1.11 41.31 80 .13 0 .5 1 6 0 .0 6 3 0 .58
Cystine 1 .34 3 0 .3 8 7 7 .4 7 0 .3 9 2 0 .0 4 6 0 .5 0
Histidine 1.20 2 5 .6 6 7 3 .1 9 0.351 0 .0 4 7 0 .35
See Appendix 11 for actual concentration of specified amino acid added. 
Although none of the amino acids added to batch culture had a positive 
effect on the total number of viable cell hours or on the maximum
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growth rate, some of them did have a positive effect on production. 
The addition of 2X the concentration of methionine, tryptophan and 
cystine to the batch culture increased the final titre of antibody, the 
amount of antibody produced per viable cell hour, and the maximum 
^antibody addition of 2X the concentration of histidine resulted in 
a decreased final antibody titre and a decreased q^ntibody 
increase in the amount of antibody produced per viable cell hour. 
Therefore, increasing the concentration of methionine, tryptophan, 
cystine and histidine had a negative effect on cell growth but a positive 
effect on antibody production.
Glutamine-Fed Batch Culture
The results are shown in Table 6.2. In glutamine-fed batch culture once 
again the addition of extra amino acids did not increase the total viable 
cell hours. However, the addition of 2X the concentration of tryptophan 
increased the maximum viable cell concentration to 1.64 xlO^ cells/ml 
compared to 1.43 xlO^ cells/ml for the control. The addition of the 
other amino acids resulted in a lower maximum viable cell 
concentration. The increase in viable cell concentration of the 
tryptophan supplemented culture was reflected in the increased Pmax of 
0.067 h"^ compared to 0.061 h"^ for the control. All other cultures 
showed a decreased Pmax relative to the control.
The addition of 2X the concentration of methionine and cystine 
increased the final antibody titre compared to the control. Methionine, 
cystine and histidine increased the concentration of antibody produced 
per cell hour as well as the maximum q^nUbody- the other amino 
acids, apart from arginine, increased the maximum q^ntibody illative to 
the control. However, this was not reflected by increased final antibody
126
titre due to their negative effect on total viable cell hours.
The addition of extra vitamins to glutamine-fed batch culture had a 
negative effect on cell growth and monoclonal antibody production.
Table 6.2
Results of Glutamine Fed Batch Culture Supplem ented  
With 2X Concentration of Specified Amino Acids
Culture
Supplement
Maximum 
Viable Cell 
Concentration
(x1 oG/ml)
Final
Antibody
Titre
(ug/ml)
Viable Cell 
Hours/ml 
(xIO-G)
Antibody 
per 1 oG 
Viable Cell 
Hours 
(ug/1 oG 
cell h)
ix max 
(h-1)
max q 
antibody 
(ug/1 OG 
cells/h)
Control 1.43 7 7 .6 2 154 .86 0.501 0.061 0 .43
Leucine 1.44 6 4 .2 0 133 .70 0 .4 8 0 0 .0 5 3 0 .6 0
Arginine 1.22 6 2 .2 7 1 3 3 .57 0 .4 6 6 0 .0 5 0 0 .4 0
Methionine 1.06 8 0 .8 0 132 .82 0 .6 0 8 0 .0 5 0 0 .57
Tryptophan 1.64 62 .93 1 32 .15 0 .4 7 6 0 .0 6 7 0 .56
Cystine 1.18 8 0 .3 5 1 3 8 .6 4 0 .5 8 0 0 .0 5 7 0 .52
Histidine 1.06 66 .75 128 .52 0 .5 1 9 0 .0 4 9 0 .57
Vitamins 1.22 5 9 .6 0 129.51 0 .4 6 0 0.051 0 .55
From the results of this experiment it would appear that 
supplementation of batch culture with 2X the concentration of an 
individual amino acid has a negative effect on cell growth and a negative 
or positive effect on monoclonal antibody production. It is difficult 
under these conditions to determine whether the extra amino acid 
/ ^ ^ fe c te d  antibody production directly or whether it was an indirect
( y
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effect due to its influence on growth rate. However, there was no 
apparent correlation between Pmax and q^ntibody suggest that a 
decrease in pmax resulted in an increase in q^ntibody ^  possible reason
for the observed negative effect of increased amino acid concentration 
on cell growth could have been the influence of competition between 
amino acids for access to amino acid transport systems into the cell. 
Therefore, by increasing the concentration of one amino acid another 
amino acid sharing the same transport mechanism may become limiting. 
The possibility of this occurring is highlighted by the fact that when all 
amino acids were added to the culture medium (Chapter 3) increased 
growth and production were observed, however, addition of individual 
amino acids had a negative effect on growth. Duval et al. (1991) also 
observed that addition of all consumed amino acids resulted in increased 
growth and antibody production, while selective addition of only four 
of the most rapidly consumed amino acids did not increase cell 
concentration or extend the life span of the culture. This will be 
discussed in Chapter 8.
6.4.2 TWO-STAGE CHEMOSTAT CULTURE
The positive effect of glutamine, cystine, methionine and tryptophan on 
monoclonal antibody production was further studied in two-stage 
chemostat culture.
The second stage of a two-stage chemostat was fed with additional 
glutamine to give an added concentration of 4 pmoles/ml, i.e. equal to 
the concentration in the first stage feed. The dilution rate in stage one 
was 0.030h"^ and in stage two was 0.032h"T The difference in dilution 
rate was the equivalent of only 4ml/h so as to make these results 
comparable to a control with no second stage feed and therefore a
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dilution rate of 0.03Oh'^ in stage one and two. Experiments were also 
run in which the second stage was fed with glutamine and cystine, 
glutamine and methionine, and glutamine and tryptophan all at 
concentrations equal to the first stage feed (i.e. glutamine: 4pmoles/ml: 
cystine: 0.26pmoles/ml; methionine: 0,18pmoles/ml; tryptophan: 
0.06pmoles/ml). For each alteration of the second stage feed, the 
conditions in the first stage remained constant. The effects of a second 
stage feed on growth and production are shown in Table 6.3.
Table 6.3
Effect Of A Second S tage  Amino Acid Feed On Growth 
And Monoclonal Antibody Production
Amino Acid 
Feed
Viable Cell 
Concentration
(x10G/ml)
Specific
Growth
Rate
(h-1)
Antibody
Concentration
(ug/ml)
Specific 
Production 
Rate 
(ug/1 oG viable 
cells/h)
Volumetric
Production
Rate
(m g/l/h)
Control 1.22 0 .0 1 4 5 27 .03 0 .3 3 4 0 .4 0 7
Glutamine 1.72 0 .0 2 1 3 2 8 .78 0 .2 5 2 0 .4 3 3
Glutamine + 
Cystine 1.23 0 .0 2 1 7 24 .69 0 .2 4 6 0 .3 0 2
Glutamine + 
Methionine 1.65 0 .0 3 6 4 2 6 .79 0 .2 2 4 0 .3 7 0
Glutamine + 
Tryptophan 1.46 0 .0 2 5 4 32.61 0 .3 6 6 0 .5 3 5
A glutamine feed to the second stage of a two-stage chemostat resulted 
in an increase in the specific growth rate of the culture and a decrease in 
the specific antibody production rate. Such a result is in keeping with 
the negatively growth-associated antibody production kinetics observed 
in chemostat cultme (Chapters 4 and 5). The increased growth rate also
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adds to the evidence for glutamine being the growth-limiting substrate 
in the first stage of a two-stage chemostat. The specific rate of 
glutamine utilisation in the first stage of the chemostat was 0.0577 
pm oles/lO ^ cells/h, while in the unfed second stage it was 0.0144 
pmoles/loG cells/h. When glutamine was fed to the second stage, the 
specific rate of utilisation increased to 0.0321 pmoles/lO^ cells/h.
In the two-stage chemostat results presented in Chapter 5 cystine was 
indicated as a possible growth-limiting substrate due to its apparent 
depletion from the medium. However it is possible that its depletion was 
due to its instability in the HPLC assay used. When glutamine and 
cystine were fed to the second stage of the two-stage chemostat there 
was no increase or decrease in specific growth rate or specific antibody 
production rate compared to the glutamine only fed culture. However, 
the specific rate of cystine utilisation did increase from 0.0004 
pmoles/lO^ cells/h to 0.0055 pmoles/lO^ cells/h. This is most probably 
the result of an exaggerated depletion of cystine from the medium due 
to its instability in the HPLC assay. The fact that the cell and antibody 
concentration was unchanged compared to the glutamine only fed 
second stage suggests that cystine was not a hmiting nutrient along with 
glutamine. This result also suggests that an increased cystine 
concentration does not have a positive or negative effect on growth or 
production in two-stage chemostat culture.
A glutamine and methionine feed to the second stage resulted in an 
increased specific growth rate and in a decreased specific production 
rate relative to the control and glutamine only fed second stage. This 
result may either indicate that besides glutamine, methionine was also at 
a growth-limiting concentration, or that an increased methionine
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concentration had a positive effect on growth rate. Out of an initial 
concentration of 0.20 pmoles/ml of methionine in DMEM, 0.06 
pmoles/ml remained for stage two at a dilution rate of 0.03 h“l. In stage 
one methionine was utilised at a rate of 0.0025 pm oles/lO^ viable 
cells/h, but was being supplied to stage two at a rate of 0.0018 pmoles/h. 
Therefore it is possible that methionine could be a limiting nutrient in 
stage two. The specific rate of methionine utilisation was unchanged at 
0.0006 pm oles/10^ cells/h in the non fed and the glutamine and 
methionine fed second stages, but the volumetric rate of methionine 
utilisation was increased from 0.0007 millimoles/l/h to 0.0010 
millimoles/l/h, reflecting the increased concentration of viable cells. The 
decrease in specific antibody production rate is in keeping with 
negatively growth-associated production.
These results suggest that the positive effect increased concentrations of 
glutamine, cystine and methionine had in batch culture was caused 
indirectly by effecting the growth rate of the cell.
A glutamine and tryptophan feed to the second stage of a two-stage 
chemostat resulted in an increased specific growth rate and an increased 
specific production rate relative to the control and the glutamine-fed 
culture. Compared to the glutamine and methionine fed culture the 
specific growth rate was less but the specific production rate was 
greater. This suggests that tryptophan is able to have a positive effect on 
antibody production as well as on cell growth. This result goes against 
the trend of decreasing production rate with increasing growth rate, and 
therefore suggests that in batch and chemostat culture tryptophan has a 
positive effect on production rate independently of growth rate.
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Overall, these results suggest that feeding amino acids to the second 
stage of a chemostat had a negative effect on antibody production 
because it had a positive effect on cell growth. A more satisfactory 
method of increasing the specific production rate in stage two of a 
chemostat culture may therefore be to feed the second stage whilst 
maintaining a low growth rate. This is theoretically possible by 
increasing the volume of the second stage relative to the first stage so 
that the dilution rate in the second stage is decreased. The feasibility of 
achieving this with NB 1 hybridoma cells was tested.
6.4.3 TWO-STAGE CHEMOSTAT CULTURE WITH UNEQUAL 
VOLUMES
A two-stage chemostat was set up in which the dilution rate of the first 
stage was 0.03h“  ^ feeding into a second stage with an increased volume 
and therefore a decreased dilution rate of 0.02h"l. The effect of this 
‘shift down’ in dilution rate on growth and monoclonal antibody 
production was observed when the second stage was not fed, fed with 
extra glutamine, and fed with all amino acids present in DMEM. The 
concentration of the amino acid feed into the second stage was equal to 
the amino acid feed into the first stage,The results are shown in Table 
6.4.
The results were taken from one chemostat experiment after four volume 
changes had passed and a steady state was observed in the second stage. 
Glutamine was fed into the second stage of the glutamine fed culture at a 
rate of 17.04 mg/l/h to replace the 17.04 mg/l/h of glutamine utilised in 
stage-one, calculated from the results for stage-one given in Appendix 9. 
When all amino acids utilised in stage-one were fed into the second stage 
the rate at which they were fed (calculated from the results for stage-one 
in Appendix 9) is given in Appendix 12.
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Table 6 .4
E ffec t  Of A Shift-D ow n In Dilution R a te  On S eco n d  
S ta g e  G row th And M onoclonal A n tib o d y  P rod u c tio n
Second Viable Cell Specific Antibody Specific Volumetric
Stage Concentration Growth Titre Production Rate Production
Feed and Viability 
(x1 ^ / m l )
Rate (h‘ 1) W /m l) (jxg/1 oG viable 
cells/h)
Rate (m g/l/h )
Control 0.à9
24%
0.0180 38.93 0.271 0.268
Glutamine
Total
1.66
44%
0 .0 2 1 0 39.78 0.198 0.329
Amino
Acids
1.65
72%
-0.001 46.09 0.365 0.603
The specific growth rate of the second stage control culture was 0.018 
hr^ compared to 0.015 h'^ in the equal volumed second stage. Having a 
shift down in dilution rate did not therefore decrease the specific 
growth rate. Once again the specific production rate decreased as the 
specific growth rate increased when the second stage was fed with 
glutamine. When total amino acids were fed, the viability of the culture 
was increased from 24% for the control to 72%, but the total cell 
concentration decreased relative to stage one giving a negative growth 
rate. Specific production rate increased, but the most dramatic increase 
was seen in the volumetric production rate which increased from 0.268 
mg antibody/l/h to 0.603 mg antibody/l/h.
The second stage of a two-stage chemostat culture therefore appeared to 
resist attempts to achieve a low specific growth rate and an increased 
specific production rate through feeding the second stage with extra 
nutrients. However, increases in growth and antibody productivity were 
seen in terms of the volumetric rates.
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6.5 CONCLUSIONS
• The addition of increased concentrations of individual amino acids 
had a negative effect on cell growth in batch culture, but in some 
cases had a positive effect on antibody production. The positive 
effect on production was likely to be due to the negative effect on 
cell growth.
• Feeding the second stage of a two-stage chemostat with particular 
amino acids had a positive effect on cell growth and a negative effect 
on antibody production, except when glutamine and tryptophan were 
the feed in which case growth and production increased.
• Reducing the dilution rate in stage two compared to stage one did not 
decrease the specific growth rate compared to a two-stage chemostat 
with equal dilution rates in stage one and two. However, it did 
increase the volumetric production rate.
• Feeding the second stage of a two-stage chemostat decreased the 
specific production rate of antibody but increased the volumetric 
production rate, due to the increase in the viability of the second 
stage.
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7.0 THE EFFECT OF AMINO ACID 
LIMITATION ON GROWTH AND ANTIBODY 
PRODUCTION DURING BATCH CULTURE OF 
NBl HYBRIDOMA CELLS
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7.1 SUMMARY
Fifteen stirred batch cultures of NB1 hybridoma cells were set up. In 
each culture the concentration of a different amino acid was reduced in 
order to observe the effect, on growth and antibody production, of 
depletion of a specific amino acid. Depending on which amino acid was 
reduced in concentration in the medium, the percentage of antibody 
produced during the decline phase of the culture ranged from 2% to 
69% of the total. Based on these observations in stirred batch culture, 
amino acids were classified into those whose depletion had a positive 
effect on antibody production and those whose depletion had a negative 
effect on antibody production. This classification was tested in batch and 
two-stage chemostat culture to see if depletion of all amino acids whose 
limitation had a positive effect on antibody production could be used to 
increase the productivity of batch and chemostat culture.
7.2 INTRODUCTION
The addition of extra amino acids in batch and two-stage chemostat 
culture appears in certain cases to be able to increase antibody 
production either by increasing the concentration of viable cells and 
therefore increasing volumetric production, or by increasing the 
specific production rate. In two-stage chemostat culture the 
supplementation of the second stage with various amino acids generally 
resulted in increased specific growth rates and decreased specific 
production rates. Attempts to maintain a low growth rate while feeding 
the second stage by decreasing the dilution rate relative to the first stage 
were unsuccessful, however an increased volumetric production rate 
was observed. An alternative method is therefore necessary in order to 
optimise specific antibody production in the second stage of a two-stage 
chemostat.
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In batch culture glutamine has been shown to be an essential amino acid 
for growth and antibody production. However, it does not necessarily 
have to be the case that all amino acids are equally important for both 
growth and production. A concentration of a particular amino acid 
which is limiting in terms of growth may not be limiting for antibody 
production. Therefore when growth is limited on that particular amino 
acid, production may be able to continue in the absence of growth. If 
such an amino acid(s) was found, it may be possible to limit growth in 
the second stage of a two-stage chemostat on a nutrient which is more 
essential for growth than antibody production. Therefore growth will be 
inhibited but production will have a competitive advantage and will 
continue, hopefully at a greater specific production rate due to the 
slowed growth rate of the cell.
In a typical batch culture in serum supplemented DMEM growth and 
antibody production cease when glutamine is depleted at about 60 hours. 
Therefore DMEM media were made up in which the concentration of an 
amino acid intended to become limiting before glutamine was reduced 
so that under normal batch culture conditions it would have become 
limiting by 45 hours. Fifteen media were made up each with a different 
limiting amino acid and a control of normal strength DMEM was 
included in which glutamine was the limiting nutrient.
The concentrations of the limiting amino acids are given in Appendix 13.
7.3 AIM
The aim of this set of experiments was to reduce the concentration of an 
individual amino acid in the medium so that it would become the first 
nutrient to limit growth in batch culture. If production of antibody then 
continued into the decline phase of the culture it could be assumed that
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the limiting amino acid was not so important in terms of production, 
whereas if growth and production ceased simultaneously this would 
suggest that the limiting amino acid was necessary for both.
7.4 RESULTS AND DISCUSSION
7.4.1 Batch Culture Limited on Individual Amino Acids
Batch culture experiments were performed in stirred spinner bottles. A
compilation of the results are shown in Table 7.1 while specific
utilisation rates of amino acids are given in Appendix 10.
The amino acid concentrations from which the utilisation rates in
Appendix 10 are calculated are given in Appendix 14.
Control:
At 66 hours glutamine was depleted from the medium and the culture 
entered the decline phase. In order to make comparisons between 
cultures grown under different amino acid limitations, the effect of 
limitation on growth and production was determined by calculating total 
viable cell hours of the whole culture, antibody produced per viable cell 
hour, and the percentage of total antibody produced during the decline 
phase of growth. In the control culture 36% of the total antibody 
produced was produced during the decline phase and the antibody was 
produced at a rate of 0.197 [ig/cell hour.
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Table 7.1
E ffect Of Amino Acid Limitation On Growth And A ntibody
Production In Batch Culture
Limiting 
Amino Acid
Maximum 
Viable Cell 
Concentration
(xlO^/ml)
Total
Antibody
(ug/ml)
Total Viable 
Cell Hours 
(x10-G/ml)
% Antibody 
Produced in 
Decline Phase
Antibody/ 
10® Cell 
Hours 
(u g /1 0^ 
cell h)
Tryptophan 0 .46 1.94 13.76 0 0.141
Serine 0 .83 6 .16 4 2 .8 9 2 0 .1 4 4
Lysine 1.24 11.03 56 .95 18 0 .1 9 4
Threonine 0.43 6 .60 23 .05 18 0 .2 8 6
Methionine 1.04 10 .40 53.71 24 0 .1 9 4
Phenylalanine 1.09 9 .48 57 .29 25 0 .1 6 5
Valine 1.17 13 .22 5 5 .3 4 28 0 .2 3 9
Arginine 1.22 9 .68 4 8 .3 2 30 0 .2 0 0
Tyrosine 0 .97 10 .57 54 .72 33 0 .1 9 3
Control 1 .7 2 1 7 .1 8 8 7 .3 9 3 6 0 .1 9 7
Glycine 1.20 18.66 7 3 .8 2 37 0 .2 5 3
Histidine 1.74 17 .68 84 .35 4 9 0 .2 1 0
Cystine 1.15 2 0 .4 8 6 6 .80 54 0 .3 0 7
Leucine 1.65 2 1 .77 8 5 .89 62 0 .2 5 3
Isoleucine 1.62 26 .15 1 0 2 .9 4 69 0 .2 5 4
Glycine Limited:
Glycine is both consumed and produced by this cell line in culture, 
therefore it was not surprising that at 48 hours glutamine and an 
increased concentration of glycine were present in the medium. Growth 
therefore continued until 62 hours when glutamine was depleted from 
the medium. This culture was therefore a reflection of glutamine rather 
than glycine limitation. 37% of the antibody was produced during the 
decline phase compared to 36% in the control culture. Glycine can 
therefore be classed as a non essential amino acid for this cell line. 
There was no significant change in the rates of amino acids utilised 
during the first 48 hours in terms of jamoles of amino acid utilised per
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viable cell hour.
Lysine, Methionine, Phenylalanine, Valine and Tyrosine Limited:
The lysine, methionine, phenylalanine, valine and tyrosine limited 
cultures all responded in a similar manner to their limitation. The 
limiting amino acid and glutamine both reached limiting concentrations 
at 48 hours, therefore the effect of the limitation in the presence of 
glutamine was not observed during the decline phase. However, the 
percentage of antibody produced during the decline phase was less than 
the 37% observed in the glutamine only limited culture (see Table 7.1). 
Limitation on these five amino acids individually appeared to have a 
negative effect on both cell growth and antibody production, reflected 
by a decrease in total viable cell hours and a decrease in the percentage 
of antibody produced during the decline phase. However, the amount of 
antibody produced per viable cell hour was less than the control for 
lysine, methionine, phenylalanine and tyrosine limitation but greater 
than the control for valine limitation.
Threonine Limited:
At 48 hours of culture threonine and glutamine were still present in the 
medium therefore the growth phase continued until 62 hours. However, 
the growth observed in this medium was very poor with a maximum 
viable cell concentration of 0.43 xlO^ cells/ml compared to 1.72 xlO^ 
cells/ml in the control culture. The threonine concentration was 
therefore limiting growth. Although the percentage of antibody 
produced during the decline phase was less than the control at 18%, the 
concentration produced per viable cell hour was greater than the control 
at 0.286 jag/10^ viable cell hour compared to 0.197 jag/10^ viable cell 
hour. This suggests that threonine limitation has a negative effect on cell
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growth but a direct or indirect positive effect on antibody production. 
Serine Limited:
Glutamine reached a limiting concentrations at 48 hours at which point 
growth and production ceased. However serine was produced by the 
culture. In typical batch and chemostat culture net utilisation and 
production of serine have both been observed during the course of the 
same culture (see Chapters 3, 4, and 5). An enhanced capacity for serine 
synthesis in cancer cells has been reported as well as it being 
preferentially directed towards the provision of nucleotide precursors 
(Snell et al., 1987). However, this does not explain the net production of 
serine in a culture where its concentration was limiting growth unless 
the cells were unable to maintain a high enough internal concentration 
of serine. Glutamine showed an increased rate of utilisation during the 
first 48 hours. The amount of glutamine utilised per viable cell hour 
increased from 0.121 [imoles to 0.228 jxmoles in the serine limited 
culture. The effect of serine limitation in the presence of glutamine was 
not observed during the decline phase. However, only 2% of the 
antibody was produced during the decline phase which is significantly 
less than the 37% in the glutamine only limited culture.
Tryptophan Limited:
At 48 hours of culture tryptophan and glutamine were still present in 
the medium, however the growth phase ceased at 16 hours. The growth 
observed in this medium was very poor with a maximum viable cell 
concentration of 0.46 xlO^ cells/ml compared to 1.72 xlO^ cells/ml in 
the control culture. The tryptophan concentration was having a limiting 
effect on growth even though it was being produced by the cell. As with 
serine limitation, glutamine was the only amino acid whose rate of
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utilisation was increased significantly by the tryptophan limitation. 
Glutamine utilisation increased from 0.121 jimoles/lO^ viable cell hour 
in the control to 0.348 jLimoles/lO^ viable cell hour in the tryptophan 
limited culture. Less than 2 fig/ml of antibody was produced during the 
culture, and the production rate was the lowest seen at 0.071 jag/10^ 
viable cell hour.
Arginine Limited:
At 48 hours the culture entered the decline phase even though arginine 
and glutamine were still present in the medium. However, arginine was 
produced by the culture rather than consumed. Although arginine was 
being produced by the cells its concentration in the medium had a 
negative effect on growth, total viable cell hours were decreased to just 
over half of the control. Although arginine limitation decreased the 
percentage of total antibody produced during the decline phase to 30%, 
it did not have a negative effect on the rate of antibody produced per 
cell hour. Arginine limitation therefore had a negative effect on cell 
growth without effecting antibody production except during the decline 
phase. All amino acids were utilised at a decreased rate in terms of 
jamoles/viable cell hour.
Cystine Limited:
At 48 hours cystine and glutamine were still present in the medium at 
which point the culture entered a stationary followed by a decline phase. 
As the culture entered a stationary phase at 48 hours and the 
concentration of cystine in the medium changed very little from that 
point until the end of the culture it is likely that although cystine was 
present its concentration was limiting to growth. 54% of the antibody 
was produced during the decline phase which is significantly greater
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than the 36% produced in the control. This suggests two possibilities: 1) 
cystine is essential for growth but not for production so that when 
growth stops production can continue, or 2) the concentration of cystine 
which is limiting for growth is not limiting for antibody production, 
therefore when growth stops production is able to continue. Not only 
was the percentage of antibody produced in the decline phase greater 
than the control, but also the final antibody titre was greater despite the 
total viable cell hours being less. The amount of antibody produced per 
viable cell hour was therefore greater than the control. There was no 
significant change in the rates of amino acids utilised during the first 48 
hours in terms of jimoles of amino acid utilised per viable cell hour.
Histidine Limited:
At 48 hours histidine and glutamine were still present in the medium 
and growth continued until 66 hours when histidine was depleted but not 
glutamine. 49% of the total antibody was produced during the ensuing 
decline phase. Histidine limitation did not therefore appear to have a 
negative effect on antibody production.
Leucine Limited:
At 48 hours leucine and glutamine were still present in the medium. 
However, at 48 hours the culture entered the decline phase. At this point 
enough glutamine was still present in the medium for it to not be 
limiting to growth suggesting that growth was limited by the decreased 
leucine concentration. In terms of jimoles utilised/10^ viable cell hour, 
all the amino acids were utilised to a lesser extent than in the control 
culture. Antibody production continued during the decline phase with 
62% of the total production occurring after leucine was limiting 
growth. As with cystine limitation, this suggests that 1) leucine is
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essential for growth but not for production so that when growth stops 
production can continue, or 2) the concentration of leucine which is 
limiting for growth is not limiting for antibody production, therefore 
when growth stops production is able to continue.
Isoleucine Limited:
At 48 hours isoleucine and glutamine were still present in the medium. 
However, at 48 hours the culture entered the decline phase. As 
glutamine was still present at a concentration known not to inhibit 
growth it was assumed that the concentration of isoleucine was growth- 
limiting. Decreased rates of utilisation were observed for all amino 
acids during the growth phase compared to the control culture. 
Antibody production continued during the decline phase with 69% of 
the total production occurring after isoleucine was limiting to growth.
Leucine and isoleucine limitation appears to cause an alteration in the 
kinetics of antibody production from growth-associated production to 
growth-dissociated production. A possible reason for the change in the 
kinetics of production may be due to the reported effect of isoleucine 
limitation on the cell cycle. Ley and Tobey (1970) reported that cultures 
of Chinese hamster cells (line CHO) when grown in isoleucine depleted 
medium were arrested in the G1 phase of the cell cycle. A normal cell 
cycle was reinitiated upon addition of isoleucine. The increased 
production of antibody during the decline phase is consistent with other 
observations of increased production coinciding with accumulation of 
cells in the Gl/GO phase of the cell cycle. This cell line did not 
demonstrate increased production with accumulation of cells in the 
Gl/GO phase of the cell cycle under glutamine limiting conditions but 
the possibility of this occurring under different limitations, such as
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leucine and isoleucine, cannot be ruled out.
Based on this set of experiments four groups of amino acids have been 
identified:
1. Those which are consistently consumed and whose limitation has a 
negative effect on both growth and production.
i.e. Lysine, Methionine, Phenylalanine, Valine, Tyrosine, 
Threonine.
2. Those which are produced by the cells but which still have a 
negative effect at low concentrations on growth and production, 
i.e. Serine, Tryptophan, Arginine.
3. Those whose limitation has no effect on growth and production, 
i.e. Glycine.
4. Those amino acids whose limitation has a negative effect on growth 
but a positive effect on production.
i.e. Cystine, Histidine, Leucine, Isoleucine.
If this is the case then it should be possible to limit growth on the amino 
acids of group 4 in the second stage of a two-stage chemostat culture and 
observe continued production, or even increased specific production. 
Limitation on any other amino acids would be expected to decrease 
antibody production.
7.3.2 Limitation of Batch Culture on Groups of Amino Acids 
The conclusions drawn from the previous experiment were tested in 
stirred batch culture. After 45 hours of culture amino acids were added 
to the culture at a concentration equivalent to the concentration utilised 
up to that point, i.e. after 45 hours all amino acids were returned to 
their original concentration in DMEM, apart from certain amino acids
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which were left out. Four cultures were set up as follows: 1. extra 
glutamine added; 2. all amino acids added; 3. all amino acids added 
except for those whose limitation had a negative effect on growth but a 
positive effect on production (i.e. Group 4); 4. all amino acids added 
except for leucine and isoleucine.
It would be expected that when amino acids whose limitation is thought 
to have a positive effect on production are not added to a culture then 
antibody production should be greater than in the controls of glutamine 
and total amino acid fed cultures. As leucine and isoleucine limitation 
had the greatest positive effect on production they were jointly left out 
of one culture. A major assumption made in this experiment was that by 
not adding a particular amino acid whilst adding all others that 
particular amino acid would be at a limiting concentration in the 
culture, however this could not be guaranteed. The results of the 
experiment are shown in Table 7.2.
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Table 7 .2
R esults o f Supplem enting Batch Culture With All DMEM 
Amino Acids Except For Those W hose Limitation Had A 
Positive E ffect On A ntibody Production
Culture
Supplementation
Final Antibody Titre 
(ug/ml)
Total Viable 
Cell Hours 
(x10"®/ml)
Antibody/10^ 
Viable Cell Hours 
(ug/1 O^cell h)
Glutamine 58 .16 184 .83 0 .3 1 5
All DMEM Amino 
Acids 52 .03 1 6 0 .9 7 0 .3 2 3
All DMEM Amino 
Acids Except 
Those In Group 4
5 2 .27 165 .9 9 0 .3 1 5
All DMEM Amino 
Acids Except 
Leucine and 
Isoleucine
68 .85 165.11 0 .4 1 7
Adding extra amino acids to the batch cultures had a negative effect on 
cell growth compared to the glutamine only supplemented culture. It 
also had a negative effect on total antibody produced while having no 
significant effect on the rate of antibody production per viable cell hour. 
The exception was when leucine and isoleucine were omitted from the 
added amino acids. In this case the amount of antibody produced per 
viable cell hour was 25% greater than the other cultures. This is in 
keeping with the previous results showing that leucine and isoleucine 
limitation had a positive effect on antibody production in batch culture. 
This result can be more stringently tested under the steady state 
conditions experienced in chemostat culture.
7.4.3 Two-Stage Chemostat Culture
147
A two-stage chemostat culture was set up in which the first stage was fed 
with serum supplemented DMEM at a dilution rate of 0.03 h"^, while 
the second stage was fed with all amino acids present in DMEM, all 
amino acids present in DMEM except for those whose limitation had a 
positive effect on antibody production in batch culture, and finally all 
amino acids except for isoleucine at a dilution rate of 0.02 h“ .^ The 
results are shown in Table 7.3.
For amino acid concentrations in second stage feed see Appendix 15.
Table 7 ,3
Results o f Feeding Second S tag e  C hem ostat Culture 
With All DMEM Amino Acids Except For Those W hose 
Limitation Had A Positive E ffect On A ntibody Production
Second Dilution Rate 
(h-1)
Specific Antibody Production Rate _
Stage Feed Growth Rate 
(h-1) Volumetric(m a/l/h)
Specific ( u g /1 0^ 
cells/h)
All DMEM Amino
Acids 0 .02 -0 .0 3 9 0 .3 4 7 0 .4 2 4
All DMEM Amino
Acids Except 
Those In Group 4
0 .02 0 .005 0 .1 7 2 0 .1 4 4
All DMEM Amino
Acids Except 
Isoleucine
0 .02 -0 .0 2 4 0 .1 9 4 0 .2 1 6
Feeding the second stage with anything other than all the amino acids 
present in DMEM had a negative effect on specific and volumetric rates 
of antibody production. However, leaving out only isoleucine from the 
feed resulted in higher productivity than leaving out all group 4 amino 
acids, as was observed in batch culture. The reason for this decrease in 
productivity is probably because the culture was not actually limited on
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isoleucine or any of the other amino acids left out of the feed. A 
substantial amount of isoleucine is left over from stage one which is 
unlikely to be totally utilised in stage two. To overcome this, a medium 
needs to be made up with a reduced concentration of isoleucine so that 
less remains after the first stage. Time did not allow for this to be done.
7.5 CONCLUSIONS
• Amino acids can be classified into those whose limitation has a 
positive effect on antibody production, and those whose limitation 
has a negative effect on antibody production.
• The composition of the medium in which this cell line is grown can 
affect its production kinetics. Depending on which amino acid is first 
to limit growth, the majority of the antibody can be produced in the 
growth phase of the culture or in the stationary and decline phase. 
Therefore media can be designed to alter the kinetics of antibody 
production and to meet the requirements of particular production 
processes
• An amino acid may be at a concentration limiting to growth even if it 
is present in the culture medium.
• The way in which an amino acid limitation has a positive effect on 
antibody production is as yet unknown, but lends support to the 
theory suggesting competition between growth and production 
processes.
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8.0 EFFECT OF AMINO ACID 
CONCENTRATION ON UTILISATION BY NBl 
HYBRIDOMA CELLS
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8.1 SUMMARY
A linear relationship between the initial concentration of an amino acid 
and the extent to which it was depleted from the medium was observed 
in batch and chemostat culture. When the initial concentration of a 
particular amino acids was reduced the extent to which it was depleted 
from the medium was also reduced. Cells were grown in media in which 
all amino acids were present at the same initial concentration. The effect 
this had on growth and antibody production was small. The specific rate 
of amino acid utilisation was decreased when they were all present in the 
medium at an equal low concentration. Increasing the concentration of 
amino acids in the medium led to their wasteful utilisation without any 
benefit in terms of increased cell concentration or antibody titre.
8.2 INTRODUCTION
Amino acid utilisation and transport in animal cell cultures has been 
extensively reviewed by Patterson (1972), Wheatley et al. (1986) and 
Christensen (1990). Mammalian cells appear to make relatively few of 
their own amino acids and rely upon an exogenous supply. They also 
appear to use non-essential amino acids from the surrounding medium 
when these are available. There are three main pathways by which 
amino acids may enter cells: by simple diffusion, by facilitated 
diffusion, and by active transport. Although amino acids are charged 
molecules under physiological conditions, and therefore thought by 
some not to be freely diffusible across lipid membranes (Bender, 1985), 
there is evidence to suggest that amino acids can move rapidly and in 
large amounts across cell membranes in the absence of an energy source 
in a manner similar to other penetrating solutes (Wheatley et al., 1986). 
Simple diffusion however is likely to be too slow to meet the demands 
of the cell unless assisted by some form of endocirculation. There is also
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the problem of how cells retain and concentrate such molecules relative 
to the external environment. Facilitated diffusion is thought to offer 
another explanation for amino acid transfer, and it is generally assumed 
that there are protein molecules in the cell membrane which recognise 
amino acids, couple with them, and undergo a conformational change 
resulting in their flipping over to bring the attached amino acid to the 
internal side of the membrane. A further conformational change 
releases the amino acid and the carrying molecule returns to its original 
state. The process is believed to operate to drive amino acid molecules 
into the cell against a concentration gradient. Active transport has been 
the preferred method of explaining amino acid uptake for many years. 
It helps to explain the transfer of hydrophilic molecules across lipid 
membranes, it can account for the accumulation of amino acids against 
steep concentration gradients, and it offers a solution to the quasi- 
enzymic kinetics of uptake which some amino acids seem to follow.
Transporting systems have been characterised by Christensen (see 
Christensen, 1990). They are distinguished on the basis of competition 
between amino acids with one another for entry into the cell. Some 
show a preference for certain types of amino acids such as leucine, 
valine and phenylalanine, others for alanine, glycine and serine. 
Although they are relatively specific for each group of amino acids, 
they can also carry amino acids from other groups with lower affinity. 
In mammalian red blood cells, six transport systems have been identified 
which carry a discrete group of amino acids as well as two broad 
systems with wide specificities (Ellory, 1987). The main systems 
identified in mammalian cells are: Transport System A with preferred 
substrates of alanine, proline, serine, glycine and methionine; Transport 
System L with preferred substrates of leucine, isoleucine.
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phenylalanine, methionine and valine; Transport System ASC with 
preferred substrates of alanine, serine and cystine; and Transport 
System Ly+ with preferred substrates of lysine and arginine. As yet, 
none of these proposed transport systems have been characterised in 
molecular terms and their identification remains based on physiological 
studies, however, a number of mutant cell types have been identified 
which have difficulty in obtaining certain amino acids. Wheatley et al. 
(1986) have proposed that as amino acids are freely diffusible into the 
cell, there is a real possibility that the cell spends its energy holding 
molecules within its cytoplasm rather than in bringing them inside, 
transport into the cell depending on non-energy requiring diffusion 
systems.
It was noted in Chapter 6 that by adding double the concentration of 
particular amino acids to batch culture a decrease in the maximum 
viable cell concentration and in the total number of viable cell hours was 
observed. It was suggested that this might be due to competition between 
amino acids for transport into the cell, resulting in some essential amino 
acids limiting growth. Also, it has been observed that the specific rate of 
utilisation of a particular amino acid is greatest at the start of a batch 
culture, and steadily declines throughout the rest of the culture. This 
could either be due to a requirement by the cell for nutrients necessary 
for increased metabolic activity, or it may be due to the high 
concentration of an amino acid present at the start of a culture, 
reflecting an important role for diffusion as a method for transporting 
amino acids into the cell.
8.3 AIM
The aim of this set of experiments was to observe the effect of amino
153
acid concentration on its utilisation by the cell. This was achieved by 
assessing any correlation between amino acid concentration and 
utilisation in batch and chemostat culture, and by growing NBl 
hybridoma cells in medium containing all the DMEM amino acids at 
equal concentrations, to see how this effected utilisation.
8.4 RESULTS AND DISCUSSION
8.4.1 Typical Batch and Two-Stage Chemostat Culture
The observed relationship between the initial concentration of an amino
acid in DMEM and the extent to which it was utilised by the cell in a
typical batch culture is shown in Figure 8.1.
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Figure 8.1 The observed correlation between the initial concentration 
of an amino acid in DMEM and the extent to which it is utilised by a cell 
population during the course of a glutamine-fed batch culture.
In batch culture of NB 1 hybridoma cells a high correlation between the
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initial concentration of an amino acid and the extent to which it was 
utilised was consistently observed. In single-stage chemostat culture the 
correlation was equally high, as shown in Figure 8.2.
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Figure 8.2 The observed correlation between the initial concentration 
of an amino acid in DMEM and the extent to which it is utilised by a cell 
population in single-stage chemostat culture at a dilution rate of 0.03h"l.
In batch and chemostat culture the correlation between initial 
concentration of an amino acid in DMEM medium, and the amount 
which was utilised suggests that the greater the initial concentration, the 
more that particular amino acid was utilised. This correlation may 
either be a reflection of the actual demand for an amino acid by the cell, 
and therefore suggests a well designed medium, or it may be a reflection 
of the effect concentration has on transporting amino acids into the cell. 
If amino acid transport was a simple diffusion process than it would be 
expected that the more of an amino acid there was present in the
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medium the greater would be its diffusion into the cell. Alternatively, if 
amino acid transport systems are shared between several amino acids, 
unless the transport system was very selective and only transported 
particular amino acids when they were in demand then concentration 
would play a part in deciding how much of a competing amino acid was 
transported into the cell.
When cells were grown in medium limiting in a particular amino acid 
other than glutamine, the decreased concentration of that amino acid was 
reflected by a decrease in its utilisation by the cell. Once again this 
suggests that the concentration of an amino acid in the medium plays a 
significant role in the extent to which it is utilised. This is demonstrated 
for isoleucine utilisation during an isoleucine limited batch culture in 
Figure 8.3. Data taken from Chapter 7 and Appendix 14.
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Figure 8.3 The observed correlation between the initial concentration 
of an amino acid in DMEM and the extent to which it is utilised by a cell 
population during the course of an isoleucine limited batch culture.
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Isoleucine utilisation in DMEM is usually similar to that of leucine, 
because their concentrations are similar (Figure 8.1), however its 
utilisation has been decreased in line with its concentration in an 
isoleucine limited medium.
In the second stage of a two-stage chemostat culture the correlation 
between concentration and utilisation of amino acids did not suggest any 
relationship between the two, as shown in Figure 8.4.
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Figure 8.4 The observed correlation between the initial concentration 
of an amino acid in DMEM and the extent to which it is utilised by a cell 
population in the second stage of a two-stage chemostat culture at a
dilution rate of 0.03h"^.
The results for correlation between amino acid concentration and 
utilisation in two-stage chemostat culture are given in Table 8.1.
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Table 8.1
Correlation In T w o-Stage C hem ostat Culture 
B etw een Initial C oncentration and Utilisation
Of Amino Acids
Dilution Rate Correlation
( h ~ h Stage 1 Stage 2
0 .05 0 .97 0 .47
0 .0 4 0 .97 0 .75
0 .03 0 .97 0 .65
0 .02 0 .98 0 .56
0.01 0 .98 0 .39
These results suggests that the correlation observed in batch and single- 
stage chemostat culture may be incidental, or that when the 
concentration of amino acids in the medium is reduced then diffusion is 
not such an important method of entry into the cell, or that when 
glutamine and other amino acids become limiting then the relationship 
between concentration and utilisation breaks down, ie . that the external 
concentration of the amino acid is approaching the value of the affinity 
constant for that nutrient.
The obvious way of finding out the relative importance of particular 
amino acids in the medium, and whether their utilisation is a reflection 
of demand by the cell or their concentration in the medium, would be to 
grow the cells in a medium in which all amino acids were at an equal 
initial concentration. Two media were made up, one in which all amino 
acids were at a concentration of 0.8 mM, and a second in which all 
amino acids were at a concentration of 321 mg/1. In each case the
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glutamine concentration was equal to that of standard DMEM, 4.0 mM. 
However, two sets of cultures were performed in each medium, one was 
fed with an extra 2.0 p,moles/ml of glutamine at the end of the 
exponential phase, the other was not.
8.4.2 Batch Culture With Equal Concentrations of Amino Acids 
In the control culture a strict correlation between initial amino acid 
concentration and pmoles/ml utilised was observed as before. In the 
culture in which all the amino acids were at an equal molarity an order 
of utilisation based on requirement by the cell rather than concentration 
was observed. The order of priority in terms of pmoles/ml of amino 
acid utilised by the cell was very similar for the two cultures as shown 
in Table 8.2, in which a negative value indicates production.
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TABLE 8.2
Amino Acids In Order Of pm oles Utilised per Viable 
Cell Hour When P resen t At Equal C oncen tra tions In
The Medium
Control All Amino Acids At All Amino Acids At
0.8  mM 321 mg/l
(|i moles/1 O^cell h) ( ill moles/1 O^cell h) (ti moles/1 O^cell h)
GLN 0 .0 2 3 3 GLN 0 .0 2 2 2 GLN 0 .0 3 7 3
LEU 0 .0 0 2 0 LEU 0 .0 0 1 4 LEU 0 .0 0 4 8
THR 0 .0 0 1 6 TYR 0 .0 0 1 2 ILE 0 .0 0 4 3
VAL 0 .0 0 1 6 VAL 0 .0 0 1 2 VAL 0 .0 0 3 8
LYS 0 .0 0 1 5 THR 0 .0 0 1 2 THR 0 .0 0 3 3
ILE 0 .0 0 1 4 ILE 0 .0 0 1 0 LYS 0 .0 0 2 7
ARC 0.0011 LYS 0 .0 0 1 0 SER 0 .0 0 2 4
TYR 0 .0 0 0 8 ARG 0 .0 0 0 8 ARG 0 .0 0 2 0
PHE 0 .0 0 0 7 PHE 0 .0 0 0 4 CYS 0 .0 0 1 7
MET 0 .0 0 0 5 SER 0 .0 0 0 3 GLY 0 .0 0 1 6
HIS 0 .0 0 0 4 CYS 0 .0 0 0 2 PHE 0 .0 0 1 6
CYS 0 .0 0 0 4 MET 0.0001 HIS 0 .0 0 1 6
GLU 0 .0 0 0 3 GLU 0 .0 0 0 0 MET 0 .0 0 1 5
SER 0 .0 0 0 2 ASP 0 .0 0 0 0 TYR 0.0011
ASP 0 .0 0 0 0 HIS -0 .0 0 0 0 TRP 0 .0 0 0 2
ASM -0.0001 ASN -0 .0 0 0 2 ASP -0 .0 0 0 2
GLY -0 .0 0 0 2 GLY -0 .0 0 0 4 ASN -0 .0 0 0 4
TRP -0 .0 0 0 3 TRP -0 .0 0 0 4 GLU -0 .0 0 0 8
PRO -0 .0 0 1 9 PRO -0 .0 0 2 7 PRO -0.0031
ALA -0 .0 0 6 9 ALA -0.0071 ALA -0 .0 1 3 6
Although higher concentrations of most of the amino acids were present 
in the 0.8mM equal concentration culture, the pmoles utilised per viable 
cell hour tended to be less, except in the case of serine and tyrosine. 
When all amino acids were at an equal molarity the total number of 
viable cell hours was slightly less, as was the concentration of antibody 
produced per viable cell hour (Table 8.3). However, the fact that the 
difference was so small may be a reflection of the fact that the glutamine 
concentration was the same in both cultures, and growth and production 
was more dependent on the depletion of glutamine than on any of the
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other amino acids which were present in excess.
Table 8 .3
Cell Growth And Antibody Production When Amino 
Acids Were At Equal Concentrations In The Medium
Total Viable Antibody Production 
(u g /1 0 ^  cell h)
Medium Cell Flours 
(xlO'^/ml)
DMEM 164 .6 5 0 .1 8 5
DMEM GLN-Fed 2 4 0 .3 8 0 .2 0 0
8mM Amino
Acids 1 3 1 .5 7 0 .2 0 4
8mM Amino
Acids GLN-Fed 2 3 2 .9 3 0 .1 8 8
321 mg/l Amino
Acids 182 .6 9 0 .2 2 6
321 mg/l Amino
Acids GLN-Fed 163.89 0 .2 2 2
Data for maximum viable cell concentration and concentration of 
antibody produced is given in Appendix 16.
When the amino acids were present at an equal concentration in terms of 
mg/l, their concentration in mM was greater than ImM, except for 
cystine and tryptophan. The order of amino acids in terms of pmoles 
utilised was very similar to the control and the equal molarity cultures 
(Table 8.2). However, the pmoles of amino acids utilised per viable cell 
hour was significantly greater when a much higher concentration of 
amino acid was present. The higher concentration of amino acids 
utilised was not reflected in a higher viable cell concentration, or a 
greater production of antibody (Table 8.3). This would suggest that at 
high concentrations amino acids enter the cell unnecessarily and are
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wastefully metabolised resulting in increased rates of alanine production
(Table 8.2).
8.5 CONCLUSIONS
• The initial concentration of an amino acid in the medium appears to 
affect the rate at which it is utilised, and can therefore lead to 
wasteful utilisation of certain amino acids.
• Increasing the concentration of amino acids in the medium can lead 
to their wasteful utilisation without any benefit to the cell.
• Increasing the concentration of one amino acid may limit the 
availability of another due to competition for entry into the cell.
• When amino acids are present in the medium at high concentrations, 
for example at the beginning of a batch culture, and in the first stage 
ofms ytwo-stage chemostat, diffusion into the cell appears to be the 
mam mode of entry, as demonstrated by the concentration effect on 
utilisation. However, as amino acids become depleted from the 
medium, for example in the second stage of a two-stage chemostat, 
selective transport mechanisms may become more important enabling 
the cell to be more selective in the particular amino acids it takes in 
and the rates at which it takes them in.
• By adding all amino acids at an equal molar concentration, growth 
and production were not increased. This suggests that the differential 
in concentrations between amino acids in DMEM did not result in 
any particular amino acid being limiting. However, the specific rate 
of amino acid utilisation was decreased when they were present in the
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medium at an equal molarity.
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9.0 DISCUSSION
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Monoclonal antibody production by hybridoma cells has been studied 
under a number of different culture conditions which have included 
batch culture, fed-batch culture, continuous culture, perfusion culture 
with and without total cell retention, single-stage chemostat culture, and 
now two-stage chemostat culture. Kinetics of growth and antibody 
production have been studied in these systems as well as the influence of 
various nutritional and physical conditions. A general consensus has 
been reached from these studies that factors which have a negative 
influence on cell growth will often have a positive influence on specific 
rates of antibody production, and that maintaining the viability of the 
cell culture under these stressful conditions, rather than continued 
growth, is the key to increased specific and volumetric production. This 
has led to studies on the manipulation of the cells physical environment 
to inhibit growth while increasing the specific antibody production rate 
by osmotic stress (Oyass et al, 1989; Ozturk et a l,  1992; Oh et a l ,  
1993), temperature extremes (Merten et a l,  1985), low dissolved 
oxygen tension (Reuveny et a l,  1986), low or high pH (Miller et a l ,  
1988), and even the use of metabolic inhibitors to inhibit growth but not 
antibody production (Modha, 1990). Perfusion culture has been used to 
limit cell growth while maintaining high production rates. The 
unhelpful paradox of this situation is that factors which increase the 
specific production rate of antibody by the cell tend to reduce the 
viability of the culture, and therefore do not necessarily result in 
increased volumetric productivity.
The aims of this investigation were to explore the feasibility of growing 
animal cells in a two-stage chemostat system and to use such a system to 
study the growth-associated and growth-dissociated monoclonal antibody 
production kinetics displayed by hybridoma cell lines in batch culture.
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The advantages of a two-stage chemostat culture system over batch are 
that it allows the controlled manipulation of culture conditions and cell 
growth rate during a constant and reproducible steady state, as opposed 
to the constantly changing physiological and cellular conditions 
experienced in batch culture. A two-stage chemostat system is the ideal 
medium in which to study growth-dissociated production kinetics. The 
feasibility of using single-stage chemostat culture is limited due to its 
essential requirement for cell growth, therefore studies on production 
by a non-growing population are not possible. Because the second stage 
of a two-stage system is continually inoculated by the first stage, growth 
is not a prerequisite of operation, therefore non growth-associated 
product formation can be studied under steady state conditions of low 
and zero growth rate.
Initially the kinetics of growth and antibody production by the 
hybridoma cell line NBl were studied in batch culture. Cell growth and 
antibody production ceased when glutamine was depleted at the end of 
the exponential phase of growth. This cell line therefore exhibited the 
characteristics of growth-associated antibody production as classified by 
Pirt (1975) and Merten et al. (1987). However, when batch culture was 
supplemented with extra glutamine growth stabilised at a reduced rate 
during an extended stationary phase while specific production rate 
demonstrated a second peak in a partial cubic spline plot. The specific 
production rate during the stationary phase was equal to, but not greater 
than, the production rate during the exponential phase suggesting that 
production was still growth-associated, or partially growth-associated. 
Negatively growth-associated production would be expected to be 
demonstrated by an increase in specific production rate during the 
decreased growth rate of the stationary phase, instead it remained the
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same. Supplementing batch culture with extra essential and non-essential 
amino acids resulted in increased growth rates and increased specific 
production rates, typical of growth-associated production. However, the 
possibility that the increased specific production rate was due to the 
extra amino acids rather than the increase in specific growth rate was 
not ruled out. The linear correlation between antibody concentration 
and viable cell hours, and the fact that the majority of the antibody was 
produced during the growth phase, provided evidence for antibody 
secretion from viable cells rather than release of an intracellular store 
by dead cells, as demonstrated by Renard et al. (1987).
In general, the kinetics of antibody production observed in batch culture 
have also been observed in chemostat culture, resulting in reports of 
positively growth-associated antibody production (Low et a l,  1987; 
MacMichael, 1989), inversely growth-associated production (Boraston 
et a l ,  1984; Reuveny et a l,  1986; Miller et a l,  1988; and Frame and 
Hu, 1991), as well as growth-dissociated production (Ray et a l,  1989; 
Hiller et a l, 1991).
In this study single-stage chemostat culture demonstrated the negative 
association between growth and production which had been hinted at in 
batch culture. Increasing specific rates of antibody production with 
decreasing growth rate were observed, this is typical of negatively 
growth-associated antibody production. The faà\that positively growth- 
associated and negatively growth-associated antibody production was 
observed by the same cell line but under different culture conditions 
suggested that characteristics of production may depend on the culture 
conditions rather than being absolutes determined by the cell. It is 
possible that when the growth rate of the cell population was decreased
167
by nutrient limitation, specific antibody production increased due to its 
increased competitive advantage. Factors, such as the accumulation of 
cells in the Gl/GO phase of the cell cycle are to the advantage of the 
production process. The growth demands on the cell are lessened during 
the Gl/GO phase of the cell cycle because all of its macromolecular 
synthesis pathways are known to cease, or be reduced, apart from 
protein synthesis, therefore the competition for common nutrients and 
pathways between growth and production is reduced.
In the second stage of a two-stage chemostat system increased specific 
production rates were observed with decreasing growth rate, as in the 
first stage. An increase in the specific production rate in the second 
stage compared to the first stage, even though the growth rates were 
less, was not observed except at the lowest dilution rates when the 
specific growth rate was negative. This again indicates that, as in the 
stationary phase of batch culture, decreased growth rate alone does not 
necessarily result in increased specific antibody production. An increase 
in the specific production rate of the cell would appear to depend on the 
nutrients available to the cell (therefore greater production in stage one 
compared to stage two), and a low growth rate (increased specific 
production rate with decreasing growth rate). However, an increased 
specific production rate is also observed when growth is negative in the 
second stage and nutrients are scarce, suggesting a change in the 
physiology of the cell.
Providing the correct nutritional environment for increased specific 
production while maintaining a low growth rate was attempted by 
feeding the second stage with amino acids. A second stage amino acid 
feed resulted in an increased growth rate and, consistent with negatively
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growth-associated production, a decrease in specific production rate. 
Even when a shift down in growth rate was attempted, by decreasing the 
dilution rate in the second stage relative to the first, growth rate 
remained high and production rate low in a fed compared to unfed 
culture. Feeding the second stage with all DMEM amino acids did 
however have the effect of increasing the volumetric rate of production, 
due to the increased viability of the culture. An alternative method of 
achieving a low growth rate and high production rate in the second stage 
was therefore required.
The observation that in glutamine limited batch culture antibody 
production was positively growth-associated while in glutamine depleted 
chemostat culture production was negatively growth-associated 
suggested the possibility that production kinetics could be manipulated 
by altering the nutrients available to the cell. If limitation of growth on 
an amino acid other than glutamine, which appeared essential for both 
growth and antibody production, resulted in continued or increased 
production during the decline phase of batch culture, it may also be 
possible to limit growth in the second stage of a two-stage chemostat and 
observe increased specific production.
The observation that it was possible to manipulate the kinetics of 
antibody production in batch culture was demonstrated by designing 
media with different growth-limiting amino acids. Depending on the 
identity of the growth-limiting amino acid the kinetics of antibody 
production could be altered from strictly growth-associated, as with 
serine limitation, to growth-dissociated, as with isoleucine and leucine 
limitation. The change in cellular physiology which occurred under 
these different limitations, and which gave rise to the observed
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alterations in production kinetics was not determined. The change may 
result directly from the antibody production process requiring a specific 
amino acid, or indirectly through a change in the growth and physiology 
of the cell, such as accumulation of Chinese hamster cells in the Gl/GO 
phase of the cell cycle under isoleucine limiting conditions (Ley and 
Tobey, 1970). The same result has yet to be demonstrated in two-stage 
chemostat culture possibly because the concentration of isoleucine was 
not low enough to be the growth-limiting nutrient.
These findings suggest that the classification of hybridoma cell line 
production kinetics into growth-associated and growth-dissociated may 
not be a true reflection of an inherent characteristic of the cell but 
merely a reflection of the cells response to its environment, in particular 
nutrient limitation of growth only or growth and antibody production. 
The fact that production is often observed during the decline phase of a 
cell population, and that production continues or is increased under 
conditions where cell growth is inhibited demonstrates that the 
requirements for antibody production are less stringent than for growth.
Hybridoma cells are selected primarily for their ability to grow under 
particular culture conditions. The cells ability to produce antibody, 
although essential, is secondary to its selection for growth. Growth is 
therefore the primary concern of the cell and antibody production 
processes have been selected to survive on ‘scraps’ in terms of nutrients 
and energy. That antibody production is not essential to the survival of 
hybridoma cells is demonstrated by the selection of growing non­
producers originating from a population of producers. Antibody 
production has therefore been selected for on the basis that it can 
continue in the presence of the cells over-riding need to grow. Its
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requirements must therefore be less stringent than those for growth. If 
the metabolic burden of antibody production was too great on the cell it 
would have a negative effect on growth, such a cell would be out 
competed by those with a less demanding production process because of 
their ability to grow faster. Therefore selection would favour non­
producers or producers with an undemanding or less demanding 
antibody production process. For this reason selection would favour the 
development of hybridoma cell lines which grow when nutrients are 
available and environmetal conditions ideal for growth with a minimum 
of antibody production. When conditions are no longer favourable for 
growth, production can continue at an increased rate because it is no 
longer competing with growth. Conditions which are detrimental to 
growth are not necessarily detrimental to production because production 
has been selected to survive on a lower nutrient and energy 
requirement, and when growth is inhibited by stressful conditions more 
nutrients and energy are available for antibody production. Therefore, 
as has been shown for this cell line, it is possible to selectively inhibit 
growth by nutrient limitation while not affecting or even increasing 
specific production in batch culture, so that a cell line which initially 
was thought to exhibit growth-associated production kinetics was shown 
to be capable of growth-dissociated production kinetics in a different 
environment.
In conclusion, it would appear that the kinetics of production observed 
in batch culture are the result of conditions imposed on the cell by its 
environment rather than an inherent characteristic of the cell, and that 
the growth and production kinetics observed can be explained by 
assuming that growth and production systems inside the cell are 
competing for a common pool of resources.
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APPENDIX 1.
Dulbecco's M odified Eagle Medium Formulation
Concentration
Inorganic Salts
CaCl2
(mg/1) (mM)
200.00Fe(N03).9H20 0.10KCl 400.00
M gS04 97.67
NaCl 6400.00
NaH2P04.H20 125.00
Other Components
D-Glucose 4500.00
Phenol Red 15.00
Amino Acids
L-Arginine.HCl 84.00
L-Arginine 0.40
L-Cystine.2HCl 62.57
L-Cystine 0.20L-Glutamine 584.00 4.00Glycine 30.00 0.40L-Histidine HCI.H2O 42.00
L-Histidine 0.20
L-Isoleucine 105.00 0.80
L-Leucine 105.00 0.80L-Lysine HCl 146.00L-Lysine 0.80
L-Methionine 30.00 0.20
L-Phenylalanine 66.00 0.40L-Seiine 42.00 0.40L-Threonine 95.00 0.80L-Tryptophan 16.00 0.08
L-Tyrosine (disodium salt) 104.20
L-Tyrosine 0.40
L-Valine 94.00 0.80
Vitamins
D-Ca pantothenate 4.00
Choline Chloride 4.00Folic Acid 4.00
i-Inositol 7.20
Nicotinamide 4.00
Pyridoxal HCl 4.00
Riboflavin 0.40Thiamine HCl 4.00
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APPENDIX 2.
MEM Amino Acid Solution - 50X
Amino Acids Concentration
(mg/l)
L-Arginine HCl 1050.00
L-Cystine 1050.00
L-Histidine 400.00
L-Isoleucine 1300.00
L-Leucine 1300.00
L-Lysine HCl 1823.50
L-Methionine 375.00
Phenylalanine 825.00
L-Threonine 1200.00
L-Tryptophan 200.00
L-Tyrosine 900.00
L-Valine 1175.00
APPENDIX 3.
MEM Non-Essential Amino Acids Solution - lOOX
Amino Acids Concentration
(mg/l)
L-Alanine 890.00
L-Asparagine.HzO 1500.00
L-Aspartic Acid 1330.00
L-Glutamic Acid 1470.00
Glycine 750.00
L-Proline 1150.00
L-Serine 1050.00
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APPENDIX 4.
MEM Vitamins Solution - lOOX
Components Concentration
(mg/l)
NaCl 8500.00
D-Ca Pantothenate 100.00
Choline Chloride 100.00
Folic Acid 100.00
i-Inositol 2 0 0 . 0 0
Nicotinamide 100.00
Pyridoxal HCl 100.00
Riboflavin 10.00
Thiamine HCl 100.00
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APPENDIX 5. 
Amino Acid Analysis by HPLC
1. Amino Acid Derivitisation 
Solutions to be made up:
a) Drying Solution
200 p,l Methanol
200 p,l IM Sodium Acetate
100 |ll Triethylamine (TEA)
b) Derivitising Agent:
Prepared just before derivitisation
50 fil PITC 
350 p.1 Methanol 
50 111 TEA 
50 111 MQ Water
Procedure:
20 \il of sample, standard (Food Hydrolysate Standard, Sigma) or blank 
(O.IM HCl) was pipetted into a labelled glass culture tube. This was 
loaded into a vacuum vial, a vacuum pulled and the sample dried for 30 
- 45 minutes.
1 0  |il of drying solution was added to each tube, vortexed and dried 
again (30 mins).
Derivitisation was achieved by adding 20 p,l of derivitising agent, 
leaving for 20 mins at room temperature and then drying again (30 -45  
mins).
1 0  p,l of methanol was then added, vortexed and finally dried 
thoroughly (45 - 60 mins).
Derivitised samples could be stored at -20 C for up to two weeks.
195
2. HPLC Analysis 
Reagents:
Eluent A
19.0 g of sodium acetate trihydrate.
1 litre of water
0.5 ml TEA
Titrated to pH 6.40 with glacial acetic acid and filtered through a 0.2 
)im filter. 940 ml of the resulting solution was added to 60 ml 
acetonitrile.
Eluent B
600ml of acetonitrile was added to 400 ml of MQ water, after 
which it was degassed by sonicating under vacuum for 2 0  
seconds.
Sample Diluent
710 mg of disodium hydrogen phosphate (Na2  HPO4 )
1 litre of water
Titrated to pH 7.40 with 10% phosphoric acid (H3 PO4 )
The resulting solution was mixed with acetonitrile so that acetonitrile 
equalled 5% by volume.
Procedure:
The samples were resuspended in 100 p,l sample diluent by sonicating 
and vortexing. Analysis was achieved using a "Nova-Pak" C l 8  (Waters) 
HPLC column and the concentration of amino acids determined by 
comparison of peak area and retention times with standards.
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APPENDIX 6
Double-Antibody Sandwich ELISA for Estimation of Mouse 
IgM
REAGENTS
a) Coating Buffer (0.05M carbonate, pH 9.6)
Na2  COg 0.159g
NaHCOg 0.293g
NaNg 0.02g
distilled H2 O to 1 0 0 ml
Stable 7 days at 4C.
b) Wash Buffer (PBS-Tween, pH 7.4)
Stored as lOx concentrate at 4®C.
NaCl 80.0g
KH2PO4 2.0g
Na2 HP0 4  (anhydrous) 19.2g
KCl 2.0g
distilled water to 1 0 0 0 ml
Concentrate diluted 1:10 and 0.5ml/litre Tween 20 added before 
use.
c) Sample/conjugate buffer (O.IM Tris, pH 7.0).
Tris (hydroxymethyl) aminomethane 6.05g
NaCl 2.922g
Tween 20 0.1ml
BSA Fraction V (Sigma 4503) l.Og
Distilled water to 450ml, pH adjusted to 7.0 with concentrated
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HCl, and made up to final volume of 500ml with distilled water. 
Made up fresh weekly.
d) Substrate Buffer (O.IM Sodium acetate/citrate, pH6.0)
Sodium Acetate 2.1 g
Distilled water to 90ml. pH adjusted to pH 6.0 with IM citric 
acid (21 g citric acid in 100ml distilled water) and made up to 
final volume of 100ml with distilled water. Stored 1 month at
40c .
e) Substrate Stock
T etramethy Ibenzidine O.Olg
DMSO 1.0ml
Stored ambient in dark for 2 weeks.
f) Hydrogen Peroxide
1 part 30% H2 O2  diluted with 68 parts O.IM acetate/citrate
buffer (10p,l + 680|Li 1). Stored ambient for up to 2 weeks.
g) Coating Antisera
Mouse IgM (|4 chain specific) from goat (Sigma, code no. 
M8644). Reconstituted in 0.135M NaCl and diluted to a working 
concentration of 2p,g/ml (lOOjO,! + 49,900jLil) in coating buffer 
prior to use.
h) Standards
Mouse IgM, Kappa (Sigma, code no. M2770). Stored in 25\x\ 
aliquots at -20®C at a concentration of 1 mg/ml. Diluted 1 :1 0 0  
(lOjXl + 990)li1 sample/conjugate buffer); and by a further 1 :1 0 0
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(10|Xl + 990Il11) to give a l,000ng/ml working stock. This 
working stock was diluted further to give a range of standards 
between 10 - lOOng/ml.
i) Conjugate
Goat-anti-mouse (p. chain specific) horse radish peroxidase 
conjugated (Sigma, code no. A8786). Stored at 4®C. Used diluted 
in sample/conjugate buffer 1:4,000 (12.5|il in 50ml buffer).
PROTOCOL
1. Controls
a) no coating
b) no coating/ no sample or standard
c) no sample or standard
d) no conjugate
e) quality control
to check for non-specific binding (a, b, c), peroxidase in reagents 
(d) and for consistency of ELISA (e).
2. Nunc Immunoplate I (2-39454) were coated with lOOjll per well 
coating antiserum (or control coating buffer) overnight at 43C 
with plates wrapped in cling film (also for all subsequent 
incubation steps), after which they were washed 4x with PBS- 
Tween buffer and tapped dry.
3. Standards or samples were added, 100|ll per well, and left for 2 
hours at room temperature on a plate shaker, then washed and 
dried as above.
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4. lOOjil per well of conjugate was then added and the plates were 
incubated for 1 hour at room temperature on the plate shaker. 
The plates were then washed as above, the last wash being left on 
for 1 0  minutes while the substrate was prepared.
5. Substrate Preparation.
a) 1 part TMB stock was diluted in 100 parts acetate/citrate
buffer.
b) lOOp-1 H2 O2  solution was added to every 10ml of diluted TMB.
6 . 1 0 0  p,l substrate was added per well after which the plates were
wrapped in tin foil and incubated in the dark at room temperature 
for 1 hour. The reaction was stopped with 50|il 2.5M H2 SO4  per
well and read at 450nm on a plate reader, blanking on an empty 
well.
7. A standard curve was plotted and concentrations of the samples
read from the linear area of the curve.
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APPENDIX 7
Amino Acid Concentrations in Non Glutamine-Fed and Glutamine Fed 
Batch Culture
Amino Acid Concentrations in Batch Culture of NB1 Hybridoma
Cells
Amino Acid Amino Acid Concentration (mM)
Time (hrs) 0.0 22.5 34.5 47.5 58.5 71.5 83.0 98.5 123.0 146.0
ASP 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
GLU 0.06 0.05 0.03 0.02 0.00 0.00 0.00 0.00 0.00 0.02
ASN 0.00 0.04 0.04 0.04 0.00 0.00 0.00 0.00 0.00 0.00
SER 0.34 0.32 0.29 0.27 0.23 0.26 0.26 0.24 0.23 0.25
GLN 3.22 2.44 1.71 0.61 0.09 0.04 0.03 0.03 0.02 0.03
GLY 0.26 0.26 0.25 0.26 0.26 0.24 0.30 0.33 0.34 0.38
HIS 0.16 0.13 0.12 0.10 0.09 0.08 0.09 0.09 0.09 0.09
ARG 0.34 0.33 0.29 0.23 0.18 0.18 0.19 0.22 0.23 0.24
TH R 0.63 0.47 0.43 0.42 0.35 0.35 0.36 0.35 0.36 0.39
ALA 0.26 0.47 0.63 0.92 0.99 0.98 1.06 1.08 1.06 1.14
PRO 0.05 0.09 0.12 0.18 0.21 0.23 0.25 0.26 0.25 0.27
TY R 0.31 0.23 0.25 0.30 0.22 0.22 0.24 0.23 0.23 0.25
VAL 0.69 0.62 0.54 0.50 0.43 0.40 0.41 0.41 0.40 0.42
M ET 0.17 0.14 0.12 0.10 0.08 0.07 0.08 0.08 0.07 0.08
CYS 0.09 0.09 0.07 0.07 0.05 0.04 0.04 0.04 0.04 0.05
ILE 0.71 0.63 0.57 0.53 0.46 0.41 0.41 0.40 0.39 0.41
LEU 0.70 0.61 0.52 0.46 0.37 0.33 0.34 0.33 0.32 0.35
PME 0.34 0.31 0.28 0.27 0.23 0.22 0.23 0.22 0.22 0.24
TR P 0.09 0.08 0.07 0.07 0.06 0.06 0.06 0.06 0.06 0.06
LYS 0.67 0.59 0.52 0.48 0.41 0.38 0.41 0.41 0.40 0.43
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Amino Acid Concentrations in Glutamine-Fed Batch Culture of
NB1 Hybridoma Cells
Amino Acid Amino Acid Concentration (mM)
Tim e (hrs) 0.0 22.5 34.5 47.5 58.5 71.5 83.0 98.5 123.0 146.0
ASP 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02
GLU 0.06 0.04 0.03 0.02 0.01 0.00 0.00 0.00 0.00 0.01
ASN 0.00 0.03 0.04 0.04 0.08 0.10 0.11 0.11 0.08 0.07
S ER 0.34 0.28 0.29 0.27 0.25 0.28 0.27 0.28 0.22 0.21
GLN 3.22 1.66 0.95 0.64 3 .97 2.69 2.52 1.76 0.39 0.22
GLY 0.26 0.22 0.24 0.26 0.15 0.13 0.13 0.17 0.17 0.26
HIS 0.16 0.13 0.13 0.11 0.09 0.09 0.08 0.07 0.04 0.04
ARG 0.34 0.34 0.33 0.30 0.24 0.22 0.19 0.12 0.16 0.04
TH R 0.63 0.46 0.45 0.41 0.34 0.37 0.33 0.30 0.24 0.23
ALA 0.26 0.43 0.68 0.95 1.24 1.50 1.73 1.95 2.02 2.33
PRO 0.05 0.08 0.12 0.18 0.25 0.34 0.45 0.55 0.70 0.84
TYR 0.31 0.24 0.19 0.19 0.19 0.18 0.21 0.19 0.14 0.14
VAL 0.69 0.55 0.54 0.50 0.44 0.42 0.39 0.34 0.26 0.26
M ET 0.17 0.13 0.12 0.10 0.08 0.08 0.06 0.05 0.00 0.00
CYS 0.09 0.07 0.07 0.06 0.05 0.04 0.03 0.02 0.01 0.00
ILE 0.71 0.57 0.57 0.53 0.48 0.48 0.46 0.42 0.34 0.34
LEU 0.70 0.54 0.52 0.46 0.40 0.38 0.33 0.28 0.17 0.16
PHE 0.34 0.28 0.28 0.26 0.23 0.22 0.21 0.18 0.13 0.13
TR P 0.09 0.07 0.08 0.07 0.06 0.07 0.06 0.05 0.04 0.04
LYS 0.67 0.54 0.53 0.48 0.42 0.40 0.36 0.31 0.22 0.21
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APPENDIX 8
Glutamine, Ammonia, Glucose and Lactate Steady State Concentrations 
in Two-Stage Chemostat Culture
Steady-State Glucose And Lactate 
Concentrations In Two-Stage Chemostat Culture
Dilution Rate Giucose (m M ) Lactate (m M )
(1/h) S tage 1 Stage 2 Stage 1 Stage 2
0 .05 6 .64 1.76 3 0 .00 3 2 .95
0 .04 6 .12 2 .88 29 .69 3 4 .02
0 .03 2 .30 0 .63 38 .30 3 6 .00
0 .02 8.81 7 .16 16.27 2 3 .2 7
0.01 10.74 9 .32 14.99 15.27
Steady-State Glutamine And Ammonia 
C oncentrations In Two-Stage C hem ostat Culture
Dilution Rate Glutam ine (m M ) Am m onia (m M )
(1/h) S tage 1 Stage 2 S tage 1 Stage 2
0 .05 0 .18 0 .00 2 .09 2 .1 6
0 .04 0.11 0 .00 2 .17 2 .58
0 .03 0.11 0 .00 2 .29 2 .30
0 .02 0 .06 0 .00 2 .17 2 .2 7
0.01 0 .00 0 .00 2 .16 2.21
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APPENDIX 9
Two-Stage Chemostat Culture: Amino Acid Steady-State Concentrations
Steady-State Amino Acid Concentrations in Two- 
Stage Chemostat Culture
Dilution Rates
( h - b
0 .0 5
Stage One 
0 .0 4  0 .03  0 .0 2 0.01 0 .0 5
Stage Two 
0 .0 4  0 .0 3  0 .0 2 0.01
Amino Acid Amino Acid Concent ration (mM)
ASP 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0
GLU 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0
ASN 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0
SER 0 .2 0 0 .13 0 .1 7 0 .1 7 0 .1 7 0 .13 0 .1 2 0 .13 0 .13 0 .1 5
GLN 0 .1 8 0 .1 2 0.11 0 .0 6 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0
GLY 0 .35 0 .3 0 0 .3 2 0 .2 8 0 .5 8 0 .3 0 0 .33 0 .3 0 0 .43 0 .6 8
HIS 0 .1 0 0 .0 9 0 .0 9 0 .05 0 .05 0 .0 7 0 .0 7 0 .0 7 0 .05 0 .0 5
ARG 0 .13 0 .1 7 0 .19 0.11 0 .09 0 .1 4 0 .1 2 0 .1 4 0 .1 0 0 .1 0
THR 0 .3 0 0 .3 0 0.31 0 .2 0 0 .2 0 0.31 0 .3 2 0.31 0.21 0 .2 2
ALA 1.01 0 .8 4 0 .8 6 0 .7 2 0 .57 0 .9 0 0 .8 8 0 .9 0 0 .75 0 .5 9
PRO 0 .2 9 0 .36 0 .2 8 0 .1 2 0 .0 7 0 .3 0 0 .3 8 0 .3 0 0 .1 6 0 .1 0
TYR 0 .2 6 0 .2 4 0 .23 0 .1 8 0 .17 0.21 0 .1 9 0.21 0 .1 6 0 .1 6
VAL 0.41 0 .3 7 0 .42 0 .2 2 0 .1 4 0 .33 0 .2 6 0 .33 0 .1 7 0 .1 0
MET 0 .0 7 0 .0 6 0 .0 7 0 .0 0 0 .0 0 0 .0 4 0 .03 0 .0 4 0 .0 0 0 .0 0
CYS 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0 0 .0 0
ILE 0 .4 2 0 .3 7 0 .4 6 0 .19 0 .09 0 .35 0 .2 2 0 .3 5 0 .13 0 .0 6
LEU 0 .3 2 0 .25 0 .33 0 .1 0 0 .0 4 0.21 0 .1 2 0.21 0 .05 0 .0 0
PHE 0 .2 4 0.21 0 .23 0 .1 4 0 .13 0 .1 8 0 .1 8 0 .1 8 0 .1 3 0.11
TRP 0.11 0 .0 8 0 .0 7 0 .05 0 .0 0 0 .0 6 0 .0 7 0 .0 6 0 .0 4 0 .0 0
LYS 0.41 0 .3 6 0 .39 0 .23 0 .23 0 .3 2 0.31 0 .3 2 0 .2 2 0 .23
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APPENDIX 10
Specific Rates of Amino Acid Utilisation in Amino Acid Limited Batch 
Culture
The Specific R ates Of Amino Acid Utilisation During The First 
48 Hrs Of Batch Culture Limited On A Particular Amino Acid
Limiting Amino 
Acid
Control Tryptophan Serine Lysine Threonine Methionine
Amino Acid Specific Utilisation Rate (u moies/viable cell hour)
ASP 0 0 0 0 0 0
GUÜ 0.0009 -0.0037 0.0012 0.0008 -0.0028 0.0009
ASN -0.0019 -0.0042 0 0 0 0
SER 0.0031 0.0039 -0.0041 0.0039 0.0113 0.0049
GLN 0.1213 0.3481 0.2276 0.1559 0.4339 0.1893
GLY 0.0071 0.0069 0.0082 0.0054 0.0149 0.0072
HIS 0.0024 0.0011 0.0013 0.0014 0.0035 0.0019
ARG 0.0057 0.0026 0.0037 0.0036 0.0114 0.0045
THR 0.0110 0.0143 0.0155 0.0084 0.0140 0.0124
ALA -0.0240 -0.0432 -0.0283 -0.0178 -0.0632 -0.0207
PRD -0.0041 -0.0089 -0.0037 -0.0030 -0.0081 -0.0036
TYR 0.0051 0.0005 0.0022 0.0024 0.0056 0.0033
VAL 0.0071 0.0087 0.0066 0.0064 0.0163 0.0074
MET 0.0025 0.0019 0.0020 0.0019 0.0037 0.0021
CYS 0.0027 0.0020 0.0016 0.0013 0.0035 0.0017
lUE 0.0064 0.0076 0.0086 0.0085 0.0223 0.0085
LEU 0.0110 0.0096 0.0100 0.0089 0.0239 0.0119
PHE 0.0034 0.0022 0.0019 0.0021 0.0059 0.0028
TRP 0.0007 -0.0084 0.0006 0.0007 0.0017 0.0009
LYS 0.0087 0.0021 0.0033 0.0059 0.0188 0.0068
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The Specific Rates Of Amino Acid Utilisation During The First 48
Hrs Of Batch Culture Limited On A Particular Amino Acid (Cont'd)
Limiting Amino 
Acid Control PhenylalanineVaiine Arginine Tyrosine Glycine
Amino Acid Specific Utilisation Rate (m m oles/viable cell hour)
ASP 0 0 0 0 0 0
GLU 0 .0 0 0 9 0 .0 0 0 9 0 .0 0 1 0 0 .0 0 0 9 0 .0 0 0 9 0 .0 0 0 3
ASN -0 .0 0 1 9 0 0 -0 .0 0 2 9 0 -0 .0 0 2 2
SER 0 .0 0 3 1 0 .0 0 6 6 0 .0 0 3 4 -0 .0 0 0 4 0 .0 0 4 7 0 .0 0 3 5
GLN 0 .1 2 1 3 0 .1 7 9 9 0 .1 8 8 7 0 .0 9 1 9 0 .1 7 8 7 0 .1 5 3 6
GLY 0 .0 0 7 1 0 .0 0 8 0 0 .0 0 5 3 0 .0 0 2 5 0 .0 0 6 3 -0 .0 0 0 3
HIS 0 .0 0 2 4 0 .0 0 2 3 0 .0 0 0 9 0 .0 0 0 5 0 .0 0 1 6 0 .0 0 1 9
ARG 0 .0 0 5 7 0 .0 0 4 8 0 .0 0 2 7 -0 .0 0 1 4 -0 .0 0 3 1 0 .0 0 5 5
THR 0 .0 1 1 0 0 .0 1 3 3 0 .0 0 9 5 0 .0 0 5 9 0 .0 1 0 7 0 .0 1 2 0
ALA -0 .0 2 4 2 -0 .0 1 9 6 -0 .0 1 9 5 -0 .0 2 8 4 -0 .0 2 0 0 -0 .0 3 5 8
PRO -0 .0 0 4 1 -0 .0 0 3 3 -0 .0 0 3 6 -0 .0 0 5 5 -0 .0 0 3 6 -0 .0 0 6 4
TYR 0 .0 0 5 1 0 .0 0 3 9 0 .0 0 1 3 0 .0 0 0 6 0 .0 0 2 7 0 .0 0 1 9
VA L 0 .0 0 7 1 0 .0 0 8 5 0 .0 0 1 8 0 .0 0 2 9 0 .0 0 7 1 0 .0 0 6 4
MET 0 .0 0 2 5 0 .0 0 2 8 0 .0 0 1 9 0 .0 0 1 0 0 .0 0 1 7 0 .0 0 2 3
CYS 0 .0 0 2 7 0 .0 0 1 6 0 .0 0 1 5 0 .0 0 0 8 0 .0 0 2 2 0 .001  2
ILE 0 .0 0 6 4 0 .0 0 9 9 0 .0 0 4 9 0 .0 0 2 9 0 .0 0 8 9 0 .0 0 6 2
LEU 0 .0 1 1 0 0 .0 1 2 8 0 .0 0 7 6 0 .0 0 4 2 0 .0 1 0 2 0 .0 0 9 9
PHE 0 .0 0 3 4 0 .0 0 2 3 0 .0 0 1 4 0 .0 0 0 8 0 .0 0 2 1 0 .0 0 1 8
TRP 0 .0 0 0 7 0 .0 0 1  1 0 .0 0 0 4 3 .3E -05 0 .0 0 0 4 0 .0 0 0 9
LYS 0 .0 0 8 7 0 .0 0 8 7 0 .0 0 5 2 0 .0 0 2 9 0 .0 0 6 9 0 .0 0 8 3
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The Specific Rates Of Amino Acid Utilisation During The First 48
Hrs Of Batch Culture Limited On A Particular Amino Acid (Cont'd)
Limiting Amino 
Acid
Amino Acid
Control Histidine Cystine Leucine Isoleucine 
Specific Utilisation Rate (u moles/viable cell hour)
ASP 0 0 0 0 0
QUU 0.0009 0.0009 0.0005 0.0006 0.0008
ASN -0.0020 -0.0025 -0.0017 -0.0019 -0.0017
SER 0.0031 0.0013 -0.0001 2.3E-05 0.0022
GLN 0.1213 0.1104 0.1631 0.1000 0.0854
GLY 0.0071 0.0029 -0.0085 0.0019 0.0039
HIS 0.0024 0.0013 0.0021 0.0004 0.0006
ARG 0.0057 0.0040 0.0057 0.0031 0.0034
THR 0.0110 0.0065 0.0113 0.0028 0.0040
ALA -0.0241 -0.0281 -0.0497 -0.0331 -0.0185
PRD -0.0041 -0.0043 -0.0070 -0.0068 -0.0031
TYR 0.0051 0.0018 0.0035 -4.6E-05 0.0019
VAL 0.0071 0.0033 0.0072 -0.0011 0.0014
MET 0.0025 0.0014 0.0023 0.0009 0.0016
CYS 0.0027 0.0016 0.0024 0.0004 0.0017
ILE 0.0064 0.0037 0.0063 -0.0013 0.0028
LEU 0.0110 0.0073 0.0100 0.0054 0.0069
PhE 0.0034 0.0014 0.0029 -2.3E-05 0.0012
TRP 0.0007 0.0002 0.0009 0.0004 0.0007
LYS 0.0087 0.0056 0.0068 0.0025 0.0038
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Appendix 11
Concentration of Amino Acid in Culture 
Supplemented With 2X Specified Amino Acid 
(all other amino acids as in DMEM, Appendix 1 )
Culture Amino AcidSupplem ent C oncentration
(m g/1)
Control A s for DMEM in Appendix 1
Leucine 2 1 0
Arginine 1 6 8
M ethionine 6 0
Tryptophan 3 2
C ystine 9 6
Histidine 8 4
Refered to on page 125
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Appendix 12
Rate of Amino Acid Feed to Stage-Two of an 
Unequal Volume Two-Stage Chemostat (pg. 132)
Amino Acid Amino Acid Feed Rate 
(mg/l/h)
SER 0.73GLN 17.04GLY 0.17HIS 0.52ARG 1.09THR
TYR 1.75
VAL 1.25
MET 1.35
CYS 0.59
ILE 1.44
LEU 1.85
PHE 0.86
TRP 0.02
LYS 1.79
Refered to on page 132
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Appendix 13
Concentration of the Limiting Amino Acid in Batch 
Culture (pg. 137)
Limiting Amino Acid Amino Concentration
(mM)
SER 0.10
GLY 0.09
HIS 0.08
ARG 0.14
THR 0.34
TYR 0.14
VAL 0.26
MET 0.08
CYS 0.10
ILE 0.23
LEU 0.31
PHE 0.11
TRP 0.00
LYS 0.31
Refered to on page 137
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Appendix 14
Concentration of Amino Acids During Culture Under Conditions W here
the Specified Amino Acid was Designed to be Limiting to Growth. 
Refered to on page 138
C o n t r o l
Time (hours) 0 48 119
Amino Acid Concentration (mM)
ASP 0.00 0.00 0
GLU 0.03 0.00 0
ASN 0.00 0.06 0.55
SER 0.42 0.33 0.451
GLN 5.23 1.70 0.084
GLY 0.53 0.33 0.429
HIS 0.21 0.14 0.158
ARG 0.51 0.35 0.315
THR 0.84 0.52 0.561
ALA 0.08 0.78 1.763
PRO 0.02 0.14 0.348
TYR 0.42 0.28 0.333
VAL 0.83 0.62 0.597
MET 0.21 0.14 0.116
CYS 0.18 0.10 0.035
ILE 0.87 0.68 0.605
LEU 0.88 0.56 0.484
PHE 0.42 0.32 0.341
TRP 0.09 0.07 0.058
LYS 0.83 0.58 0.618
Phenylalanine Limited
Time (hours) 0 48 110
Amino Acid Concentration (mM)
ASP 0.00 0.00 0.00
GLU 0.03 0.00 0.00
ASN 0.00 0.00 0.00
SER 0.42 0.23 0.36
GLN 5.23 0.00 0.00
GLY 0.53 0.30 0.40
HIS 0.21 0.14 0.16
ARG 0.51 0.38 0.39
THR 0.84 0.45 0.55
ALA 0.08 0.65 1.00
PRO 0.02 0.12 0.15
TYR 0.42 0.31 0.35
VAL 0.83 0.58 0.63
MET 0.21 0.13 0.14
CYS 0.18 0.13 0.14
ILE 0.87 0.58 0.56
LEU 0.88 0.51 0.52
PHE 0.11 0.04 0.06
TRP 0.09 0.06 0.07
LYS 0.83 0.58 0.66
212
S er in e  L im ited
Time (hours) 0 48 86
Amino Acid Concentration (mM)
ASP 0.00 0.00 0.00
GLU 0.03 0.00 0.01
ASN 0.00 0.00 0.00
SER 0.10 0.19 0.26
GLN 5.23 0.00 0.00
GLY 0.53 0.34 0.38
HIS 0.21 0.18 0.18
ARG 0.51 0.43 0.41
THR 0.84 0.48 0.54
ALA 0.08 0.73 0.89
PRO 0.02 0.11 0.11
TYR 0.42 0.37 0.36
VAL 0.83 0.68 0.67
MET 0.21 0.16 0.16
CYS 0.18 0.14 0.15
ILE 0.87 0.67 0.63
LEU 0.88 0.65 0.61
PHE 0.42 0.37 0,36
TRP 0.09 0.08 0.07
LYS 0.83 0.75 0.75
T h r e o n i n e  L i m i t e d
Time (hours) 0 48 86
Amino Acid Concentration (mM)
ASP 0.00 0.00 0.00
GLU 0.03 0.06 0.03
ASN 0.00 0.00 0.00
SER 0.42 0.29 0.32
GLN 5.23 0.12 0.00
GLY 0.53 0.36 0.36
HIS 0.21 0.17 0.17
ARG 0.51 0.38 0.36
THR 0.34 0.17 0.17
ALA 0.08 0.83 1.02
PRO 0.02 0.12 0.12
TYR 0.42 0.36 0.34
VAL 0.83 0.64 0.61
MET 0.21 0.17 0.16
CYS 0.18 0.14 0.14
ILE 0.87 0.61 0.55
LEU 0.88 0.60 0.54
PHE 0.42 0.35 0.34
TRP 0.09 0.07 0.07
LYS 0.83 0.61 0.59
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T ryp top h an  L im ited
Time (hours) 0 48 86
Amino Acid Concentration (mM)
ASP 0.00 0.00 0.00
GLU 0.03 0.08 0.09
ASN 0.00 0.06 0.06
SER 0.42 0.37 0.41
GLN 5.23 0.71 0.62
GLY 0.53 0.44 0.47
HIS 0.21 0.19 0.21
ARG 0.51 0.48 0.48
THR 0.84 0.65 0.68
ALA 0.08 0.64 0.73
PRO 0.02 0.14 0.15
TYR 0.42 0.42 0.44
VAL 0.83 0.72 0.76
MET 0.21 0.19 0.20
CYS 0.18 0.15 0.17
ILE 0.87 0.77 0.82
LEU 0.88 0.76 0.81
PHE 0.42 0.39 0.41
TRP 0.00 0.11 0.15
LYS 0.83 0.80 0.84
T y r o s i n e  L i m i t e d
Time (hours) 0 48 86
Amino Acid Concentration (mM)
ASP 0.00 0.00 0.00
GLU 0.03 0.00 0.00
ASN 0.00 0.00 0.00
SER 0.42 0.29 0.36
GLN 5.23 0.00 0.00
GLY 0.53 0.35 0.39
HIS 0.21 0.16 0.17
ARG 0.51 0.60 0.60
THR 0.84 0.52 0.55
ALA 0.08 0.67 0.88
PRO 0.02 0.13 0.13
TYR 0.14 0.06 0.06
VAL 0.83 0.62 0.60
MET 0.21 0.16 0.16
CYS 0.18 0.12 0.09
ILE 0.87 0.61 0.54
LEU 0.88 0.58 0.53
PHE 0.42 0.36 0.36
TRP 0.09 0.08 0.07
LYS 0.83 0.63 0.64
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V a lin e  L im ited
Time (hours) 0 48 86
Amino Acid Concentration (mM)
ASP 0.00 0.00 0.00
GLU 0.03 0.00 0.00
ASN 0.00 0.00 0.00
SER 0.42 0.33 0.42
GLN 5.23 0.00 0.00
GLY 0.53 0.38 0.43
HIS 0.21 0.18 0.18
ARG 0.51 0.44 0.43
THR 0.84 0.57 0,62
ALA 0.08 0.62 0.90
PRO 0.02 0.12 0.14
TYR 0.42 0.39 0.42
VAL 0.26 0.21 0.21
MET 0.21 0.16 0.16
CYS 0.18 0.14 0.13
ILE 0.87 0.73 0.66
LEU 0.88 0.67 0.63
PHE 0.42 0.38 0.39
TRP 0.09 0.08 0.08
LYS 0.83 0.69 0.70
A r g i n i n e  L i m i t e d
Time (hours) 0 48 79
Amino Acid Concentration (mM)
ASP 0.00 0.00 0.01
GLU 0.03 0.00 0.10
ASN 0.00 0.09 0.11
SER 0.42 0.44 0.47
GLN 5.23 2.47 1.00
GLY 0.53 0.45 0.47
HIS 0.21 0.19 0.19
ARG 0.14 0.19 0.18
THR 0.84 0.66 0.64
ALA 0.08 0.93 1.77
PRO 0.02 0.19 0.30
TYR 0.42 0.41 0.40
VAL 0.83 0.74 0.71
MET 0.21 0.18 0.17
CYS 0.18 0.16 0.09
ILE 0.87 0.78 0.72
LEU 0.88 0.76 0.70
PHE 0.42 0.39 0.38
TRP 0.09 0.09 0.08
LYS 0.83 0.74 0.74
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H istid in e  L im ited
Time (hours) 
Amino Acid
0 48 
Concentration (mM)
99
ASP 0.00 0.00 0.00
GLU 0.03 0.00 0.00
ASN 0.00 0.07 0.05
SER 0.42 0.39 0.38
GLN 5.23 1.99 0.00
GLY 0.53 0.44 0.43
HIS 0.08 0.04 0.00
ARG 0.51 0.40 0.30
THR 0.84 0.65 0.55
ALA 0.08 0.90 1.66
PRO 0.02 0.15 0.37
TYR 0.42 0.37 0,31
VAL 0.83 0.73 0.59
MET 0.21 0.17 0.12
CYS 0.18 0.13 0.03
ILE 0.87 0.76 0.58
LEU 0.88 0.67 0.47
PHE 0.42 0.37 0.32
TRP 0.09 0.08 0.07
LYS 0.83 0.66 0.57
Isoleucine Limited
Time (hours) 1 0 24 48 66 79 92 99|
Amino Acid Concentration (mM)
ASP 0.00 0.00 0.00 0.00 0.00 0.00 0.00
GLU 0.03 0.03 0.00 0.00 0.00 0.00 0.00
ASN 0.00 0.03 0.06 0.07 0.06 0.04 0.04
SER 0.42 0.41 0.35 0.33 0.33 0.29 0.30
GLN 5.23 4.31 2.19 0.79 0.15 0.00 0.00
GLY 0.53 0,46 0.39 0.35 0.33 0.31 0.32
HIS 0.21 0.23 0.19 0.17 0.16 0.14 0.15
ARG 0.51 0.49 0.39 0.33 0,28 0.28 0.27
THR 0.84 0.82 0.70 0.63 0.58 0.55 0.56
ALA 0.08 0.28 0.74 1.01 1.23 1.18 1.20
PRO 0.02 0.06 0.13 0.24 0.34 0.35 0.36
TYR 0.42 0.42 0.35 0.31 0.30 0.26 0.27
VAL 0.83 0.91 0.78 0.70 0.68 0.62 0.60
MET 0.21 0.21 0.15 0.12 0.11 0.09 0.09
CYS 0.18 0.15 0.12 0.08 0.05 0.03 0.03
ILE 0.23 0.22 0.13 0.09 0.06 0.04 0.04
LEU 0.88 0.81 0.63 0.52 0.46 0.40 0.41
PHE 0.42 0.44 0.37 0.33 0.31 0.29 0.30
TRP 0.09 0.09 0.06 0.05 0.05 0.04 0.04
LYS 0.83 0.86 0.69 0.60 0.55 0.53 0.54
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G ly c in e  L im ited
Time (hours) 0 48 110
Amino Acid Concentiation (mM)
ASP 0.00 0.00 0.00
GLU 0.03 0.02 0.00
ASN 0.00 0.05 0.00
SER 0.42 0.34 0.40
GLN 5.23 1.51 0.00
GLY 0.09 0.10 0.12
HIS 0.21 0.16 0.15
ARG 0.51 0.38 0.31
THR 0.84 0.55 0.50
ALA 0.08 0.95 1.62
PRO 0.02 0.18 0.30
TYR 0.42 0.38 0.33
VAL 0.83 0.67 0.59
MET 0.21 0.16 0.12
CYS 0.18 0.15 0.10
ILE 0.87 0.72 0.61
LEU 0.88 0.64 0.49
PHE 0.42 0.37 0.34
TRP 0.09 0.07 0.05
LYS 0.83 0.63 0.56
C y s t i n e  L i m i t e d
Time (hours); 0 48 110
Amino Acid Concentration (mM)
ASP 0.00 0.00 0.00
GLU 0.03 0.01 0.00
ASN 0.00 0.05 0.00
SER 0.42 0.43 0.55
GLN 5.23 0.76 0.00
GLY 0.53 0.76 0.80
HIS 0.21 0.15 0.14
ARG 0.51 0.36 0.31
THR 0.84 0.53 0.53
ALA 0.08 1.44 1.90
PRO 0.02 0.21 0.26
TYR 0.42 0.33 0.30
VAL 0^3 0.63 0.57
MET 0.21 0.15 0.12
CYS 0.10 0.04 0.01
ILE 0.87 0.70 0.58
LEU 0.88 0.61 0.48
PHE 0.42 0.33 0.31
TRP 0.09 0.06 0.05
LYS 0,83 0.64 0.61
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L eu c in e  L im ited
Time (hours) 
Amino Acid
0 16 36 48 62 
Concentration (mM)
86 110
ASP 0.00 0.00 0.00 0.00 0.00 0.00 0.00
GLU 0.03 0.03 0.00 0.00 0.00 0.00 0.00
ASN 0.00 0.04 0.05 0.08 0.04 0.03 0.03
SER 0.42 0.32 0.28 0.42 0.31 0.34 0.33
GLN 5.23 3.02 1.47 0.89 0.11 0.00 0.00
GLY 0.53 0.36 0.32 0.45 0.29 0.33 0.34
HIS 0.21 0.17 0.15 0.19 0.12 0.13 0.13
ARG 0.51 0.43 0.36 0.38 0.30 0.31 0.31
THR 0.84 0.58 0.52 0.72 0.48 0.55 0.52
ALA 0.08 0.30 0.72 1.52 1.16 1.30 1.30
PRO 0.02 0.07 0.15 0.32 0.27 0.31 0.30
TYR 0.42 0.35 0.32 0.43 0.27 0.29 0.28
VAL 0.83 0.76 0.74 0.88 0.62 0.65 0.63
MET 0.21 0.16 0.13 0.17 0.10 0.10 0.10
CYS 0.18 0.13 0.11 0.16 0.09 0.08 0.08
ILE 0.87 0.68 0.66 0.93 0.59 0.62 0.58
LEU 0.31 0.22 0.11 0.07 0.02 0.04 0.04
PHE 0.42 0.33 0.30 0.42 0.26 0.28 0.27
TRP 0.09 0.08 0.06 0.07 0.05 0.05 0.05
LYS 0.83 0.61 0.53 0.72 0.45 0.49 0.48
L y s i n e  L i m i t e d
Time (hours) 0 48 86
Amino Acid Concenti ation (mM)
ASP 0.00 0.00 0.00
GLU 0.03 0.00 0.00
ASN 0.00 0.00 0.00
SER 0.42 0.29 0.36
GLN 5.23 0.00 0.00
GLY 0.53 0.35 0.41
HIS 0.21 0.16 0.17
ARG 0.51 0.39 0.39
THR 0.84 0.56 0.62
ALA 0.08 0.68 0.88
PRO 0.02 0.12 0.14
TYR 0.42 0.34 0.37
VAL 0.83 0.62 0.65
MET 0.21 0.15 0.16
CYS 0.18 0.14 0.15
ILE 0.87 0.59 0.57
LEU 0.88 0.58 0.58
PHE 0.42 0.35 0.36
TRP 0.09 0.07 0.07
LYS 0.31 0.11 0.13
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M eth io n in e  L im ited
Time (hours) 0 48 86
Amino Acid Concentiation (mM)
ASP 0.00 0.00 0.00
GLU 0.03 0.00 0.00
ASN 0.00 0.00 0.00
SER 0.42 0.29 0.36
GLN 5.23 0.00 0.00
GLY 0.53 0.33 0.39
HIS 0.21 0.16 0.17
ARG 0.51 0.39 0.39
THR 0.84 0.50 0.57
ALA 0.08 0.65 0.91
PRO 0.02 0.12 0.14
TYR 0.42 0.33 0.36
VAL 0.83 0.62 0.67
MET 0.08 0.02 0.03
CYS 0.18 0.13 0.14
ILE 0.87 0.64 0.64
LEU 0.88 0.55 0.57
PHE 0.42 0.34 0.37
TRP 0.09 0.07 0.07
LYS 0.83 0.64 0.71
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Appendix 15
Rate of Amino Acid Feed to Stage-Two of an Unequal 
Volume Two-Stage Chemostat (pg. 148)
Amino Acid Amino Acid Feed Rate (mg/l/h). . .  All Ammo Acids All Amino AcidsAll Ammo Acids Except Group 4 Except lie
S e r 0 .7 3 0 .7 3 0 .7 3GLN 1 7 .0 4 17 .04 1 7 .0 4GLY 0 .1 7 0 .1 7 0 .1 7HIS 0 .5 2 0 .0 0 0 .5 2ARG
THR
TYR
VAL
1.09 1 .09 1 .09
1 .7 5 1.75 1 .75
1 .25 1.25 1 .25
MET 1.35 1.35 1 .35
CYS 0 .5 9 0 .0 0 0 .5 9
ILE 1 .4 4 0 .0 0 0 .0 0
LEU 1.8 5 0 .0 0 1 .85
PHE 0 .8 6 0 .8 6 0 .8 6
TRP 0 .0 2 0 .0 2 0 .0 2
LYS 1.79 1 .79 1 .79
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Appendix 16
Maximum Viable Cell Concentration and Antibody When Amino 
Acids Were At Equal Concentrations In The Medium (pg. 161)
Medium Max Viable Cell Max A ntibody  
C oncentration (u g /m l)C oncentration(x ic r ^ /m l)
DMEM 1 .2 8 3 0 .5
DMEM GLN-Fed 1 .3 4 4 7 .8
8mM Amino
A cids 1 . 1 9 2 6 .8
8mM Amino
A cids GLN-Fed 1 . 1 6 4 3 .7
321  m g /l Amino
A cids 0 .9 9 4 1 . 3
321  m g /l Amino
A cids GLN-Fed 1. 35 3 6 .3
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Appendix 17 
Amino Acid Concentration During Glutamine Fed Batch Culture In 
Home-Made Dmem And When All Amino Acids Were At An Equal 
Concentration, mM And mg/L. Refered to on Page 159
Amino Acid Concentration During Control Culture in Home-Made DMEM
Time (hours) jlnitial 
Amino Acid |
0 24 46 70 91 124 
Amino Acid Concentration (mM)
165j
ASP 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
GLU 0.00 0.08 0.09 0.00 0.00 0.00 0.00 0.01
ASN 0.00 0.00 0.05 0.07 0.12 0.08 0.04 0.03
SER 0.40 0.31 0.31 0.35 "0.37 0.25 0.19 0.26
GLN 4.00 3.61 2.53 3.14 2.80 0.99 0.00 0.00
GLY 0.40 0.33 0.38 0.33 0.32 0.26 0.28 0.36
HIS 0.20 0.21 0.20 0.19 0.18 0.12 0.10 0.11
ARG 0.40 0.43 0.37 0.27 0.23 0.18 0.14 0.16
THR 0.80 0.67 0.55 0.50 0.49 0.33 0.26 0.28
ALA 0.00 0.17 0.55 0.91 1.19 1.24 1.55 1.83
PRO 0.00 0.05 0.10 0.19 0.35 0.41 0.46 0.49
TYR 0.46 0.30 0.28 0.24 0.21 0.13 0.09 0.09
VAL 0.80 0.66 0.59 0.55 0.50 0.36 0.27 0.28
MET 0.20 0.15 0.13 0.10 0.08 0.03 0.04 0.04
CYS 0.20 0.10 0.10 0.09 0.08 0.04 0.00 0.00
ILE 0.80 0.62 0.56 0.52 0.51 0.38 0.28 0.28
LEU 0.80 0.66 0.58 0.50 0.46 0.28 0.16 0.17
PHE 0.40 0.31 0.30 0.27 0.25 0.17 0.13 0.13
TRP 0.08 0.07 0.06 0.04 0.20 0.17 0.13 0.13
LYS 0.80 0.60 0.57 0.49 0.45 0.29 0.23 0.25
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Amino Acid Concentration, All Amino Acids Initially At Equal mM
Time (hours) 
Amino Acid
Initial 0 24 46 70 91 
Amino Acid Concentration (mM)
124 165
GLU 0.03 0.05 0.00 0.00 0.00 0.00 0.02 0.02
ASN 0.00 0.00 0.06 0.09 0.08 0.04 0.04 0.04
SER 0.56 0.51 0.61 0.59 0.59 0.54 0.55 0.50
GLN 3.18 2.08 0.74 1.90 0.68 0.00 0.00 0.00
GLY 0.44 0.48 0.54 0.50 0.49 0.51 0.57 0.52
HIS 0.56 0.56 0.68 0.61 0.64 0.63 0.65 0.57
ARG 0.58 0.54 0.56 0.51 0.45 0.42 0.43 0.39
THR 0.66 0,56 0.56 0.51 0.44 0.42 0.42 0.38
ALA 0.07 0.34 1.01 1.30 1.63 1.80 1.90 1.72
PRO 0.02 0.07 0.18 0.32 0.51 0.68 0.72 0.65
TYR 0.66 0.48 0.59 0.40 0.43 0.41 0.38 0.37
VAL 0.64 0.59 0.59 0.51 0.45 0.39 0.40 0.36
MET 0.56 0.57 0.66 0.60 0.60 0.58 0.59 0.53
CYS 0.31 0.32 0.36 0.31 0.27 0.25 0.27 0.25
ILE 0.58 0.52 0.55 0.49 0.44 0.38 0.37 0.34
LEU 0.61 0.54 0.53 0.45 0.37 0.31 0.31 0.28
PHE 0.56 0.54 0.62 0.55 0.54 0.51 0.52 0.47
TRP 0.55 0.59 0.73 0.69 0.73 0.71 0.72 0.65
LYS 0.55 0.51 0.51 0.43 0.37 0.33 0.34 0.32
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Amino Acid mg/i Concentration, Amino Acids Initially At Equal
Time (hours) 
Amino Acid
hiitial 0 24 46 70 91 
Amino Acid Concentration (mM)
124
GLU 0.04 0.05 0.05 0.00 0.00 0.01 0.02
ASN 0.00 0.00 0.04 0.05 0.04 0.00 0.00
SER 2.60 2.51 2.19 1.99 2.55 2.42 2.24
GLN 4.03 2.83 0.81 0.43 0.00 0.00 0.00
GLY 3.42 3.64 3.27 2.98 3.95 3.88 3.66
HIS 1.68 1.69 1.50 1.32 1.75 1.73 1.62
ARG 1.40 1.37 1.18 1.06 1.30 1.25 1.17
THR 1.80 1.60 1.33 1.20 1.51 1.47 1.39
ALA 0.09 0.35 0.99 0.97 1.37 1.48 1.40
PRO 0.03 0.08 0.15 0.19 0.31 0.39 0.38
TYR 0.95 0.91 1.06 0.75 1.01 0.79 0.80
VAL 2.35 2.21 1.83 1.63 2.11 1.99 1.82
MET 1.83 1.82 1.60 1.41 1.89 1.84 1.70
CYS 0.54 0.58 0.45 0.34 0.49 0.48 0,45
ILE 2.22 2.06 1.69 1.49 1.93 1.75 1.58
LEU 2.26 2.09 1.69 1.46 1.89 1.72 1.56
PHE 1.57 1.55 1.36 1.18 1.58 1.52 1.41
TRP 0.59 0.59 0.52 0.47 0.63 0.61 0.56
LYS 1.63 1.57 1.27 1.13 1.48 1.44 1.33
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